A
free translation from Portuguese into English of Individual and Consolidated Financial Statements prepared in Brazilian currency
in accordance with accounting practices adopted in Brazil and in accordance with International Financial Reporting Standards (IFRS),
issued by International Accounting Standards Board (IASB).
NATURA
&CO HOLDING S.A. (“Natura &Co”), previously Natura Holding S.A., was incorporated on January 21, 2019 under
the Brazilian laws and is engaged in holding investments in other entities in the cosmetics, fragrances and personal hygiene business
through the development, manufacturing, distribution and sales of related products. Natura &Co and its subsidiaries is referred
to as the “Company”.
The
brands under management by the Company include "Natura", “Avon”, "The Body Shop" and "Aesop".
In addition to using the retail market, e-commerce, business-to-business (B2B) and franchises as product sales channels, its subsidiaries
are engaged in the direct sales channel, through consultants that act as sales representatives of the Natura and Avon brands.
In
December 2019, Natura &Co became the holder of 100% of the shares of Natura Cosméticos S.A. (“Natura”),
under the ticker NATU3. Accordingly, since December 18, 2019, (“NATU3”) shares stopped being traded at B3 and (“NTCO3”)
shares started to be traded at B3's Novo Mercado segment. After several restructuring activities carried out for the acquisition
process of Avon Products, Inc. (“Avon”), which was completed on January 3, 2020 (note 4), the Natura &Co became
the holding company of the Natura Group. Additionally, on January 6, 2020, the Natura &Co began trading American Depositary
Receipts (ADRs) on the New York Stock Exchange (“NYSE”), under the ticker “NTCO”.
The
individual and consolidated financial statements have been prepared and are being presented in accordance with accounting practices
adopted in Brazil, which comprise the rules of the Brazilian Securities and Exchange Commission (“CVM”) and the standards
of the Brazilian Accounting Standards Committee (“CPC”) and in accordance with the International Financial Reporting
Standards (“IFRS”) issued by the International Accounting Standards Board (“IASB”), and by the statements
from the Brazilian Corporation Law. The financial statements show all the relevant information specific to the financial statements,
and only that, which are consistent with those used by Management.
The
comparative historical consolidated information presented, for the statements of income, comprehensive income, changes in equity,
cash flows and added value for the year ended December 31, 2019, do not include information from the subsidiary Avon Products Inc.,
since the Business Combination was completed on January 3, 2020.
The
financial statements were approved by the Board of Directors and authorized for issuance on the meeting held on March 3, 2021.
The
individual and consolidated financial statements were prepared based on the historical cost, except for derivative financial instruments,
financial investments and carbon credits recognized in other current and non-current assets that were measured at fair value and
are expressed in thousands of Brazilian Reais (“R$”), rounded to the nearest thousand, as well as the disclosure of
amounts in other currencies, when necessary, were also expressed in thousands. Items disclosed in other currencies are duly identified,
whenever applicable.
The
main accounting policies applied in the preparation of these individual and consolidated financial statements are defined below.
These policies have been applied consistently in all years presented, with the exception of (i) the presentation of segment information
(note 26), which changed as a result of the acquisition of Avon (note 4) and (ii) the application of the practical expedient related
to benefits granted in lease agreements that occurred as a direct consequence of the Covid-19 pandemic.
The
Company presents assets and liabilities in the statement of financial position based on current/non-current classification. An
asset is current when it is (i) expected to be realized or intended to be sold or consumed in the normal operating cycle; (ii)
held primarily for the purpose of trading; (iii) expected to be realized within twelve months after the reporting period; or (iv)
cash or cash equivalent unless restricted from being exchanged or used to settle a liability for at least twelve months after the
reporting period. All other assets are classified as non-current.
A liability
is current when (i) it is expected to be settled in the normal operating cycle; (ii) it is held primarily for the purpose of trading;
(iii) it is due to be settled within twelve months after the reporting period; or (iv) there is no unconditional right to defer
the settlement of the liability for at least twelve months after the reporting period. The Company classifies all other liabilities
as non-current.
Deferred
tax assets and liabilities are classified as non-current assets and liabilities, as disclosed on note 3.18.
The
items included in the financial statements of the Company and each of the companies included in the consolidated financial statements
are measured using the currency of the main economic environment in which each the companies operates ("functional currency").
Foreign
currency transactions, that is, any currency other than the functional currency, are converted into the functional currency of
the entities included in these consolidated financial statements using the exchange rates prevailing on the dates of the transactions.
The financial statements are presented in thousands of Brazilian Reais (R$), corresponding to the functional currency of the Company's
presentation.
Balance
sheet account balances are remeasured using the exchange rates prevailing at the end of the reporting period. Foreign exchange
gains and losses arising on the settlement of such transactions and the remeasured of monetary assets and monetary liabilities
denominated in foreign currency are recognized in the statement of income, as “Financial income” and “Financial
expenses”.
In
preparing the consolidated financial statements, the statement of income and statement of cash flows and all other changes of assets
and liabilities of foreign subsidiaries, whose functional currency is not the Brazilian Real, are translated into Brazilian Reais
at the monthly average exchange rates, which approximates the exchange rate in effect on the date of the transactions.
The
balance sheet is translated into reais at the exchange rate prevailing at the reporting date. The effects of exchange rate variations
resulting from these translations are presented under the Other Comprehensive Income (“OCI”) in the statement of comprehensive
income, and in equity.
The
translation calculation is different for Natura Cosméticos S.A. – Argentina (“Natura Argentina”), which
became a hyperinflationary economy as of July 1, 2018 (see below), in which the balance sheet is translated into Brazilian Reais
at the exchange rates prevailing at the reporting date.
Starting
on July 2018, Argentina has been considered a hyperinflationary economy. As per CPC 42 - Financial Reporting in Hyperinflationary
Economies (IAS 29), the non-monetary assets and liabilities, equity items and the statement of income of the subsidiary Natura
Argentina, whose functional currency is the Argentinean peso, are adjusted so that the figures are reported in the monetary measurement
unit at the reporting date. The monetary
unit considers the effects measured by the Consumer Price Index (“IPC”) in
Argentina starting January 1st, 2017, and Argentina’s Domestic Retail Price Index (“IPIM”) up to December 31,
2016. Consequently, as required by CPC 42 (IAS 29), the operating results of the subsidiary Natura Argentina must be disclosed
as highly inflationary starting from July 1, 2018 (with reflections from January 1st, 2018, year in which the existence of hyperinflation
was first identified).
Non-monetary
assets and liabilities recorded at historical cost and equity items of Natura Argentina were adjusted for inflation based on the
aforementioned indices, and effects of hyperinflation resulting from changes in the overall purchasing power were presented in
the statement of income. The statement of income is adjusted at the end of each reporting period based on the variation in the
general price index for the period.
The
net effect of inflation adjustment in 2020 on (i) non-monetary assets and liabilities, (ii) items in the statement of changes in
equity, and (iii) statement of income, was presented in a specific line for hyperinflation as finance expenses (see note 30).
For
the translation of the accounting balances of the subsidiary Natura Argentina to the presentation currency (R$) used in the Company's
individual and consolidated financial statements, the following procedures, as required by CPC 02 (R2) - The effects of changes
in foreign exchange rates (IAS 21), were adopted:
The
accumulated inflation for the year ended December 31, 2020 was 36.1% (54.5% as at December 31, 2019), as per IPC index.
As
of December 31, 2020, the application of CPC 42 (IAS 29) resulted in (i) a negative impact on the financial expenses of R$ 20,625
(R$ 13,947 as at December 31, 2019), and (ii) a negative impact on net income for the year of R$ 106,206 (R$ 68,940 as at December
31, 2019).
The
translation of the statement of income at the exchange rate on the reporting date, instead of average monthly exchange rate of
the year, resulted in a positive impact on OCI for the fiscal year ended December 31, 2020 of R$ 32,160 (R$ 17,666 as at December
31, 2019).
The following procedures are
applied in the preparation of the consolidated financial statements:
The Company controls an entity
when it is exposed to, or is entitled to, the variable returns arising from its involvement with the entity and can affect those
returns by exercising its power over the entity. The financial statements of subsidiaries are included in the consolidated financial
statements from the date when the Company obtains control until the date when the control ceases to exist. The Company has interests
in subsidiaries only.
In the individual financial
statements, the investments in subsidiaries are accounted for using the equity method. The financial statements of the subsidiaries
are prepared as at the same reporting date as the parent company. Whenever necessary, adjustments are made to suit subsidiaries
accounting policies to those of the Company.
In accordance with the equity
method, the portion attributable to the Company on the net profit or loss for the year of these investments is recorded in the
statement of income of the parent company under the line “Equity income”. All intra-group balances, income and expenses
and unrealized gains and losses arising from intra-group transactions are eliminated completely. The OCI of subsidiaries is recorded
directly in the Company's equity under the item “OCI”.
Below is a list of the Company's
subsidiaries as of December 31, 2020 and 2019:
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
|
Ownership - %
|
|
2020
|
2019
|
Direct ownership:
|
|
|
Avon Products, Inc.
|
100.00
|
-
|
Natura Cosméticos S.A.
|
100.00
|
100.00
|
Natura &Co International S.à r.l.
|
100.00
|
-
|
In the preparation of the consolidated
financial statements, financial statements as at the same reporting date and consistent with the Company's accounting policies
were used. Investments were eliminated in proportion to the investor's interest in shareholders' equity and in the results of subsidiaries,
assets and liabilities balances, income and expenses and unrealized results, net of income tax and social contribution, resulting
from operations between the companies.
Direct subsidiaries activities
are as follows:
|
Ø
|
Natura Cosméticos S.A.: is a publicly-held corporation, established in accordance with the
laws of the Federative Republic of Brazil on June 6, 1993, for an indefinite term. Founded in 1969 in the Federal State of São
Paulo, Brazil, it is among the ten largest direct sales companies in the world. Under the Natura brand, most of products are developed
from natural ingredients originating from Brazilian biodiversity and distributed predominantly through direct sales by independent
beauty consultants. The subsidiary's focus is the sale of cosmetics and fragrances in general. It also operates through e-commerce
and has an expanded network of its own physical stores, with 61 stores in Brazil (43 in 2019), 7 stores abroad (France, Argentina
and Chile) in 2020 (9 stores in 2019), and 474 franchised stores (256 in 2019). The Body Shop International Limited (The Body Shop)
e Emeis Holding Pty Ltd. (Aesop) subsidiaries are also classified in this entity.
|
|
Ø
|
Avon Products, Inc.: a global manufacturer and marketer of beauty and related products, with operations
started in 1886 and established under the laws of the State of New York in the United States of America on January 27, 1916. It
conducts its business in the beauty sector and other consumer products through direct selling companies to create, manufacture
and market beauty and non-beauty products. Its business is carried out mainly through one channel: direct selling.
|
|
Ø
|
Natura &Co International S.à r.l.: company established in 2020 with the purpose of acquiring,
managing and selling stakes in national and foreign companies, in addition to raising and lending funds to other entities consolidated
by the Company.
|
|
b)
|
Ownership interest of non-controlling shareholders
|
The Company opted to measure
any non-controlling interest initially by the proportionate interest in acquiree’s identifiable net assets on the acquisition
date. Changes in the Company’s interest in a subsidiary that do not result in loss of control are recorded as “Transactions
with shareholders” in the statement of changes in equity.
As at December 31, 2020, and
2019, there are no subsidiaries directly or indirectly controlled that have significant interests held by non-controlling shareholders.
|
3.4
|
Business combinations and goodwill
|
Business combinations (except
for those involving entities under common control) are accounted for by applying the acquisition method. The consideration transferred
is measured at fair value as at the date of the acquisition, as well as the identifiable assets acquired, and liabilities assumed.
The consideration transferred does not include amounts related to the settlement of pre-existing relationships, which are generally
recognized in the statement of income for the year.
The Company determines that
it has acquired a business when the acquired set of activities and assets include an input and a substantive process that together
significantly contribute to the ability to create outputs. The acquired process is considered substantive if it is critical to
the ability to continue producing outputs, and the inputs acquired include an organized workforce with the necessary skills, knowledge,
or experience to perform that process or it significantly contributes to the ability to continue producing outputs. The financial
assets and liabilities assumed are assessed for appropriate classification and designation in accordance with the contractual terms,
economic circumstances and pertinent conditions as at the acquisition date.
Acquisition-related costs are
recorded as expenses as incurred and recognized as other operating expenses. Any goodwill arising from the transaction is tested
annually for impairment, and when circumstances indicate that the carrying value may be impaired.
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
Goodwill is initially measured
at cost, as the excess of the aggregate amount of (i) the consideration transferred, measured at fair value; (ii) the amount of
any non-controlling interest in the acquiree; and (iii) in a business combination achieved in stages, the fair value of the acquirer’s
previously held equity interest in the acquiree at the acquisition-date; over the net of the amounts of the identifiable assets
acquired and the liabilities assumed. When this aggregate amount is lower than the net of the amounts of the identifiable assets
acquired and the liabilities assumed, a gain on a bargain purchase is recognized immediately in the statement of income. Subsequently,
goodwill is measured at cost less any accumulated impairment losses. For the purpose of impairment testing, goodwill acquired in
a business combination is, from the acquisition date, allocated to each of the Company’s cash-generating units (“CGU”)
that are expected to benefit from the combination, irrespective of whether other assets or liabilities of the acquiree are assigned
to those units.
In a business combination involving
entities under common control, in which all of the combining entities or business are ultimately controlled by the same party or
parties both before and after the business combination, and that control is not transitory, the Company applies the predecessor
accounting method.
When applying this method, the
financial statements consider the historical accounting records of the acquired entity as equivalent to the Company's records,
reflecting (a) the operating results and equity position of the acquired company in previous years; (b) the operating results of
the Company and its acquired entity resulting from the restructuring; (c) the Company's assets and liabilities at historical cost
(and at the preceding fair value, when applicable); and (d) the earnings per share of the Company in all years presented (adjusted
when applicable). In these cases, therefore, there is no calculation of goodwill and any effect recorded in equity.
|
3.5
|
Cash and cash equivalents
|
Cash and cash equivalents are
maintained for the purpose of meeting short-term cash commitments, not for investment or other purposes. Cash and cash equivalents
include cash, demand deposits and short-term investments realizable within 90 days of the original date of the security or considered
to be highly liquid granted by the issuer or convertible into a known amount of cash and which are subject to an insignificant
risk of changes in value. Instruments that are not eligible for the classification of cash and cash equivalents, due to their liquidity,
maturity or even the risk of changes in value, are classified as short-term investments.
|
3.6
|
Financial instruments
|
Initial
recognition and measurement
Upon
initial recognition, a financial asset is measured at fair value and, subsequently, is measured at amortized cost, at fair value
through other comprehensive income (“FVTOCI”), or at fair value through profit or loss (“FVTPL”).
The
classification of financial assets at initial recognition depends on the characteristics of the contractual cash flows of the financial
asset and the business model of Company and its subsidiaries for the management of these financial assets. The business model for
managing financial assets refers to how the company manages its financial assets in order to generate cash flows. The business
model determines whether cash flows will result from collecting contractual cash flows, selling the financial assets, or both.
Financial assets classified and measured at amortized cost are held within a business model with the objective to hold financial
assets in order to collect contractual cash flows, while financial assets classified and measured at fair value through OCI are
held within a business model with the objective of both holding to collect contractual cash flows and selling.
Except
for trade accounts receivable that do not contain a significant financing component or to which the Company has applied the practical
expedient, the Company initially measures a financial asset at its fair value plus transaction costs, in the case of financial
asset not measured at fair value through profit or loss. In general, all financial assets are subsequently measured at fair value
through profit or loss.
Subsequent
measurement
Financial
assets at amortized cost
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
Financial assets at amortized
cost are subsequently measured using the effective interest method and are subject to impairment analysis. Gains and losses are
recognized in the statement of income when the asset is derecognized, modified, or impaired.
The financial assets of the Company
and its subsidiaries classified as at amortized cost include trade accounts receivable, other current assets (except for carbon
credits measured at fair value, as disclosed in note 3.9) and non-current assets balances (see note 6.6).
Financial
assets at fair value through OCI (debt instruments)
For debt instruments at fair
value through OCI, interest income, foreign exchange remeasurement and impairment losses or reversals are recognized in the statement
of income and calculated in the same manner as for financial assets measured at amortized cost. The resulting changes in fair value
are recognized in OCI; upon derecognition, the cumulative fair value change recognized in OCI is recycled to profit or loss. The
Company and its subsidiaries do not hold any financial asset classified under this category.
Financial
assets classified as at fair value through OCI (equity instruments)
Upon initial recognition, the
Company can elect to irrevocably classify its equity investments as equity instruments designated at fair value through OCI when
they meet the definition of equity under CPC 39 / IAS 32- Financial Instruments: Presentation and are not held for trading. Classification
is determined on an instrument-by-instrument basis.
Gains and losses on these financial
assets are never recycled to profit or loss. Dividends are recognized as other operating income (expenses), net, in the statement
of income when the right of payment has been established, except when the Company benefits from such proceeds as a recovery of
part of the financial asset’s cost, in which case, such gains are recorded in OCI. Equity instruments classified as at fair
value through OCI are not subject to impairment assessment. The Company and its subsidiaries do not hold any financial asset classified
under this category.
Financial
assets at fair value through profit or loss
Financial assets at fair value
through profit or loss are carried in the statement of financial position at fair value with net changes in fair value recognized
in the statement of income. This category includes derivative instruments and short-term investments which the Company and its
subsidiaries had not irrevocably elected to classify as at fair value through OCI.
Reassessment only occurs if there
is either a change in the terms of the contract that significantly modifies the cash flows that would otherwise be required or
a reclassification of a financial asset out of the fair value through profit or loss category.
Derecognition
(write-off) of financial instruments
A financial asset (or, where
applicable, a part of a financial asset or part of a group of similar financial assets) is derecognized when the rights to receive
cash flows from the asset have expired, when the Company and its subsidiaries transfer its rights or risk to receive cash flows
of the asset or when the Company and its subsidiaries have assumed an obligation to pay the full amount of received cash flows,
without significant delay to a third party under an on-lending agreement and either (i) the Company and its subsidiaries transfer
substantially all risks and benefits of the asset, or (ii) the Company and its subsidiaries neither transferred nor retained substantially
all risks and benefits of the asset, but transferred the asset control.
When the Company and its subsidiaries
transfer its rights to receive cash flows of an asset or execute an on-lending agreement, it assesses whether, and at which extent,
they have retained the risks and benefits of ownership. When the Company and its subsidiaries neither transfers or retains substantially
all risks and benefits of the asset, nor transferred the control over the asset, the Company and its subsidiaries continue to recognize
the asset transferred to the extent of its continued involvement. In this case, the Company and its subsidiaries also recognize
an associated liability. The transferred asset and the associated liability are measured on a basis that reflects the rights and
obligations that the Company and its subsidiaries have retained.
Impairment
of financial assets
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
The
Company and its subsidiaries recognize an allowance for expected credit losses (“ECL”) for all debt instruments not
held at fair value through profit or loss. ECLs are based on the difference between the
contractual cash flows due in accordance with the contract and all the cash flows that the Company and
its subsidiaries expect to receive, discounted at an approximation of the original effective
interest rate.
ECLs are recognized in two stages.
For credit exposures for which there has not been a significant increase in credit risk since initial recognition, ECLs are provided
for credit losses that result from default events that are possible within the next 12-months (a 12-month ECL). For credit exposures
for which there has been a significant increase in credit risk since initial recognition, a loss allowance is required for credit
losses expected over the remaining life of the exposure (a lifetime ECL), irrespective of the timing of the default.
For trade accounts receivable,
the Company and its subsidiaries apply a simplified approach in calculating ECLs. Therefore, the Company and its subsidiaries do
not track changes in credit risk, but instead recognize a loss allowance based on lifetime ECLs at each reporting date. The Company
and its subsidiaries have recorded a provision that is based on its historical credit loss experience, adjusted for forward-looking
factors specific to the debtors and the economic environment. Further details are disclosed in note 5.6.
The Company and its subsidiaries
consider a financial asset in default when internal or external information indicates that the Company is unlikely to receive the
outstanding contractual amounts in full. A financial asset is written off when there is no reasonable expectation of recovering
the contractual cash flows.
|
3.6.2
|
Financial liabilities
|
Initial recognition
and measurement
All financial liabilities are
recognized initially at fair value and, in the case of borrowings, financing and debentures, net of directly attributable transaction
costs. The Company and its subsidiaries’ financial liabilities include borrowings, financing and debentures (note 20), derivative
financial instruments (note 6) and trade accounts payable and reverse factoring operations (note 21).
Subsequent
measurement
For purposes of subsequent measurement,
financial liabilities are classified in two categories: (i) financial liabilities at fair value through profit or loss; or (ii)
financial liabilities at amortized cost.
Financial
liabilities at fair value through profit or loss
Financial liabilities at fair
value through profit or loss include financial liabilities held for trading and financial liabilities classified upon initial recognition
as at fair value through profit or loss.
Financial liabilities are classified
as held for trading if they are incurred for the purpose of repurchasing in the near term. This category also includes derivative
financial instruments entered into by the Company that are not designated as hedging instruments in hedge relationships as defined
by CPC 38 / IAS 39 – Financial Instruments. Separated embedded derivatives are also classified as held for trading unless
they are designated as effective hedging instruments.
Gains or losses on liabilities
held for trading are recognized in the statement of income.
Financial liabilities designated
upon initial recognition at fair value through profit or loss are designated at the initial date of recognition, and only if the
criteria in CPC 48 (IFRS 9) are satisfied. The Company has not designated any financial liability as at fair value through profit
or loss, except for derivatives and carbon credits (notes 3.6.3 and 3.9), respectively.
Financial
liabilities at amortized cost
This
is the most relevant category for the Company and its subsidiaries.
After initial recognition, interest-bearing borrowings and financing are subsequently measured at amortized cost using the effective
interest method. Gains and losses are recognized in profit or loss when the liabilities are derecognized as well as through the
effective interest rate amortization process.
Amortized cost is calculated
by considering any premium or discount on acquisition and fees or costs that are an integral part of the effective interest method.
The effective interest amortization is included as finance costs in the statement of income.
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
This category generally applies
to borrowings and financing granted and contracted, subject to interest, included in note 20.
Derecognition
A financial liability is derecognized
when the obligation under the liability is discharged, cancelled or expires. When an existing financial liability is replaced by
another from the same lender on substantially different terms, or the terms of an existing liability are substantially modified,
such an exchange or modification is treated as the derecognition of the original liability and the recognition of a new liability.
The difference in the respective carrying amounts is recognized in the statement of income.
Offsetting
of financial instruments
Financial assets and financial
liabilities are offset, and the net amount is reported in the statement of financial position if there is a currently enforceable
legal right to offset the recognized amounts and there is an intention to settle on a net basis, to realize the assets and settle
the liabilities simultaneously.
The offsetting of financial instruments
is also applied to bank balances subject to the central treasury management system (“cash pooling”) instituted with
the financial institution, in which the current account positions of the Company and its subsidiaries (including overdraft balances)
they are offset since the Company has a legally enforceable right to settle at the net amount and intends to settle the positions
on a net basis.
|
3.6.3
|
Derivative financial instruments
|
Derivative instruments transactions
contracted by the Company and its subsidiaries consist of swaps and non-deliverable forwards (“NDF”) intended exclusively
to hedge against the foreign exchange risks related to balance sheet positions, acquisitions of inputs and property, plant and
equipment, forecasted exports and forecasted foreign-denominated cash outflows for capital increases in foreign subsidiaries.
They are measured at fair value,
and changes in fair value are recognized through profit or loss, except when they are designated as cash flow hedges, to which
changes in fair value are recorded in OCI.
The fair value of derivative
instruments is measured by the treasury departments of the Company and its subsidiaries based on information on each contracted
transaction and related market inputs as at reporting date, such as interest and exchange rates.
For the purpose of hedge accounting,
hedges are classified as (i) fair value hedges when hedging the exposure to changes in the fair value of a recognized asset or
liability or an unrecognized firm commitment; (ii) cash flow hedges when hedging the exposure to variability in cash flows that
is either attributable to a particular risk associated with a recognized asset or liability or a highly probable forecast transaction
or the foreign currency risk in an unrecognized firm commitment; or (iii) hedges of a net investment in a foreign operation.
Even with the adoption of CPC
48 / IFRS 9, the Company and its subsidiaries opted to maintain the hedge accounting practice in accordance with CPC 38 / IAS 39,
according to the transition method provided for in item 7.2.21 of CPC 48 / IFRS 9.
At the inception of a hedge
relationship, the Company and its subsidiaries formally designate and document the hedge relationship to which it wishes to apply
hedge accounting, the risk management objective and the strategy for undertaking the hedge.
The
documentation includes identification of the hedging instrument, the hedged item, the nature of the risk being
hedged and how the Company will assess the effectiveness of changes in the hedging instrument’s
fair value in offsetting the exposure to changes in the hedged item’s fair value or cash flows attributable to the hedged
risk. Such hedges are expected to be highly effective in achieving offsetting changes in fair value or cash flows and are assessed
on an ongoing basis to determine that they actually have been highly effective throughout the financial reporting periods for which
they were designated.
During
the years ended on December 31, 2020 and 2019, the Company did not enter transactions related to hedge of fair value or hedge of
net investment. Cash flow hedges that meet all the qualifying criteria for hedge accounting are accounted for as described below.
Cash
flow hedges
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
Consists in providing hedge
against variation in cash flows attributable to a specific risk related to a known asset or liability or a highly probable forecast
transaction and that may affect profit or loss.
The effective portion of changes
in fair value of derivative instruments that is designated and qualified as cash flow hedge is recognized in OCI and accumulated
in the item “Gain (loss) from cash flow hedge operations” and “tax effect on gain (loss) from cash flow hedge
operations”. In a cash flow hedge, the effective portion of gain or loss from the hedge instrument is recognized directly
in OCI, in equity, while the ineffective portion of hedge is immediately recognized in finance income (expenses).
For
the years ended on December 31, 2020 and 2019, the Company and its subsidiaries used
derivative financial instruments, applying cash flow hedge accounting and, as disclosed in note 6.6, for hedge against the risk
of change in exchange rates related to borrowings in foreign currency and purchase and sale transactions in foreign currency and
intercompany borrowings operations that (i) are highly related to the changes in the market value of the hedged item, both at the
beginning as well as during contract term (effectiveness between 80% and 125%), (ii) have documentation of the operation, hedged
risk, risk management process and methodology used in assessing effectiveness, and (iii) are considered effective to reduce the
risk related to the exposure to be hedged. It allows the application of the hedge accounting methodology, with their fair value
measurement effect being recognized in equity and from their realization, on profit or loss in the line item related to the hedged
item.
Hedge
accounting is discontinued when the Company and its subsidiaries terminate
the hedge relationship, the hedge instrument matures or is sold, revoked or executed, or no longer qualifies to hedge accounting.
Any gains or losses recognized in OCI and accumulated in equity up to that date remain in equity and are recognized when the forecasted
transaction is eventually recognized in profit or loss.
If a planned transaction results
in the subsequent recognition of a non-financial asset or liability, the cumulative gain or loss in OCI is recycled to profit or
loss during the same year for which the non-financial asset acquired or non-financial liability assumed affects the profit or loss.
For example, when the non-financial asset is depreciated or sold.
On the other hand, if a planned
transaction results in the subsequent recognition of a financial asset or liability, the cumulative gain or loss in OCI is recycled
to profit or loss during the same period for which the financial asset acquired or financial liability assumed affects the profit
or loss. For example, when financial income or expense is recognized.
When the forecasted transaction
is no longer expected, cumulative gains or losses deferred in equity are immediately recognized in the statement of income.
The Company assesses, throughout
the hedge term, the effectiveness of its derivative financial instruments, as well as changes in their fair value.
For the years ended December
31, 2020 and 2019, there were no losses related to the ineffective portion recognized in statement of income. The fair values of
derivative financial instruments are disclosed in note 6.6.
|
3.7
|
Trade accounts receivable
|
Trade
accounts receivable correspond to amounts receivable for the sale of goods and services in the normal course of the activities
of the Company and its subsidiaries and are recognized
to the extent that the consideration that is unconditional is due by the customer (that is, only the passage of time required before
payment of the consideration is due).
Inventories are valued at the
lower of cost and net realizable value. Net realizable value is the estimated selling price in the ordinary course of business,
less estimated costs of completion and the estimated costs necessary to make the sale.
The Company and its subsidiaries
consider the following items when determining its provision for inventory losses: discontinued products, products with slow turnover,
expired products or products nearing the expiration date and products that do not meet quality standards, recorded as “Cost
of sales”.
|
3.9
|
Carbon Credits – Carbon Neutral Program
|
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
In
2007, the Company and its subsidiaries assumed a commitment
to be a Carbon Neutral company, which is to neutralize its emissions of greenhouse gas (“GHG”), throughout its production
chain, from extraction of raw materials to post- consumption. The commitment, which currently refers only to operations under the
Natura brand, is not a legal obligation, since Brazil does not have a reduction target, despite being a signatory to the Kyoto
Protocol. For this reason, it is considered a constructive obligation under CPC 25 / IAS 37 – Provisions, Contingent Liabilities
and Contingent Assets, which requires the recognition of a provision in the financial statements if it is subject to disbursement
and measurable.
The liability is estimated through
annually audited inventories of carbon emissions and measured at fair value based on the market price for the acquisition of licenses
for neutralization. On December 31, 2020, the balance recorded as "Other non-current liabilities" (see note 24), refers
to the total carbon emissions during the period of 2007 to 2020 that have not yet been offset by corresponding projects and therefore
no execution of the carbon certificate.
The Company and its subsidiaries
elected to make purchases of carbon credits by investing in projects with environmental benefits arising from the voluntary market.
Thus, the costs will generate carbon credits after completion or maturation of these projects. Such expenses were recorded at their
respective fair value in the line item “Other current assets” (see note 15).
Upon effective delivery of the
related carbon credit certificates to the Company and its subsidiaries, the obligation of being carbon neutral is effectively fulfilled;
therefore, the asset balances are offset against those of the liabilities.
The difference between the carrying
amounts of assets and liabilities as at December 31, 2020 refers to the amount of cash disbursed in advance for investments in
ongoing projects and, for this reason, not yet available for neutralization of emissions and offset of the liability.
|
3.10
|
Property, plant and equipment
|
Property, plant and equipment
is measured at cost of acquisition or construction, plus interest capitalized during construction period, in the case of qualifying
assets, and reduced by accumulated depreciation and impairment losses, if applicable. Depreciation methods, useful lives and residual
values are reviewed at each reporting date and adjusted, if applicable.
Land is not depreciated. Depreciation
of the other assets is calculated to reduce the cost of items of property, plant and equipment less their estimated residual values
using the straight-line method over their useful lives and is recognized in the statement of income. The estimated useful lives
of the assets are mentioned in note 17.
Gains and losses on disposals
are calculated by comparing the proceeds from the sale with the net carrying amount and are recognized in the statement of income
as “Other operating income (expenses), net”.
Subsequent expenditure is capitalized
only if it is probable that the future economic benefits associated with the expenditure will flow to the Company and its subsidiaries.
Intangible assets acquired separately
are measured on initial recognition at cost. The cost of intangible assets acquired in a business combination is their fair value
at the date of acquisition. Following initial recognition, intangible assets are carried at cost less any accumulated amortization
and accumulated impairment losses. Internally generated intangibles, excluding capitalized development costs, are not capitalized
and the related expenditure is reflected in profit or loss in the period in which the expenditure is incurred.
The useful lives of intangible
assets are assessed as either finite or indefinite.
Intangible assets with finite
lives are amortized over the useful economic life and assessed for impairment whenever there is an indication that the intangible
asset may be impaired. The amortization period and the amortization method for an intangible asset with a finite useful life are
reviewed at least at each reporting date. Changes in the expected useful life or the expected pattern of consumption of future
economic benefits embodied in the asset are considered to modify the amortization period or method, as appropriate, and are treated
as changes in accounting estimates. The amortization expense on intangible assets with finite lives is
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
recognized in the statement
of profit or loss in the expense category that is consistent with the function of the intangible assets.
Intangible
assets with indefinite useful lives are not amortized, but are tested for impairment annually, and
when circumstances indicate that the carrying value may be impaired, either individually
or at the CGU level. The assessment of indefinite life is reviewed annually to determine whether the indefinite life continues
to be supportable. If not, the change in useful life from indefinite to finite is made on a prospective basis.
An intangible asset is derecognized
upon disposal (i.e., at the date the receiver of the asset obtains control) or when no future economic benefits are expected from
its use or disposal. Any gain or loss arising upon derecognition of the asset (calculated as the difference between the net disposal
proceeds and the carrying amount of the asset) is included in the statement of profit or loss in the line item “other operating
income (expenses), net”.
The main classes of intangibles
are set forth below.
Licenses of software and enterprise
management systems acquired are capitalized and amortized according to the useful lives described in note 18, and maintenance costs
are recognized as expenses when incurred.
System acquisition and implementation
costs are capitalized as intangible assets when the asset is identified, when there is evidence that future economic benefits will
flow into the entity and when the asset is controlled by the Company, taking into consideration its economic and technologic viability.
The amounts incurred on software development recognized as assets are amortized under the straight-line method over its estimated
useful life. The expenditures related to software maintenance are expensed when incurred.
|
3.11.2
|
Trademarks and patents
|
Separately acquired trademarks
and patents are stated at their historical cost. Trademarks and patents acquired in a business combination are recognized at fair
value on the acquisition date. For trademarks and patents with definite useful lives, amortization is calculated on a straight-line
basis at the annual rates described in note 18.
|
3.11.3
|
Relationship with retail clients, franchisees and sub-franchisees
|
Relationships with retail clients,
franchisees and sub-franchisees acquired in business combinations are recognized at fair value on the acquisition date and their
amortization is calculated on a straight-line basis, based on rates shown in note 18.
|
3.11.4
|
Key money with defined useful life
|
Key money with defined useful
life is recorded at the acquisition cost and amortized on a straight-line basis during the rental period, as shown in note 18.
|
3.11.5
|
Developed technologies
|
Developed technologies include
technology for product development (including formulas, labeling data, manufacturing processes, regulatory approvals, product packaging
and designs) arising from business combination, and are recognized at fair value on the date of acquisition and its amortization
is calculated using the straight-line method, based on the rates shown in note 18.
|
3.12
|
Impairment of non-financial assets
|
The Company and its subsidiaries
assess, at each reporting date, whether there is an indication that an asset may be impaired. If any indication exists, or when
annual impairment testing for an asset is required, the Company and its subsidiaries estimates the asset’s recoverable amount.
An asset’s recoverable amount is the higher of an asset’s or the CGU fair value less costs of disposal and its value
in use. The recoverable amount is determined for an individual asset, unless the asset does not generate cash inflows that are
largely independent of those from other assets or groups of assets. When the carrying amount of an asset or CGU exceeds its recoverable
amount, the asset is considered impaired and is written down to its recoverable amount.
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
In assessing value in use, the
estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects the entity’s
weighted average cost of capital in which the generating cash unit operates, and that reflects the current perceptions of market
participants.
The Company bases its impairment
calculation on most recent budgets and forecast calculations, which are prepared separately for each of the Company’s CGU
to which the individual assets are allocated. These budgets and forecast calculations generally cover a period of five years. A
long-term growth rate is calculated and applied to project future cash flows after the fifth year.
Impairment losses are recognized
in the statement of profit or loss in expense categories consistent with the function of the impaired asset.
For assets excluding goodwill,
an assessment is made at each reporting date to determine whether there is an indication that previously recognized impairment
losses no longer exist or have decreased. If such indication exists, the Company estimates the asset’s or CGU recoverable
amount. A previously recognized impairment loss is reversed only if there has been a change in the assumptions used to determine
the asset’s recoverable amount since the last impairment loss was recognized. The reversal is limited so that the carrying
amount of the asset does not exceed its recoverable amount, nor exceed the carrying amount that would have been determined, net
of depreciation, had no impairment loss been recognized for the asset in prior years. Such reversal is recognized in the statement
of income.
Goodwill is tested for impairment
annually as at December 31, and when circumstances indicate that the carrying amount may be impaired.
Impairment is determined for
goodwill by assessing the recoverable amount of each CGU (or group of CGU) to which the goodwill relates. When the recoverable
amount of the CGU is less than it carrying amount, an impairment loss is recognized. Impairment losses relating to goodwill cannot
be reversed in future periods.
Intangible assets with indefinite
useful lives are tested for impairment annually as at December 31, at the CGU level, as appropriate, and when circumstances indicate
that the carrying value may be impaired.
On January 1, 2019, the Company
and its subsidiaries applied CPC 06 (R2) / IFRS16 - Leases, which introduced one sole lease model, replacing the concept of classifying
between operating and finance lease (previously according to IAS 17 / CPC 06 (R1) – Leases), which was applied by the Company
and its subsidiaries up to December 31, 2018.
The Company and its subsidiaries
assess at contract inception whether a contract is, or contains, a lease. That is, if the contract conveys the right to control
the use of an identified asset for a period in exchange for consideration. The Company and its subsidiaries (as a lessee) apply
a single recognition and measurement approach for all leases, except for short-term leases and leases of low-value assets. The
Company and its subsidiaries recognize lease liabilities to make lease payments and right-of-use assets representing the right
to use the underlying assets.
|
3.13.1
|
Right-of-use assets
|
Right-of-use assets are recognized
at the commencement date of the lease (i.e., the date the underlying asset is available for use). Right-of-use assets are measured
at cost, less any accumulated depreciation and impairment losses, and adjusted for any remeasurement of lease liabilities. The
cost of right-of-use assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments
made at or before the commencement date less any lease incentives received. Right-of-use assets are depreciated on a straight-line
basis over the shorter of the lease term and the estimated useful lives of the assets, disclosed in note 19.
The right-of-use assets are
also subject to impairment, as disclosed on note 3.12.
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
At the lease commencement date,
the Company and its subsidiaries recognizes lease liabilities measured at the present value of lease payments to be made over the
lease term. The lease payments include fixed payments less any lease incentives receivable, variable lease payments that depend
on an index or a rate, and amounts expected to be paid under residual value guarantees. The lease payments also include the exercise
price of a purchase option reasonably certain to be exercised by the Company and its subsidiaries and payments of penalties for
terminating the lease, if the lease term reflects the Company exercising the option to terminate the lease.
Variable lease payments that
do not depend on an index or a rate are recognized as expenses (unless they are incurred to produce inventories) in the period
in which the event or condition that triggers the payment occurs.
In calculating the present value
of lease payments, the Company and its subsidiaries use its incremental borrowing rate at the lease commencement date because the
interest rate implicit in the lease is not readily determinable. After the commencement date, the amount of lease liabilities is
increased to reflect the accretion of interest and reduced for the lease payments made. In addition, the carrying amount of lease
liabilities is remeasured if there is a modification, a change in the lease term, a change in the lease payments (i.e., changes
to future payments resulting from a change in an index or rate used to determine such lease payments) or a change in the assessment
of an option to purchase the underlying asset.
The Company’s and its
subsidiaries lease liabilities are disclosed in note 19.
|
3.13.3
|
Short-term leases and leases of low-value assets
|
The Company and its subsidiaries
apply the short-term lease recognition exemption to its short-term leases regardless of its nature (that is, those leases that
have a lease term of 12 months or less from the start date and do not contain a purchase option). The Company also applied the
lease of low-value assets recognition exemption for leases that, according to its policy, are considered of low value, regardless
of its nature. Lease payments on short-term leases and leases of low-value assets are recognized as an expense using the straight-line
basis over the lease term.
|
3.14
|
Non-current assets held for sale and discontinued operations
|
The Company and its subsidiaries
classify non-current assets and disposal groups as held for sale if their carrying amounts will be recovered principally through
a sale transaction rather than through continuous use. Non-current assets and disposal groups classified as held for sale are measured
at the lower of their carrying amount and fair value less costs to sell. Costs to sell are the incremental costs directly attributable
to the disposal of an asset (disposal group), excluding finance costs and income tax expense.
The criteria for held for sale
classification is regarded as met only when the sale is highly probable, and the asset or disposal group is available for immediate
sale in its present condition. Actions required to complete the sale should indicate that it is unlikely that significant changes
to the sale will be made or that the decision to sell will be withdrawn. Management must be committed to the plan to sell the asset
and the sale expected to be completed within one year from the date of the classification.
Property, plant and equipment
and intangible assets are not depreciated or amortized once classified as held for sale. Assets and liabilities classified as held
for sale are presented separately as current items in the statement of financial position.
A disposal group qualifies as
discontinued operation if it is a component of an entity that either has been disposed of, or is classified as held for sale, and:
(i) represents a separate major line of business or geographical area of operations; (ii) is part of a single coordinated plan
to dispose of a separate major line of business or geographical area of operations; or (iii) is a subsidiary acquired exclusively
for the purpose of resale.
Discontinued operations are
excluded from the results of continuing operations and are presented as a single amount as profit or loss after tax from discontinued
operations in the statement of income.
The amounts presented as held
for sale and discontinued operations come from Avon's business combination process. These amounts refer to the discontinuity of
the acquired company's operations in North America and reflect the costs incurred in resolving contingencies associated with that
operation. The Company presents these effects as part of its discontinued operations since it considers the discontinued operations
of the
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
subsidiary Avon as an extension of the Company and for assessing that this presentation reliably represents the essence
of the associated transaction.
Borrowing costs attributable
to the acquisition, construction or production of a qualifying asset that necessarily requires a significant effort to be ready
for its intended use or sale are capitalized as part of the cost of the corresponding asset. All other borrowing costs are expensed
in the period they are incurred. Borrowing costs consist of interest and other costs incurred by an entity related to a borrowing.
|
3.16
|
Trade accounts payables under a supply chain finance arrangement
|
The Company and its subsidiaries
enter in a supply chain finance arrangement with a financial institution to facilitate administrative procedures for suppliers
to advance receivables related to the routine purchases of the Company and its subsidiaries. In this operation, the financial institution
separately offers to pay the supplier in advance in exchange for a discount and, when there is the agreement between the bank and
the supplier (the decision to join this transaction is solely and exclusively of the supplier), the Company and its subsidiaries
pay the financial institution on the original payment date at the full-face value of the originating payable.
This operation does not change
the amounts, nature and timing of the liability (including previously agreed-upon terms, prices and conditions) and it does not
affect the Company and its subsidiaries with financial charges practiced by the financial institution, on performing a thorough
analysis of suppliers by category. There is not guarantee granted by the Company.
Additionally, the payments made
by the Company represent purchases of goods and services, are directly related to invoices from suppliers and do not change the
Company's cash flows. Thus, the Company and its subsidiaries continue to recognize the liability as a trade accounts payable and
these transactions are presented as operating activities in the statement of cash flows.
|
3.17
|
Provisions for risks
|
Provisions are recognized when
the Company and its subsidiaries have a legal or constructive obligation as a result of past events, and it is probable that an
outflow of resources embodying economic benefits will be required to settle the obligation, and its value can be reliably estimated.
Provisions are quantified at the present value of the expected outflow of resources embodying economic benefits to settle the obligations
using the appropriate discount rate according to risks related to the liability.
The provisions for tax, civil,
and labor risks are adjusted for inflation through the end of the reporting period to cover probable losses, based on the nature
of the risk and the opinion of the Company’s legal advisors.
Contingent assets are not recognized
by the Company and are only disclosed, in case of probable receipt of economic benefits. If it is practically certain that economic
benefits will be received, the asset and the corresponding gain are recorded in the financial statements of the year corresponding
to the change in the estimate.
A contingent liability recognized
in a business combination is initially measured at its fair value. Subsequently, it is measured at the higher of the amount that
would be recognized in accordance with the requirements for provisions above or the amount initially recognized less (when appropriate)
cumulative amortization recognized in accordance with the requirements for revenue recognition.
|
3.18
|
Current and deferred income tax and social contribution
|
Current income tax assets and
liabilities are measured at the amount expected to be recovered from or paid to the tax authorities based on the tax rates and
tax laws used to compute the amount are those that are enacted or substantively enacted at the reporting date in the countries
where the Company operates and generates taxable income. Management periodically assesses the tax treatment assumed in the determination
of taxes on profit with respect to situations in which the applicable tax regulation gives rise to interpretations that may be
different and considers whether it is likely that the tax authority would accept the uncertain tax treatment. The Company assesses
these taxes balances based on the most probable or expected value, depending on which method is assessed as the one that provides
the best forecast for resolving the uncertainty.
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
The Company and its subsidiaries
have material uncertain tax positions, any of which an unfavorable outcome under litigation could result in a material adverse
impact to our financial statements.
In Brazil, they include the
corporate income tax (“IRPJ”) and the social contribution on net income (“CSLL”), which are calculated
based on taxable income by applying the 15% rate plus additional of 10% on taxable income exceeding R$ 240 for IRPJ and 9% for
CSLL and considers the offset of tax losses and tax loss carryforwards, limited to 30% of taxable income. Taxable income reflects
profit before taxes adjusted by non-taxable and non-deductible items (both temporary and permanent items).
Deferred taxes represent tax
debits and credits on temporary differences between tax base and accounting base of assets and liabilities on accrued tax losses.
Deferred tax and contribution assets and liabilities are classified as “non-current” as required by CPC 32 / IAS 12
– Income taxes.
The carrying amount of deferred
tax assets is reviewed at each reporting date and reduced to the extent that it is no longer probable that sufficient taxable profit
will be available to allow all or part of the deferred tax asset to be utilized. Unrecognized deferred tax assets are re-assessed
at each reporting date and are recognized to the extent that it has become probable that future taxable profits will allow the
deferred tax asset to be recovered.
Deferred tax assets and liabilities
are measured at the tax rates that are expected to apply in the year when the asset is realized or the liability is settled, based
on tax rates (and tax laws) that have been enacted or substantively enacted at the reporting date and reflect the uncertainties
relating to these taxes, when applicable.
Deferred tax assets and liabilities
are offset if there is a legal feasible right to offset tax liabilities against tax assets, and if they are related to taxes registered
by the same tax authority under the same taxable entity. Thus, for presentation purposes, tax asset and liability balances are
disclosed separately.
|
3.19
|
Borrowings and financing
|
Borrowings and financing are
initially recognized at fair value, net of transaction costs incurred and are, subsequently, measured at amortized cost. Any difference
between raised and settled the amounts is recognized in the statement of income, using the effective interest rate method during
the period in which the borrowings and financing are outstanding.
Borrowings and financing costs,
whether specific or not, that are directly attributable to the acquisition, construction or production of a qualifying asset in
accordance with the Company's policy, are capitalized as part of the asset’s cost when it is likely to result in future economic
benefits to the entity and that such costs can be reliably measured. Other borrowing costs are recognized as expenses in the period
in which they are incurred.
|
3.20.1
|
Short-term benefits
|
The obligations of short-term
benefits for employees are recognized as payroll expenses as the corresponding service is rendered. The liability is recognized
at the amount of the expected payment if the Company has a legal or constructive obligation to pay the amount due to services rendered
by the employee in the past and the obligation can be reliably estimated.
|
3.20.2
|
Profit sharing program
|
The Company and its subsidiaries
recognize a liability and an expense for its profit sharing program based on criteria that it considers the profit attributable
to its shareholders after certain adjustments and which is tied to the achievement of specific operational goals and objectives,
which are established and approved in the beginning of each year.
|
3.20.3
|
Defined contribution plans
|
Obligations to contribute to
defined contribution plans are recognized in the statement of income as personnel expenses when the related services are rendered
by employees. Contributions paid in advance are recognized as an asset to the extent that a cash refund or a reduction in future
payments is possible.
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
|
3.20.4
|
Defined benefit plans
|
The Company's net obligation
for defined benefit plans (retirement and post-employment health care) is calculated for each plan based on the estimated amount
of future benefit that the beneficiaries receive in return for services in exercises previous years. This amount is discounted
to its present value and is presented net of any plan asset’s fair value. The calculation of the defined benefit plan obligation
is carried out annually by a qualified actuary using the Projected Unit Credit Method. When the calculation results in a potential
asset for the Company, the asset to be recognized is limited to the present value of economic benefits available in the form of
future reimbursements or reductions in future plan contributions. To calculate the present value of economic benefits, any minimum
cost requirements are considered.
The current service cost and
accrued interest on the present value of the liability are recognized in the statement of income and the actuarial gains and losses,
generated by the remeasurement of the liability due to changes in actuarial assumptions, are recognized in OCI. In case of changes
or reductions in the plan, the effects of the cost of past services are recognized in the statement of income on its occurrence
date.
The Company's executives are
granted the following stock option plans, settled exclusively with its own shares:
|
ii)
|
Restricted stock plan, and
|
|
iii)
|
Strategy acceleration program.
|
The plans are measured at fair
value at the grant date. In determining the fair value, the Company uses an adequate valuation method, details of which are disclosed
in note 29.1.
The cost of transactions settled
with equity instruments is recognized, together with a corresponding increase in shareholders’ equity under the heading "Additional
paid-in capital", throughout the period in which the service conditions are fulfilled, ending on the date on which the employee
acquires the full right to the award (acquisition date). The cumulative expense recognized for equity instruments transactions
settled on each base date up to the acquisition date reflects the extent to which the vesting period has transpired and the Company’s
best estimate of the number of equity instruments to be acquired. The expense or credit of the period is recorded in the line item
"Selling or Administrative expenses" in the statement of income, depending on the internal department where the eligible
employee is allocated.
For the stock option plan and
the strategy-acceleration program, despite the expiration of the term for exercise, the recognized expense is not reversed since
the right has been acquired by executives.
When an award of equity instruments
settlement is cancelled (except when the cancellation occurs due to loss of right over the equity instrument for not fulfilling
the grants conditions), it is treated as if it had been acquired on the date of cancellation, and any expense not recognized is
registered immediately. This includes any award for which Company, or the counterparty have the option not to fulfill the non-acquisition
obligation. All cancellations of transactions settled with equity securities are treated in the same way.
The dilution effect of options
granted is reflected as additional share dilution in the calculation of diluted earnings per share (note 32).
|
3.22
|
Dividends and interest on equity
|
The proposed distribution of
dividends and interest on capital made by Management that is within the portion equivalent to the minimum mandatory dividend is
recorded in the line item “Dividends and interest on equity” in current liabilities, as it is considered as a legal
obligation provided for by the Company’s bylaws. However, the portion of dividends exceeding minimum dividends declared by
management after the reporting date, but before the authorization date for the issuing of the financial statements, is recognized
in the line item “Additional proposed dividend”, in shareholders' equity.
For corporate and accounting
purposes, interest on capital is stated as allocation of income directly in shareholders’ equity.
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
The Company’s own equity
instruments which are reacquired (treasury shares) are recognized at acquisition cost and deducted from shareholders' equity. No
gain or loss is recognized in profit or loss on the purchase, sale, issuance or cancellation of the Company's own equity instruments.
Government grants are recognized
where there is reasonable assurance that the grant will be received, and all attached conditions will be complied with. When the
grant relates to an expense item, it is recognized as income on a systematic basis over the periods that the related costs, for
which it is intended to offset, are accounted for. When the grant relates to an asset, it is recognized as income in equal amounts
over the expected useful life of the related asset.
Government grants received relate
to measures introduced by governments where the Company and its subsidiaries operate as a measure to mitigate the impacts of the
Covid-19 pandemic. Those grants are mostly related to payroll assistance resulting from job maintenance programs offered by different
jurisdictions in which the Company and its subsidiaries operate and totaled R$ 192,686 (before income taxes), recognized in the
statement of income during the year 2020 (no subsidies of this nature were received in 2019). There are no unfulfilled conditions
or contingencies linked to these grants.
The information per business
segment is presented in note 26 in a manner consistent with the internal report provided to the chief operating decision maker.
The main decision-making body
of the Company, which is responsible for defining the allocation of resources and for the performance assessment of the operating
segments, is the Board of Directors.
Additionally, the Company has
a Group’s Operational Committee (“GOC”), that includes the CEOs of Natura &Co, Natura &Co Latam, Avon
International, The Body Shop and Aesop, in addition to representatives of key business areas (Finance, Human Resources, Business
Strategy and Development, Legal, Innovation and Sustainability, Operations and Corporate Governance), which advises the Board of
Directors and is responsible for, among others things, monitoring the implementation of short and long-term strategies and making
recommendations to the Board of Directors regarding the management of the Company, from the perspective of its results, allocation
of resources among business units, cash flow and talent management.
|
3.26
|
Revenue from contract with customer
|
Revenue
from contracts with customer is recognized when control of the goods or services are transferred to the customer at an amount that
reflects the consideration to which the Company and its subsidiaries expect
to be entitled in exchange for those goods or services. The Company and its subsidiaries
have concluded that it is the principal in its revenue arrangements.
The Company considers whether
there are other promises in the contract that are separate performance obligations to which a portion of the transaction price
needs to be allocated. In determining the transaction price, the Company considers the effects of variable consideration, existence
of a significant financing component, noncash consideration, and consideration payable to the customer (if any).
Below are set forth the nature
and other considerations on the transaction price and the moment in which the performance obligation is fulfilled for each of the
main revenue streams.
Revenue from sales is generated
by sales to the Company’s subsidiaries consultants (our customers) based on the fair value of consideration received/receivable,
excluding discounts, rebates and taxes or charges on sales. Revenue from sales is recognized when the performance obligation is
fulfilled, i.e., when the promised product is physically delivered, and the consultant obtains control over the product.
Revenue from sales is generated
and accrued initially in the sales subsidiary ledger of the Company’s subsidiaries from the moment when the dispatch slip
is issued in the customers’ name. However, since revenues are recorded only when the final delivery of products actually
occurs, the Company registers a provision to eliminate the amount of revenue related to products dispatched and not yet received
by the consultants on each reporting date.
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
|
3.26.2
|
Direct sales – Additional charges and penalties for late payments
|
The Company’ subsidiaries
Natura, Avon and The Body Shop International Limited (“The Body Shop” or “TBS”) charges its customers (consultants)
additional charges and penalties for late payments in the settlement of sales receivables. Due to the level of uncertainty in collecting
these amounts (variable consideration), the subsidiaries recognize revenue from additional charges and penalties for late payments
only upon its collection.
In direct and indirect subsidiaries,
responsible for Natura, Avon, Aesop and TBS brands, which operate in the retail market, sales revenues are measured based on the
fair value of consideration received/receivable, excluding discounts, rebates and taxes or charges on sales. These revenues are
recognized when the performance obligation is fulfilled, i.e., when the promised product is physically transferred, and the consumer
obtains control over the product.
|
3.26.4
|
Other performance obligation
|
|
3.26.4.1
|
Loyalty program (points campaign)
|
The Company subsidiaries offer
points campaign (loyalty program), in which customers accumulate points while buying the Company's products to be exchanged (redeemed)
for products in the future. Measurement of points is based on their expected cost, plus a margin. The amount allocated to the loyalty
program is deferred and the revenue is recognized upon redemption of the points accumulated by Natura, Avon and TBS consultants
for retail and direct sales, or when they expire or are no longer considered redeemable. The loyalty program points are valid for
up to approximately 5 months (6 cycles).
|
3.26.4.2
|
Program for recognition of Natura and Avon consultants’ performance
|
The Company’s subsidiaries
have performance recognition programs, in which it awards its consultants based on achievement of targets and objectives. The Company’s
subsidiaries believe that this performance recognition program has a high value and hence is considered a performance obligation.
Measurement of performance recognition programs is based on their expected cost, plus a margin. The amount allocated to performance
recognition programs is deferred and revenue is recognized when awards are delivered to the Company’s Consultants.
The Company and its subsidiaries
organize events to encourage and recognize the best Consultants. The Company and its subsidiaries believe that these events have
an added value for consultants, in addition to generating in them an expectation to participate in these events. Thus, the Company
believes that these events are a performance obligation. Measurement of events is based on their expected cost, plus a margin.
The amount allocated to events is deferred and the revenue is recognized when the event is held.
|
3.26.4.4
|
Franchises (courses, training and consulting/outfit and opening)
|
Upon execution of the agreement,
the Company charges from franchisees a fixed amount, part of which is allocated to courses, training and consultancy to train and
instruct the franchisee to sell “Natura” and “The Body Shop” brand products. In addition, other part of
the charged amounts refers to outfit (specific products to be used at the franchisee store) and inauguration (franchisee’s
store opening event). The Company and subsidiaries believe that these items represent a material right and, for such, they are
considered a performance obligation. Measurement is based on the market value of these items, which are initially recognized as
deferred revenue. When the franchisee’s store is opened, this deferred revenue is allocated to the statement of income.
|
3.26.4.5
|
Franchisees (advertising fund)
|
Upon the execution of the agreement,
the Company charges from franchisees a fixed amount, a part of which is for the advertising fund (monthly delivery of showcases).
The Company believes that this item represents a material right and, for such, it was considered a performance obligation. Measurement
is based on the market value of this item, which is initially recognized as deferred
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
revenue. This revenue is deferred and allocated
to the statement of income upon the delivery of showcases to the franchisees.
|
3.26.4.6
|
Franchises (brand-right of use)
|
Upon the execution of the agreement,
the Company’s subsidiaries charge from franchisees a fixed amount, part of which is for the use of the “Natura”
brand. The Company and its subsidiaries believe that this item represents a material right and, for such, it was considered a performance
obligation. Measurement is based on residual value, i.e., the remaining value after excluding the market value of courses, training
and consultancy services, outfit and inauguration, and the advertising fund. The amount is initially recognized as deferred revenue,
which is allocated to profit or loss, on a straight-line basis, over the term of the franchise agreement.
|
3.26.4.7
|
Royalties revenues
|
Sales by franchisees and sub-franchisees
of the subsidiary The Body Shop are recognized when performance obligations are satisfied, goods are transferred to the customer
and the customer is in control. The performance obligation is the license to operate in the market.
Revenues are allocated to the
license and are recognized over time, in accordance with the license agreement. Under IFRS 15 – Revenue from contract with
customer, the initial franchise fee is not considered a separate performance obligation and, as a result, the amounts charged to
the customer are therefore allocated to the license performance obligation and recognized over the term of the agreement.
|
3.26.4.8
|
Incentives related to “free-of-charge” products and promotional gifts
|
The Company and its subsidiaries
grant incentives related to “free-of-charge” products and promotional gifts for its customers (Natura and Avon Consultants
and/or end consumers). Since it is considered a material right, the Company and its subsidiaries recognize it as a performance
obligation. Considering that the delivery of products and the fulfillment of the performance obligation to delivery “free-of-charge”
products or promotional gifts occurs at the same time, the Company and its subsidiaries concluded that an allocation of prices
and monitoring these two performance obligations separately are not applicable. Thus, revenue is recognized when the physical transfer
of the product occurs, and the customer obtains control of the product.
Expenses and assets are recognized
net of sales taxes, except (i) when sales taxes incurred on the purchase of goods or services are not recoverable from the tax
authorities, in which case the sales tax is recognized as part of the acquisition cost. the asset or expense item, as the case
may be; (ii) when the amounts receivable and payable are presented together with the value of taxes on sales; and (iii) when the
net amount of taxes on sales, recoverable or payable, is included as a component of the amounts receivable or payable in the balance
sheet.
|
3.27.1
|
Non-inclusion of ICMS in the bases for calculating contributions to PIS and COFINS
|
The Company and its subsidiaries
filed lawsuits to challenge the non-inclusion of ICMS in the calculation basis of contributions to PIS and COFINS.
On March 31, 2017, the Company,
based on the conclusion of the judgment by the Plenary of the Supreme Federal Court, of Extraordinary Appeal No. 574.706 / PR,
in which it was defined by the system of general repercussion that the ICMS cannot compose the PIS and COFINS tax base, reversed
the provision set up in the amount of R$ 297,216 and started to exclude the amount of ICMS from contributions to PIS and COFINS
on a monthly basis. The Company's decision was based on the position of its legal advisors who understand that the Supreme Court's
judgment should be immediately applicable to all taxpayers and, therefore, the prospect of loss of shares is classified as remote.
Despite the fact that the Extraordinary
Appeal No. 574.706 / PR has no final judgment, considering that the Motion for Clarification with request for modulation of the
effect of the decision opposed by the PGFN is still pending judgment by the Supreme Federal Court, the Company, supported in the
opinion
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
of legal advisors, understands that (i) the decision of the Supreme Federal Court was categorical when determining that
“the ICMS - without any limitation - does not compose the calculation basis for the incidence of PIS and COFINS” and
(ii) due to elements proceedings in Extraordinary Appeal No. 574,706 / PR and in the lawsuits of the Company and its subsidiaries,
the risk of loss for possible discussion on the ICMS to be excluded from the calculation basis of contributions to PIS and COFINS
is classified as remote.
The Company and its subsidiaries
recognize tax credits arising from lawsuits for the exclusion of ICMS from the PIS and COFINS basis, as a result of the unappealable
conclusion of these lawsuits. Existing credits for the lawsuits that have not yet been concluded, are considered contingent assets
in the financial statements (note 23.3).
|
3.27.2
|
Concept of supplies for calculating credits of PIS and COFINS contributions
|
The Company and its subsidiaries
claim that PIS and COFINS credits are measured and calculated reliably and based on the best interpretation of current legislation
and the country's jurisprudential scenario, whose evolution is permanently assessed by the Company and its legal advisors.
|
3.28
|
Statement of added value
|
The purpose of this statement
is to disclose the wealth created by the Company and its subsidiaries and their distribution during a certain reporting period,
and is presented by the Company, as required by the Brazilian Corporate Law, as an integral part of its individual financial statements,
and as supplementary information of the consolidated financial statements, since this statement is not set forth nor mandatory
by IFRS.
The statement of added value
was prepared using information obtained in the same accounting records used to prepare the financial statements and pursuant to
the provisions of the Brazilian accounting standard CPC 09 - Statement of Added Value. The first part of the statement presents
the wealth created by the Company, represented by revenues (taxable gross revenue, including taxes levied thereon, other income,
and the effects of the expected credit losses), inputs acquired from third parties (cost of sales and purchase of materials, energy,
and services from third parties, including taxes levied at the time of the acquisition, the effects of impairment losses, and depreciation
and amortization), and the value added received from third parties (profit of equity method investees, financial income, and other
income). The second part of the statement presents the distribution of wealth among personnel, taxes, fees and contributions, lenders
and lessors, and shareholders.
|
3.29
|
New standards and interpretations issued but not yet effective
|
The new and amended standards
and interpretations that are issued, but not yet effective, up to the date of issuance of the Company’s and its subsidiaries
financial statements are disclosed below, except for those which, in Management's assessment, have no potential effect on the financial
statements. The Company and its subsidiaries intend to adopt these standards, if applicable, when they become effective.
|
3.29.1
|
Amendments to IAS 1 (CPC 26 (R1)): Classification of liabilities as current or non-current
|
In January 2020, the IASB issued
amendments to paragraphs 69 to 76 of IAS 1 - Presentation of Financial Statements (correlated to CPC 26 (R1)) to specify the requirements
for classifying liabilities as current or non-current. The amendments clarify: (i) what is meant by a right to defer settlement;
(ii) that a right to defer must exist at the end of the reporting period; (iii) that classification is unaffected by the likelihood
that an entity will exercise its deferral right; and (iv) that only if an embedded derivative in a convertible liability is itself
an equity instrument would the terms of a liability not impact its classification.
The amendments are effective
for annual reporting periods beginning after January 1st, 2023 and must be applied retrospectively. The Company and its subsidiaries
are currently assessing the impact the amendments will have.
|
3.29.2
|
Reference to the Conceptual Framework (CPC 00 (R2)), amendments to IFRS 3 (CPC 15 (R1))
|
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
In May 2020, the IASB issued
amendments to IFRS 3 – Business Combinations (correlated to CPC 15(R1)), “Business Combinations - Reference to the
Conceptual Framework”. The amendments are intended to replace a reference to the Framework for the Preparation and Presentation
of Financial Statements, issued in 1989, with a reference to the Conceptual Framework for Financial Reporting issued in March 2018
without significantly changing its requirements.
The Board also added an exception
to the recognition principle of IFRS 3 (CPC 15(R1)) to avoid the issue of potential “day 2” gains or losses arising
for liabilities and contingent liabilities that would be within the scope of IAS 37 (CPC 25) or IFRIC 21 – Levies (ICPC 19),
if incurred separately.
At the same time, the Board decided
to clarify existing guidance in IFRS 3 (CPC 15(R1)) for contingent assets that would not be affected by replacing the reference
to the Framework for the Preparation and Presentation of Financial Statements.
The amendments are effective
for annual reporting periods beginning after January 1st, 2022 and, although not having any current impact on the Company, they
may be applicable to new business combinations in the future.
|
3.29.3
|
IFRS 9 (CPC 48), Financial Instruments – Fees in the “10 per cent” test for derecognition
of financial liabilities
|
As part of its 2018-2020 annual
improvements to IFRS standards process the IASB issued amendment to IFRS 9 (CPC 48). The amendment clarifies the fees that an entity
includes when assessing whether the terms of a new or modified financial liability are substantially different from the terms of
the original financial liability. These fees include only those paid or received between the borrower and the lender, including
fees paid or received by either the borrower or lender on the other’s behalf. An entity applies the amendment to financial
liabilities that are modified or exchanged on or after the beginning of the annual reporting period in which the entity first applies
the amendment.
The amendment is effective for
annual reporting periods beginning on or after January 1st, 2022. The Company will apply the amendments to financial liabilities
that are modified or exchanged on or after the beginning of the annual reporting period in which it first applies the amendments.
The amendments are not expected to have a material impact on the Company but may be applicable to changes and/or derecognition
of liabilities in the future.
|
3.29.4
|
Amendments to IFRS 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16 (CPC 48, CPC 38, CPC 40 (R1), CPC 11 and
CPC 06 (R2), respectively), Reference interest rate reform (Phase 2)
|
In 2020, the IASB completed the
second phase of the review process for IFRS 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16 (CPC 48, CPC 38, CPC 40 (R1), CPC 11 and CPC
06 (R2), respectively ), in response to the reform of the interest rate reference index (started in phase 1, as disclosed in note
3.30.2) . The changes address the possible effects that may arise from changes in contractual cash flows or hedge relationships
when replacing the interest rate reference index by the entity as well as additional disclosure requirements relating to the effect
of the interest rate benchmark reform on the entity’s financial instruments and risk management strategy, including the nature
and extent of risks to which the entity is exposed and how the entity manages these risks and the entity’s progress in completing
the transition to an alternative benchmark rates.
Considering the extinction of
LIBOR over the next few years, the Company and its subsidiaries are evaluating their contracts with clauses that envisage the discontinuation
of the interest rate. Most debt contracts linked to LIBOR have some clause to replace this rate with a reference index or equivalent
interest rate and, for contracts that do not have a specific clause, a renegotiation will be carried out between the parties. Derivative
contracts linked to LIBOR provide for a negotiation between the parties to define a new rate or an equivalent rate will be provided
by the calculation agent.
It is important to note that
the clauses for changing the indexes of the debt contracts of the Company and its subsidiaries indexed to LIBOR, establish that
any replacement of the indexation rate in the contracts can only be evaluated in 2 (two) circumstances (i) after communication
of an official government entity with formalization of the extinction and exchange of the contract's effective rate, and this communication
must define the exact date on which LIBOR will be extinguished and / or (ii)
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
syndicated operations begin to be executed at a rate
indexed to Secured Overnight Financing Rate (“SOFR”). Therefore, the negotiation of debt contracts and their related
derivatives will start after these events.
The Company mapped all of its
contracts subject to LIBOR reform that have not yet been subject to the transition to an alternative reference rate and as of December
31, 2020, the Company and its subsidiaries had R$ 761,074, related to loan and financing contracts and, until the moment, awaits
the official event of the extinction of LIBOR to start negotiating its contracts with counterparties.
The Company understands that
it will not be necessary to change the risk management strategy due to the change in the indexes of financial contracts linked
to LIBOR. The Company believes it is reasonable to assume that the negotiation of the indexes of its contracts, when the official
trigger allows, will move towards the replacement of LIBOR by SOFR, as the available information indicates that SOFR will be the
new interest rate adopted by the capital market. Based on the information available to date, the Company does not expect to have
significant impacts on its debts and derivatives linked to LIBOR.
|
3.30
|
New standards, amendments and interpretations of standards adopted for the first time for the year
beginning on January 1st, 2020
|
The Company applied for the
first-time certain standards and amendments, which are effective for annual periods beginning on or after January 1st, 2020. The
Company has not early adopted any other standard, interpretation or amendment that has been issued but is not yet effective.
|
3.30.1
|
Amendments to IFRS 3 - Definition of a Business
|
The amendment to IFRS 3 –
Business Combinations (CPC 15(R1)), clarifies that to be considered a business, an integrated set of activities and assets must
include, at a minimum, an input and a substantive process that, together, significantly contribute to the ability to create output.
Furthermore, it clarifies that a business can exist without including all of the inputs and processes needed to create outputs.
These amendments had no impact on the consolidated financial statements of the Company but may impact future periods if the Company
enters any new business combination.
|
3.30.2
|
Amendments to IFRS 7, IFRS 9 and IAS 39 (CPC 40(R1), CPC 48 and CPC 38, respectively), Interest
Rate Benchmark Reform (Phase 1)
|
The amendments to IFRS 9 and
IAS 39 – Financial Instruments: Recognition and Measurement (CPC 48 and 38, respectively) provide several reliefs, which
apply to all hedging relationships that are directly affected by interest rate benchmark reform. A hedging relationship is affected
if the reform gives rise to uncertainty about the timing and/or amount of benchmark-based cash flows of the hedged item or the
hedging instrument. These amendments have no impact on the consolidated financial statements of the Company as it does not have
any interest rate hedge relationships.
|
3.30.3
|
Amendments to IAS 1 and IAS 8 (CPC 26(R1) and CPC 23, respectively), Definition of Material
|
The amendments provide a new
definition of “material” that states “information is material if omitting, misstating or obscuring it could reasonably
be expected to influence decisions that the primary users of general purpose financial statements make on the basis of those financial
statements, which provide financial information about a specific reporting entity.” The amendments clarify that materiality
will depend on the nature or magnitude of information, either individually or in combination with other information, in the context
of the financial statements. A misstatement of information is material if it could reasonably be expected to influence decisions
made by the primary users. These amendments had no impact on the financial statements of, nor is there expected to be any future
impact to the Company and subsidiaries.
|
3.30.4
|
Conceptual Framework for Financial Reporting issued on March 29, 2018 (CPC 00(R2))
|
The Conceptual Framework is
not a standard, and none of the concepts contained therein override the concepts or requirements in any standard. The purpose
of the Conceptual Framework is to assist the
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
IASB in developing standards, to help preparers develop consistent accounting policies where
there is no applicable standard in place and to assist all parties to understand and interpret the standards. This will affect
those entities which developed their accounting policies based on the Conceptual Framework. The revised Conceptual Framework includes
some new concepts, updated definitions and recognition criteria for assets and liabilities and clarifies some important concepts.
These amendments had no impact on the financial statements of the Company and subsidiaries.
|
3.30.5
|
Amendments to IFRS 16 (CPC 06 (R2)), Covid-19 Related Rent Concessions
|
On May 28, 2020, the IASB issued
Covid-19-Related Rent Concessions - amendment to IFRS 16 – Leases (CPC 06 (R2)). The amendments provide relief to lessees
from applying IFRS 16 guidance on lease modification accounting for rent concessions arising as a direct consequence of the Covid-19
pandemic. As a practical expedient, a lessee may elect not to assess whether a Covid-19 related rent concession from a lessor is
a lease modification. A lessee that makes this election accounts for any change in lease payments resulting from the Covid-19 related
rent concession the same way it would account for the change under IFRS 16, if the change were not a lease modification.
The amendment applies to annual
reporting periods beginning on or after June 1st, 2020. This change brought a positive financial impact of R$ 58,700 in the statement
of income of the Company and its subsidiaries.
Avon acquisition
On January 3rd, 2020,
the Company acquired 100% of the voting shares of Avon. The Company’s acquisition was driven to significantly amplify the
reach of its multi-channel, multi-brand group. As a result of the restructuring process held upon acquisition, Avon became a wholly
owned subsidiary of the Company and the former shareholders of Avon became shareholders of the Company. As a result, Natura &Co
acquired control of Avon and the acquisition was accounted for using the acquisition method.
The transaction costs incurred
by the Natura &Co until the conclusion of the transaction on January 3rd, 2020, were approximately R$ 112,000.
The following table summarizes
the preliminary calculation of the fair value of the compensation transferred on January 3rd, 2020.
|
In
millions of R$, except for the number of shares
|
Number of Avon outstanding common shares as of January 3rd, 2020
|
536,383,776
|
Multiplied by the exchange ratio of 0.600 Natura &Co Holding Shares per each Avon common share
|
321,830,266
|
Multiplied by the market price of Natura &Co shares on January 3 d, 2020
|
41,00
|
Compensation in the issuance of shares
|
13,195,041
|
Adjustment to the transferred compensation (a)
|
171,073
|
Fair value of the Compensation to be transferred
|
13,366,114
|
|
a)
|
Related to the effects of replacements and settlements of share-based payment plans, of which the
amount of R$80 thousand refers to the share-based payment plans of Avon, in which it was substituted by Natura &Co, and R$
91 thousand refers to the stock option plans liquidated as a result of the conclusion of the transaction. These are pre-combination
installments that were regarded as a transferred compensation.
|
The fair values of the identifiable
assets and liabilities of Avon as at the date of acquisition were:
|
In thousands of R$
|
|
|
Purchase consideration transferred (1)
|
13,366,114
|
|
|
Fair value of assets acquired:
|
|
Cash and cash equivalents
|
2,636,108
|
Trade accounts receivable (2)
|
1,135,269
|
Inventories
|
1,919,683
|
Other current assets
|
1,031,136
|
Non-current assets held for sale
|
199,050
|
Property, plant and equipment
|
2,912,482
|
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
Deferred income tax and social contribution
|
667,034
|
Right of use (3)
|
564,669
|
Other non-current assets
|
475,096
|
Judicial deposits
|
283,885
|
Recoverable taxes
|
531,930
|
Surplus pension plan (other assets)
|
553,297
|
Intangibles (4)
|
5,846,812
|
|
|
Fair value of liabilities assumed:
|
|
Borrowings, financing and debentures
|
7,256,583
|
Accounts payable
|
2,915,418
|
Salaries, profit sharing and social charges
|
621,203
|
Dividends and interest on equity payable
|
405,916
|
Derivative financial instruments
|
15,518
|
Operating expenses accruals
|
999,653
|
Provision for restructuring (other liabilities)
|
152,896
|
Lease liabilities
|
777,200
|
Tax liabilities
|
341,258
|
Income tax and social contribution
|
30,068
|
Provision for tax, civil and labor risks (5)
|
1,693,096
|
Liabilities from discontinued operations (other liabilities)
|
64,844
|
Deferred income tax and social contribution (6)
|
592,534
|
Other liabilities
|
1,007,623
|
Total identifiable net assets at fair value
|
1,882,641
|
|
|
Non-controlling interest
|
27,555
|
|
|
Goodwill arising on acquisition (7)
|
11,511,028
|
|
(1)
|
Refers to the fair value of the acquired shares, which is the amount
disbursed on the shares exchange.
|
|
(2)
|
The fair value of the trade accounts receivable amounts to R$ 1,135,269
and is equivalent to it carrying amount and, it is expected that the carrying amount can be collected.
|
|
(3)
|
The Company measured the acquired lease liabilities using the present
value of the remaining lease payments at the date of acquisition. The right-of-use assets were measured at an amount equal to the
lease liabilities and adjusted to reflect the favorable terms of the lease relative to market terms.
|
|
(4)
|
The fair value of intangibles includes the intangible assets acquired
and recognized by Avon before the allocation of the fair value, in the amount of R$ 291,235, plus the effects of the allocation
of the fair values described below.
|
Fair value for the intangibles
“Avon” tradename, power brands and developed technology has been calculated based on the income approach and the relief-from-royalty
method. The relief from royalty method is often used to calculate the value of a trademark or trade name. This method is based
on the concept that if an entity owns a trademark, it does not have to pay for the use of it and therefore is relieved from paying
a royalty. The amount of that theoretical payment is used as a surrogate for income attributable to the intangibles. The valuation
is arrived at by computing the present value of the after-tax royalty savings, calculated by applying an appropriate royalty rate
to the projected revenue, using an appropriate discount rate.
Fair value for relationship with
sales representatives has been calculated based on the Multi Period Excess Earnings Method (“MEEM”), method that isolates
the income/cash flow that is related to the intangible asset being valued and estimates fair value through the sum of the discounted
future excess earnings attributable to the intangible asset.
|
Nature
|
Fair value
|
Useful life
|
“Avon” tradename
|
Represents the fair value of the "Avon" tradename. The relief-from-royalty method has been applied considering a benchmark of similar royalty transactions.
|
2,022,163
|
Indefinite
|
Power brands
|
Represents the fair value of Avon's main brands. The relief-from-royalty method has been applied considering a benchmark of similar royalty transactions as well as the relative importance of the respective brands for Avon’s revenue generation.
|
517,592
|
20 years
|
Developed technology
|
Represents the fair value of all technology necessary to develop Avon products, including formulae, labeling data, manufacturing processes, regulatory approvals, product packaging, and designs. the relief-from-royalty method has been applied based on existing contractual relations involving Avon’s developed technology.
|
1,131,573
|
5 years
|
Sales Representatives
|
Represents the fair value of the relationship between Avon and its sales representatives. Fair value is calculated based on the active representatives by country as of the valuation date, multiplied by the respective average ticket price as well as projected information on the average ticket growth which includes future inflation. The churn rate and the projected information have been considered as significant assumptions.
|
1,884,249
|
7 to 12 years
|
|
|
5,555,577
|
|
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
|
(5)
|
Contingent liabilities assumed in the acquisition that are considered
present obligations arising from past events and that can be measured reliably were recognized and are initially measured at fair
value on the acquisition date and subsequently measured in accordance with the requirements of IFRS 3 (CPC 15 (R1)), to a higher
amount that would be recognized in accordance with IAS 37 (CPC 25). The fair value of the contingent liabilities includes the liabilities
assumed and recognized by Avon before the allocation of the fair value, in the amount of R$ 872,993, plus the effects of the allocation
of the fair values, which totaled R$ 820,103. The table below shows the total amount of contingent liabilities assumed on the date
of the transaction, including the attributed fair value:
|
|
In thousands of R$
|
Tax
|
1,381,418
|
Civil
|
92,988
|
Labor
|
218,690
|
Total
|
1,693,096
|
|
(6)
|
Consists of deferred tax liabilities of approximately R$ 81,423 related
to Avon opening balance and net position of deferred tax asset and liabilities related to purchasing price allocation of tax liabilities
of R$ 511,111.
|
|
(7)
|
Goodwill is attributable to strong market position and geographic regions
and will result in a more diversified and balanced global portfolio, as well as expected future profitability and operational synergies,
such as supply, manufacturing, distribution and efficiency of the administrative structure and revenue growth. This goodwill arising
from the transaction is not expected to result in a tax benefit, that is, deductible for tax purposes.
|
Since the acquisition date,
Avon contributed with R$18,612,091 to revenues and impacted R$1,542,596 in losses in the Company’s consolidated financial
statements. As the acquisition date is January 3rd, 2020 and there was no significant transaction on the first three
days of 2020, such revenues and losses represent the impact in the Company's financial statements as if the acquisition date had
occurred at the beginning of the year.
The disclosure of the net assets
acquired in the financial statements of December 31, 2019 (in a note of subsequent events, given the date of acquisition) was made
based on a preliminary assessment of fair value, since the Company was in the period of measurement of net assets at fair value.
The table below demonstrate the variation between these preliminary effects presented on December 31, 2019 and the final effects
presented in these individual and consolidated financial statements:
|
As reported in 2019
|
Measurement period adjustments
|
2020
|
Total estimated consideration to be transferred
|
13,366,114
|
-
|
13,366,114
|
(-) Fair value of assets acquired:
|
|
|
|
Intangibles (1)
|
5,709,326
|
137,486
|
5,846,812
|
Other assets
|
12,911,674
|
(2,035)
|
12,909,639
|
|
|
|
|
(+) Fair value of liabilities assumed:
|
|
|
|
Provision for risks and contingencies (2)
|
651,000
|
1,042,096
|
1,693,096
|
Deferred income tax and social contribution (3)
|
671,693
|
(79,159)
|
592,534
|
Other liabilities
|
14,571,307
|
16,873
|
14,588,180
|
(-) Net assets
|
2,727,000
|
(844,359)
|
1,882,641
|
|
|
|
|
(+) Non-controlling interests
|
27,555
|
-
|
27,555
|
Goodwill from business combination
|
10,666,669
|
844,359
|
11,511,028
|
|
(1)
|
During the measurement period, the Company completed
the identification and measurement of intangible assets obtained with the acquisition.
|
|
(2)
|
During the measurement period, the Company completed the identification
and measurement of the contingent liabilities assumed evaluated as present obligations, as discussed above.
|
|
(3)
|
Reflects tax effects arising from the adjustments identified in the
measurement period.
|
|
5.
|
CRITICAL ACCOUNTING ESTIMATES AND ASSUMPTIONS
|
The preparation of the individual
and consolidated financial statements requires management to make certain judgments and use assumptions and estimates based on
experience and other factors considered relevant, which affect the values of assets and liabilities and which may present results
that differ from actual results.
The areas that require a higher
level of judgment and have greater complexity, as well as the areas in which assumptions and estimates are significant for the
financial statements, are disclosed below.
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
|
5.1
|
Deferred Income tax and social contribution
|
Deferred tax assets are recognized
for unused tax losses to the extent that it is probable that taxable profit will be available against which the losses can be utilized.
Significant management judgement is required to determine the amount of deferred tax assets that can be recognized, based upon
the likely timing and the level of future taxable profits, together with future tax planning strategies and other sources of income.
The Company has R$ 13,636,522
of tax losses carried forward as at December 31, 2020 (R$ 880,516 as at December 31, 2019). These losses relate to subsidiaries
that have a history of losses, do not expire, and may not be used to offset taxable income in other subsidiaries. The subsidiaries
neither have any taxable temporary difference nor any tax planning opportunities available that could partly support the recognition
of these losses as deferred tax assets. Based on this, the Company determined that cannot recognize deferred tax assets on the
tax losses carried forward.
|
5.2
|
Provision for tax, civil and labor risks
|
The Company and its subsidiaries
are parties to several legal and administrative procedures as described in note 23. Provisions are recorded for tax, civil and
labor risks related to lawsuits that represent probable, except for those related to business combinations, and are estimated with
a certain degree of certainty. The assessment of the likelihood of loss includes the assessment of the available evidence, the
hierarchy of laws, the available jurisprudence, the most recent court decisions, and their relevance in the legal system, as well
as the assessment of legal advisors.
|
5.3
|
Post-employment healthcare plan
|
The cost of the post-employment
healthcare plan is determined using actuarial valuations. An actuarial valuation involves making various assumptions that may differ
from actual developments in the future. These are based on a series of financial and demographic assumptions, such as the discount
rate, medical inflation, and percentage of adhesion to the plan, which are disclosed in note 24. Due to the complexities involved
in the valuation and its long-term nature, a defined benefit obligation is highly sensitive to changes in these assumptions. All
assumptions are reviewed at each reporting date.
|
5.4
|
Stock option plan, restricted share plan and strategy acceleration program
|
Estimating fair value for share-based
payment transactions requires determination of the most appropriate valuation model, which depends on the terms and conditions
of the grant. This estimate also requires determination of the most appropriate inputs to the valuation model including the expected
life of the share option or appreciation right, volatility and dividend yield and making assumptions about it.
The stock option plan, restricted
share plan and strategy acceleration program are measured at fair value at the grant date and the expense is recognized in profit
or loss during the vesting period and in “Additional paid-in capital” in shareholders’ equity. At the balance
sheet dates, Management reviews the estimates as to the number of stock options/restricted shares and, where applicable, recognizes
the effect arising from this review in profit or loss for period against shareholders’ equity. The assumptions and models
used to estimate the fair value of the stock option plan, restricted share plan and strategy acceleration program are disclosed
in note 29.1.
|
5.5
|
Impairment of non-financial assets
|
An impairment loss exists when
the carrying amount of an asset or CGU exceeds its recoverable amount, which is the higher of fair value less cost of disposal
and value in use. Fair value less costs of disposal is calculated based on information available about similar assets sold or market
prices less additional costs to dispose of the asset.
Value in use is calculated based
on the discounted cash flow model. Cash flows derive from a budget prepared for the following three to five years, according to
the operating segment, and their projections consider the market’s expectations for operations, estimated investments and
working capital, as well as other economic factors. The value in use is sensitive to the discount rate used under the discounted
cash flow method, as well as the growth rate and perpetuity used for extrapolation purposes.
|
5.6
|
Allowance for trade accounts receivable expected credit losses
|
The allowance for expected losses
on trade accounts receivable from customers is estimated based on the loss risk in an aging list model. The characteristics of
the Company's trade accounts receivable are (i) immaterial
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
financial component; (ii) non-complex receivables portfolio; and (iii)
low credit risk.
For trade accounts receivable,
the Company applies the simplified approach in calculating expected credit losses (“ECL”) based on expected credit
losses at each reporting date. The allowance determined based on (i) each of the subsidiaries credit losses historical experience,
observed in each group of the accounts receivable aging list, and (ii) adjustments for specific prospective factors for defaulters
and the economic environment. An estimated range is used based on the weighted average of the losses for the last 12 months. The
calculation also considers the length of time of the relationship of the independent beauty consultant and a division between renegotiated
and non-renegotiated overdue accounts receivable.
|
5.7
|
Allowance for losses on inventories
|
The allowance for losses on
inventories is estimated using a methodology to contemplate discontinued products, materials with slow turnover, materials with
an expired expiration date or close to the expiration date, and materials outside the quality parameters.
|
5.8
|
Leases - Estimating the incremental borrowing rate
|
The Company cannot readily determine
the interest rate implicit in the lease, therefore, it uses its incremental borrowing rate (“IBR”) to measure lease
liabilities. The IBR is the rate of interest that the Company would have to pay to borrow over a similar term, and with a similar
security, the funds necessary to obtain an asset of a similar value to the right-of-use asset in a similar economic environment.
The IBR therefore reflects what the Company “would have to pay”, which requires estimation when no observable rates
are available (such as for subsidiaries that do not enter into financing transactions) or when they need to be adjusted to reflect
the terms and conditions of the lease (for example, when leases are not in the subsidiary’s functional currency).
The Company estimates the IBR
using observable inputs (such as market interest rates) when available and is required to make certain entity-specific estimates.
|
5.9
|
Measurement at fair value of financial instruments
|
When the fair value of financial
assets and liabilities recorded in the balance sheet cannot be measured based on prices quoted in active markets, the fair value
is measured based on valuation techniques, including the discounted cash flow model. The inputs considered in these models are
obtained from observable markets, when possible. In situations where these inputs cannot be obtained from observable markets, a
degree of judgment is necessary to establish the respective fair values. Associated judgments include assessment of liquidity risk,
credit risk and volatility. Changes in the assumptions related to these factors could affect the fair value of financial instruments.
|
5.10
|
Business combination
|
As disclosed in note 3.4, business
combinations are accounted for using the acquisition method, which involves the valuation of assets acquired and liabilities assumed
at the respective fair values. This assessment involves the use of estimates and assumptions that include significant judgments
by the Company, including those applied in the measurement of brand, sales representatives and developed technology assets, as
well as lease liabilities (adjustments to reflect favorable lease conditions in relation to market terms) and measurement and recognition
of contingent liabilities.
The disclosures associated with
these topics are included in note 4.
|
6.
|
FINANCIAL RISK MANAGEMENT
|
|
6.1.
|
General considerations and policies
|
Risks and financial instruments
are managed through policies, the definition of strategies and implementation of control systems, defined by the risk management
committees of the entities of the group, and approved by the Company's Board of Directors. The compliance of treasury financial
instruments positions, including derivatives, in relation to these policies, is presented and assessed on a monthly basis by the
Company’s Treasury Committee and subsequently submitted to the analysis of the Audit and Risk Management and Finance Committees,
the Executive Committee and the Board of Directors.
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
Risk management of Natura &Co
group operations is performed by the Company's Corporate Treasury, which is also responsible for approving short-term investments
and borrowings transactions. Risk management of the subsidiaries Aesop, The Body Shop, Avon International and Natura &Co Latam
is conducted by local treasury teams, subject to monitoring and approval of the Company’s Corporate Treasury.
|
6.2.
|
Financial risk factors
|
The activities of the Company
and its subsidiaries expose them to several financial risks: market risk (including foreign currency and interest risks), credit
risk and liquidity risk. The Company’s overall risk management program is focused on the unpredictability of financial markets
and seeks to minimize potential adverse effects on the financial performance, using derivatives to hedge certain risk exposures.
The Company and the subsidiaries
are exposed to market risks arising from their business activities. These risks mainly comprise possible fluctuations in exchange
and interest rates.
To hedge the current balance
sheet positions of the Company and its subsidiaries from market risks, the following derivative financial instruments are used,
which are comprised of the balances presented below, as of December 31, 2020 and 2019:
|
Fair value (Level 2)
|
Description
|
Consolidated
|
|
2020
|
2019
|
“Financial” derivatives
|
1,857,869
|
725,060
|
“Operating” derivatives
|
(11,092)
|
512
|
Total
|
1,846,777
|
725,572
|
The Company and its subsidiaries
are exposed to foreign currency risk resulting from financial instruments in currencies other than their functional currencies,
as well as to operating cash flows in foreign currencies. To reduce this exposure, policies were implemented to hedge the Company
from foreign currency risk, which establish exposure levels related to these risks.
The treasury procedures defined
by the current policies include monthly projection and assessment of the consolidated foreign exchange rate exposure of the Company
and its subsidiaries, on which Management’s decision-making is based.
The Company’s foreign
currency hedge policy considers the amounts of foreign currency of receivables and payables balances from commitments already assumed
and recorded in the financial statements, as well as future cash flows, with a six-month average term, not yet recorded on the
balance sheet.
Pursuant to the Foreign Exchange
Hedge Policy, the derivatives entered into by the Company or its subsidiaries should eliminate the foreign currency risk of financial
instruments in currencies other than their functional currencies and should also limit losses due to foreign exchange rate variations
on future cash flows.
To protect from the foreign
exchange exposures in relation to foreign currency, the Company and its subsidiaries enter into transactions with derivative financial
instruments such as swap and forward exchange contracts (“NDF”).
c) Derivatives
instruments to hedge foreign exchange rate risk
The Company and its subsidiaries
classify derivatives into “Financial” and “Operating”. “Financial” derivatives include swaps
or forwards engaged to hedge from foreign currency risk of borrowings, financing, debt securities and intercompany borrowings denominated
in foreign currency. “Operating” derivatives are used to hedge from foreign currency risk from the business’s
operating cash flows.
As of December 31, 2020, the
derivative balances are composed as follows:
Financial
derivatives
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
Consolidated
|
Principal (notional) amount
|
Fair value
|
Gain (loss)
|
Description
|
2020
|
2019
|
2020
|
2019
|
2020
|
2019
|
Swap contracts: (a)
|
|
|
|
|
|
|
Asset position:
|
|
|
|
|
|
|
Long position - U.S. dollar
|
2,576,890
|
2,664,001
|
4,683,900
|
3,729,691
|
421,897
|
312,984
|
Liability position:
|
|
|
|
|
|
|
CDI floating rate:
|
|
|
|
|
|
|
Short position in CDI
|
(2,576,890)
|
(2,664,001)
|
(2,803,797)
|
(3,002,623)
|
(172,885)
|
(248,028)
|
|
|
|
|
|
|
|
Forward contracts (NDF):
|
|
|
|
|
|
|
Liability position:
|
|
|
|
|
|
|
Post-fixed CDI rate:
|
|
|
|
|
|
|
Short position at interbank rate
|
1,409,102
|
200,896
|
(22,234)
|
(2,008)
|
(16,778)
|
(160)
|
Total net derivative financial instruments:
|
1,409,102
|
200,896
|
1,857,869
|
725,060
|
232,234
|
64,796
|
|
(a)
|
Swap transactions consist of swapping the exchange rate fluctuation for a correction related to
a percentage of the fluctuation of the Interbank Deposit Rate (post-fixed CDI), in the case of Brazil.
|
For the derivatives held by
the Company and its subsidiaries as of December 31, 2020 and 2019, as the contracts are directly with financial institutions and
not through stock exchanges, there are no margin deposits to guarantee these operations.
Operating derivatives - Consolidated
As at December 31, 2020 and
2019, the Company and its subsidiaries held derivative financial instruments of the forward type with the objective of hedging
from foreign currency risk of operating cash flows (such as import and export operations):
|
Principal (notional) amount
|
Fair value
|
Description
|
2020
|
2019
|
2020
|
2019
|
Net position - GBP and USD
|
1,585,280
|
200,896
|
(7,670)
|
(2,008)
|
Forward contracts
|
165,830
|
1,302,869
|
(3,422)
|
512
|
Total derivative instruments, net
|
1,751,110
|
1,503,765
|
(11,092)
|
(1,496)
|
Sensitivity analysis
For the foreign currency risk
sensitivity analysis, Management of the Company and its subsidiaries believes that it is important to consider, in addition to
the assets and liabilities with exposure to fluctuations in exchange rates recorded in the balance sheet, the fair value of the
financial instruments entered into by the Company to hedge certain exposures on December 31, 2020 and 2019, as set forth in the
table below:
|
Consolidated
|
|
2020
|
2019
|
Borrowings and financing in foreign currency in Brazil (a)
|
(4,246,692)
|
(3,381,959)
|
Receivables in foreign currency in Brazil
|
236,782
|
10,007
|
Trade accounts payable in foreign currencies in Brazil
|
(14,459)
|
(10,543)
|
Fair value of financial derivatives
|
4,680,478
|
3,729,691
|
Net asset exposure
|
656,109
|
347,196
|
|
(a)
|
Excluding transaction costs.
|
This analysis considers only
financial assets and liabilities recorded in Brazil in foreign currency, since exposure to the foreign exchange rate variation
in other countries is close to zero due to the strong currency and effectiveness of its derivatives, and it is considered that
all other variables, especially interest rates, remain constant and do not consider any impact of the forecasted purchases and
sales.
The following table shows the
projection of the incremental loss that would have been recognized in profit or loss for the subsequent year, if the current net
foreign exchange exposure remains static, based on the following scenarios:
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
|
Consolidated
|
Parity - R$ vs US$
|
5.1967
|
5.1880
|
3.8910
|
2.5940
|
|
Scenario
|
Scenario
|
Scenario I
|
Scenario II
|
Operation/Instrument
|
Real
|
Probable
|
Depreciation 25%
|
Depreciation 50%
|
Assets denominated in US$
|
|
|
|
|
Fair value of “financial” derivatives
|
4,680,478
|
(7,881)
|
(1,570,668)
|
(4,696,241)
|
Trade accounts receivable recorded in Brazil in foreign currency
|
236,782
|
(399)
|
(79,459)
|
(237,579)
|
|
|
|
|
|
Liabilities denominated in US$
|
|
|
|
|
Borrowings and financing in Brazil in foreign currency (a)
|
(4,246,692)
|
7,151
|
1,425,099
|
4,260,994
|
Accounts payable registered in Brazil in foreign currency
|
(14,459)
|
24
|
4,852
|
14,508
|
Impact on net income and equity
|
|
(1,105)
|
(220,176)
|
(658,318)
|
The probable scenario considers
future US dollar rates for a 90 days-term. According to quotations obtained at the Brazilian Stock Exchange (“B3”)
as at December 31, 2020 and in line with the first maturities of financial instruments with exchange exposure, R$5.19 / US$ 1.00.
Scenarios II and III consider an increase/decrease in the US dollar of 25% (R$3.89 / US$ 1.00) and 50% (R$2.59 / US$1.00), respectively.
Management uses the probable scenario in the assessment of possible changes in the exchange rate and presents the referred scenario
in compliance with IFRS 7/CPC 40 - Financial Instruments: Disclosures.
The Company and its subsidiaries
do not use derivative financial instruments for speculative purposes.
At the subsidiary Avon, the
sensitivity analysis is prepared based on the foreign exchange contracts outstanding at December 31, 2020, all of which were entered
into to hedge foreign currency exposures. This hypothetical analysis prepared by Avon does not consider exposures other than the
US dollar. The hypothetical impact was calculated on open positions using forward rates as of December 31, 2020, adjusted for an
assumed appreciation or depreciation of 10%, 25% or 50% of the US dollar in relation to these hedge transactions. A hypothetical
appreciation of the US dollar against foreign exchange contracts would minimize gains by R$ 82,889, R$ 207,223 or R$ 414,447, respectively,
and a hypothetical depreciation of 10%, 25% or 50% of the US dollar against our foreign exchange contracts would increase gains
by R$ 82,889, R$ 207,223 or R$ 414,447, respectively.
Derivative
instruments designated for hedge accounting
The Company formally designated
its operations subject to hedge accounting for derivative financial instruments for hedging borrowings denominated in foreign currency
of Natura Cosméticos S.A. and Natura Distribuidora de México, S.A. de C.V and to protect operating cash flows from
The Body Shop's foreign currency purchase and sales transactions, documenting the following:
|
Ø
|
The hedging relationship;
|
|
Ø
|
The Company’s objective and risk management strategy in contracting the hedge transaction;
|
|
Ø
|
Identification of the financial instrument;
|
|
Ø
|
The hedged item or transaction;
|
|
Ø
|
The nature of the risk to be hedged;
|
|
Ø
|
Description of the hedging relationship;
|
|
Ø
|
The statement of the ratio between the hedging instrument and the hedged item, where applicable;
and
|
|
Ø
|
The statement of prospective effectiveness of the hedge.
|
The outstanding positions of
derivative financial instruments designated as cash flow hedge on December 31, 2020 as set forth below:
Cash flow
hedge instrument – Consolidated
|
|
|
|
Other comprehensive income
|
|
Hedged item
|
Notional currency
|
Notional value
|
Fair
value (a)
|
Accumulated contract gain (loss)
|
Gain in the 12-month period
|
Currency Swap – US$/R$
|
Currency
|
BRL
|
2,576,020
|
1,879,348
|
249,021
|
183,342
|
Forward contract (The Body Shop)
|
Currency
|
BRL
|
1,096,227
|
(4,882)
|
(4,882)
|
(5,135)
|
Forward contract (Natura Indústria)
|
Currency
|
BRL
|
17,807
|
(702)
|
(702)
|
(201)
|
Total
|
|
|
3,690,054
|
1,873,764
|
243,437
|
178,006
|
The changes in cash flow hedge
reserve recorded in OCI are shown below:
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
|
Consolidated
|
Cash flow hedge balance as at December 31, 2018
|
(27,840)
|
Change in the fair value of hedge instrument recognized in OCI
|
107,337
|
Tax effects on fair value of hedge instrument
|
(36,768)
|
Cash flow hedge balance as at December 31, 2019
|
42,729
|
Change in the fair value of hedge instrument recognized in OCI
|
178,006
|
Tax effects on fair value of hedge instrument
|
(61,658)
|
Cash flow hedge balance as at December 31, 2020
|
159,077
|
The Company designates as cash
flow hedge the derivative financial instruments used to offset variations arising from foreign currency exposure, in the market
value of contracted debts, other than the functional currency.
d) Interest
rate risk
The interest rate risk arises
from financial investments and short and long-term borrowings and financing. Financial instruments issued at variable rates expose
the Company and its subsidiaries to cash flow risk associated with interest rates. Financial instruments issued at fixed rates
expose the Company and its subsidiaries to the fair value risk associated with the interest rate.
The Company’s cash flow
risk associated with interest rate arises from investments and short-term and long-term borrowings and financing issued at floating
rates. The Company's Management holds, for the most part, the indexes of its exposures to deposit and lending interest rates tied
to floating rates. Financial investments are adjusted by the Interbank Deposit Rate (“CDI”) whereas borrowings and
financing are adjusted by the Long-Term Interest Rate (“TJLP”), CDI and fixed rates, according to the contracts entered
into with financial institutions and through the negotiation of securities with investors in that market.
Sensitivity
analysis
On December 31, 2020, there
are borrowings, financing and debentures contracts denominated in foreign currency that are linked to interest swap contracts,
changing the liability index rate to the CDI variation. Accordingly, the risk of the Company and its subsidiaries becomes the exposure
to the variation of the CDI. The following table presents the exposure to interest rate risks of transactions related to CDI, including
derivative transactions (borrowings, financing and debentures in Brazil were considered in full, given that 99.1% of the amount
is related to the CDI):
|
Company
|
Consolidated
|
Total borrowings and financing - in local currency (note 20)
|
(515,966)
|
(9,591,809)
|
Operations in foreign currency with derivatives related to CDI (a)
|
-
|
(4,231,104)
|
Short-term investments (notes 7 and 8)
|
845,197
|
3,865,319
|
Net exposure
|
329,231
|
(9,957,594)
|
|
a)
|
Refers to transactions involving derivatives related to CDI to hedge the borrowings and financing
arrangements raised in foreign currency in Brazil.
|
The sensitivity analysis considers
the exposure of borrowings and financing, net of short-term investments, linked to CDI (notes 7 and 8).
The following tables show the
projection of incremental loss that would have been recognized in profit or loss for the following year, assuming that the current
net liability exposure is static and the following scenarios:
Company
|
Description
|
Risk
|
Probable scenario
|
Scenario II
|
Scenario III
|
Net liability
|
Rate increase
|
198
|
1,811
|
3,424
|
Consolidated
|
Description
|
Risk
|
Probable scenario
|
Scenario II
|
Scenario III
|
Net liability
|
Rate increase
|
(3,626)
|
(33,235)
|
(62,844)
|
The probable scenario considers
future interest rates for 90 days-term, according to B3 quotations on the expected dates of the first maturities of financial instruments
with exposure to interest rates, as at December 31, 2020. Scenarios II and III consider an increase interest rates by 25% (2.45%
per year) and 50% (2.94% per year), respectively, over a CDI rate of 1.96% per year.
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
Credit risk refers to risk of
a counterparty not complying with its contract obligations, which would result in financial losses for the Company. The Company’s
and its subsidiaries sales are made to a high number of Natura and Avon consultants and this risk is managed through a credit granting
process. The result of this management is reflected in the “Allowance for expected credit losses” under “Trade
accounts receivables”, as shown in note 9.
The Company and its subsidiaries
are also subject to credit risks related to financial instruments entered for the management of its business, mainly represented
by cash and cash equivalents, short-term investments and derivative instruments.
The Company believes that the
credit risk of transactions with financial institutions is low, as these are considered as first tier by the Management.
The short-term investments policy
adopted by the Company’s Management establishes the financial institutions with which the Company is allowed to do business,
in addition to defining limits on funds allocation percentages and absolute amounts that may be allocated in each of these financial
institutions.
Prudent liquidity risk management
implies maintaining sufficient cash, bonds and securities, funds available through credit facilities and the ability to settle
market positions.
Management monitors the Company’s
and its subsidiaries liquidity level considering the expected cash flows in exchange for unused credit facilities, as shown in
the following table:
|
Company
|
Consolidated
|
|
2020
|
2019
|
2020
|
2019
|
Total current assets
|
988,266
|
3,050,574
|
18,734,820
|
9,430,057
|
Total current liabilities
|
(566,230)
|
(3,080,906)
|
(16,159,586)
|
(7,518,423)
|
Total net working capital
|
422,036
|
(30,332)
|
2,575,234
|
1,911,634
|
As at December 31, 2020, the
carrying amount of financial liabilities, measured using the amortized cost method, considering interest payments at a floating
rate and the value of debt securities reflecting the forward market interest rates, may be changed due to the variation in floating
interest rates. Their corresponding maturities, considering that the Company and its subsidiaries are in compliance with covenants,
are shown below:
Company
|
Less than one year
|
One to five years
|
Over five years
|
Total expected cash flow
|
Interest to be accrued
|
Carrying amount
|
Borrowings, financing and debentures
|
526,495
|
-
|
-
|
526,495
|
(10,529)
|
515,966
|
Payables to related parties, trade accounts payable and supply chain finance
|
9,693
|
-
|
-
|
9,693
|
-
|
9,693
|
Consolidated
|
Less than one year
|
One to five years
|
Over five years
|
Total expected cash flow
|
Interest to be accrued
|
Carrying amount
|
Borrowings, financing and debentures
|
4,047,276
|
9,165,849
|
1,551,721
|
14,764,846
|
(941,933)
|
13,822,913
|
Leases
|
1,231,622
|
2,644,292
|
734,771
|
4,610,685
|
(752,230)
|
3,858,455
|
Payables to related parties, trade accounts payable and supply chain finance
|
6,774,205
|
-
|
-
|
6,774,205
|
-
|
6,774,205
|
The Company and its subsidiaries
currently have a credit line of up to £70 million (seventy million British pounds), with guarantee, that can be withdrawn
in installments to meet short-term financing needs of The Body Shop. This credit line has been used by the subsidiary since the
first quarter of 2020 to reinforce its working capital and liquidity. The credit facilities up to R$ 150,000 (one hundred and fifty
million reais), which was in effect as at December 31, 2019 was closed during the first half of 2020.
The Company is monitoring the
evolution of the Covid-19 pandemic in the markets it operates, especially with, regard to restrictive measures adopted by these
jurisdictions. The Crisis Committee created in the second quarter of 2020 continuously analyzes the situation and acts to minimize
impacts on the operations and on the
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
equity and financial position of the Company and its subsidiaries, with the objective of implementing
appropriate measures, ensuring the continuity of operations, protect cash, improve liquidity and promote the health and safety
of all.
Considering the uncertainties
associated with the adversities observed in the economic scenario, Management also assesses the possible effects on the individual
and consolidated financial statements, as discussed below:
The Company's and its subsidiaries'
businesses were affected by the pandemic mainly at the beginning of the year, with results recovering from the decreasing restrictions
in the markets in which it operates, mainly in Brazil, as some of the main markets in Europe follow more restrictive measures to
open stores and shops. The transition to the digital environment continued across all our brands, making it possible to offset
the impact of store closures, with an increase in e-commerce sales, in addition to the growth seen in direct sales revenues.
|
6.3.2
|
Provision for expected losses on accounts receivable from customers
|
The Company and its subsidiaries
have been evaluating the impact of the crisis on accounts receivable, due to the possibility of increasing credit risk, with the
aim of ensuring the sustainability of the chain and supporting its customer network. Changes in provisions for expected losses
are presented in note 9 and reflect an increase in 2020 arising from the incorporation of Avon balances, acquired in the year.
We have not seen a material impact from the pandemic with respect to the default of our customers.
|
6.3.3
|
Impairment of non-financial assets
|
In the first quarter, the Company
revised the projections used in the goodwill impairment tests considering the adverse scenario brought about by the pandemic and
as a result the need to recognize an impairment provision was not identified. In the fourth quarter, the Company carried out the
annual goodwill impairment test, as indicated in notes 3.1.12 and 18, and reached a conclusion similar to that in the first quarter.
Retail operations (mainly composed
of physical stores) are not considered essential by government authorities, which led to the closure of part of these locations
during different periods of 2020. Due to this adverse scenario, we performed an impairment test for the cash generating units that
comprise these operations and as a result, a reduction in the recoverable amount of R$ 148,050 was recorded, as disclosed in note
19.
During the year, the Company
and its subsidiaries renegotiated contracts and obtained discounts on store lease payments, as mentioned in note 19.
|
6.3.5
|
Operational continuity
|
Management is not aware of any
material uncertainty that could generate significant doubts about its ability to continue operating indefinitely.
|
6.3.6
|
Capital management and liquidity risk and covenants
|
The Company uses part of the
resources from private funding and capital increase (see notes 20 and 25), to accelerate its investments in the digitization of
operations, which were intensified as a result of the Covid-19 pandemic. Continuous cost management, including on other investments
and discretionary expenditures, and Government incentives were still used in several locations during the year. The Company ended
the year with a robust cash position, resulting in greater deleveraging and ensuring compliance with our financial covenants.
In June 2020, the subsidiary
Avon became aware that it was exposed to a cyber-incident in its Information Technology (“IT”) environment that interrupted
some systems and partially affected Avon's operations. Avon involved leading external experts in cybersecurity and general IT controls,
initiating a comprehensive containment and correction effort, as well as a forensic investigation. By mid-August, Avon had reestablished
all its main business processes and resumed operations in all of its markets, including all of its distribution centers.
The cyber incident did not have
a significant impact on the revenue performance of the subsidiary for the year
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
ended December 31, 2020, despite having resulted
in a phasing of the subsidiary's revenue from the second to the third quarter of 2020, as the subsidiary met the order backlog
that was created. The incremental expense incurred as a result of the cyber-incident was not material.
Although it has no indication
that the accuracy and completeness of any financial information has been affected as a result of the incident, the subsidiary has
performed extensive procedures to validate the accuracy and completeness of its financial information.
The Company’s capital
management objectives are to ensure that the Company is continuously capable of offering return to its shareholders and benefits
to other stakeholders, in addition to maintaining an ideal capital structure to reduce this capital cost.
The Company monitors capital
based on the financial leverage ratios. This ratio corresponds to the net debt divided by equity. The net debt corresponds to total
borrowings and financings (including short and long-term borrowings and financings, as shown in the consolidated statement of financial
position), deducted from cash and cash equivalents and short-term investments (except for “Crer Para Ver” funds).
Financial instruments that are
measured at fair value at the reporting date as prescribed by IFRS 13/CPC 46 – Fair Value Measurement follow the hierarchy
below:
|
Ø
|
Level 1: Valuation based on quoted (unadjusted) prices in active markets for identical assets and
liabilities on the reporting date. A market is seen as active if quoted prices are readily and regularly available from a Commodities
and Securities Exchange, a broker, industry group, pricing service or regulatory agency, and those prices represent actual market
transactions, which occur regularly on a purely commercial basis;
|
|
Ø
|
Level 2: Used for financial instruments that are not traded in active markets (for example, over-the-counter
derivatives), whose valuation is based on techniques that, in addition to the quoted prices included in Level 1, use other inputs
adopted by the market for the asset or direct liabilities (i.e., as prices) or indirectly (i.e., derived from prices); and
|
|
Ø
|
Level 3: Valuation determined by virtue of information, for assets or liabilities, that is not
based on data adopted by the market (i.e., unobservable information).
|
The carrying amounts and fair
values of the Company’s financial instruments as at December 31, 2020 and 2019 is presented as follows:
Company
|
|
|
|
Carrying amount
|
Fair value
|
Note
|
Classification by category
|
Fair value hierarchy
|
2020
|
2019
|
2020
|
2019
|
Financial assets
|
|
|
|
|
|
|
|
Cash and cash equivalent
|
7
|
|
|
|
|
|
|
Cash and banks
|
|
Amortized cost
|
Level 2
|
1,501
|
2,173,101
|
1,501
|
2,173,100
|
Certificate of bank deposits
|
|
Amortized cost
|
Level 2
|
504,198
|
207,699
|
504,198
|
207,699
|
|
|
|
|
505,699
|
2,380,800
|
505,699
|
2,380,799
|
Short-term investments
|
|
|
|
|
|
|
|
Exclusive investment funds
|
8
|
Fair value through
profit or loss
|
Level 2
|
340,999
|
669,769
|
340,999
|
669,769
|
|
|
|
|
|
|
|
|
Accounts receivables – related parties
|
33.1
|
Amortized cost
|
Level 2
|
115,952
|
-
|
115,952
|
-
|
|
|
|
|
|
|
|
|
Financial liabilities
|
|
|
|
|
|
|
|
Borrowings in local currency
|
20
|
Amortized cost
|
Level 2
|
(515,966)
|
(2,883,382)
|
(515,966)
|
(2,883,382)
|
Trade accounts payable, supply chain finance and related parties
|
21/33.1
|
Amortized cost
|
Level 2
|
(16,887)
|
-
|
(16,887)
|
-
|
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
Consolidated
|
|
|
|
Carrying amount
|
Fair value
|
Note
|
Classification by category
|
Fair value hierarchy
|
2020
|
2019
|
2020
|
2019
|
Financial assets
|
|
|
|
|
|
|
|
Cash and cash equivalent
|
7
|
|
|
|
|
|
|
Cash and banks
|
|
Amortized cost
|
Level 2
|
4,436,123
|
3,110,220
|
4,436,123
|
3,110,220
|
Certificate of bank deposits
|
|
Amortized cost
|
Level 2
|
808,988
|
211,261
|
808,988
|
211,261
|
Repurchase transactions
|
|
Fair value through profit or loss
|
Level 2
|
576,108
|
1,192,101
|
576,108
|
1,192,101
|
|
|
|
|
5,821,219
|
4,513,582
|
5,821,219
|
4,513,582
|
Short term investments
|
8
|
|
|
|
|
|
|
Government bonds
|
|
Fair value through profit or loss
|
Level 1
|
864,940
|
221,900
|
864,940
|
221,900
|
Restricted cash
|
|
Fair value through profit or loss
|
Level 2
|
40,425
|
-
|
40,425
|
-
|
Financial treasury bill
|
|
Fair value through profit or loss
|
Level 2
|
505,152
|
374,690
|
505,152
|
374,690
|
Loan investment fund
|
|
Fair value through profit or loss
|
Level 2
|
817,253
|
407,928
|
817,253
|
407,928
|
Dynamo Beauty Ventures Ltd fund
|
|
Fair value through profit or loss
|
Level 3
|
16,104
|
7,402
|
16,104
|
7,402
|
Certificate of bank deposits
|
|
Fair value through profit or loss
|
Level 2
|
292,878
|
21,327
|
292,878
|
21,327
|
|
|
|
|
2,536,752
|
1,033,247
|
2,536,752
|
1,033,247
|
|
|
|
|
|
|
|
|
Trade accounts receivable
|
9
|
Amortized cost
|
Level 2
|
3,597,535
|
1,685,764
|
3,597,535
|
1,685,764
|
|
|
|
|
|
|
|
|
Judicial deposits
|
13
|
Amortized cost
|
Level 2
|
566,190
|
337,255
|
566,190
|
337,255
|
|
|
|
|
|
|
|
|
Carbon Credits
|
15
|
Fair value through profit or loss
|
Level 2
|
4,097
|
3,508
|
4,097
|
3,508
|
|
|
|
|
|
|
|
|
Sublease receivables
|
15
|
Amortized cost
|
Level 2
|
357,538
|
-
|
357,538
|
-
|
|
|
|
|
|
|
|
|
“Financial” and “operating” derivatives
|
|
Fair value through profit or loss - hedging instrument
|
Level 2
|
1,768,122
|
737,378
|
1,768,122
|
737,378
|
“Financial” and “operating” derivatives
|
|
Fair value through profit or loss
|
Level 2
|
139,856
|
-
|
139,856
|
-
|
|
|
|
|
1,907,978
|
737,378
|
1,907,978
|
737,378
|
|
|
|
|
|
|
|
|
Financial liabilities
|
|
|
|
|
|
|
|
Borrowings, financing and debentures
|
20
|
|
|
|
|
|
|
Local currency borrowings
|
|
Amortized cost
|
Level 2
|
(9,591,809)
|
(7,412,443)
|
(9,466,921)
|
(7,445,672)
|
Foreign currency borrowings
|
|
Amortized cost
|
Level 2
|
(4,231,104)
|
(3,373,931)
|
(4,459,081)
|
(3,541,541)
|
|
|
|
|
(13,822,913)
|
(10,786,374)
|
(13,926,002)
|
(10,987,213)
|
|
|
|
|
|
|
|
|
Carbon Credits
|
24
|
Fair value through profit or loss
|
Level 2
|
(5,560)
|
(4,519)
|
(5,560)
|
(4,519)
|
|
|
|
|
|
|
|
|
“Financial” and “operating” derivatives
|
|
Fair value through profit or loss - hedging instrument
|
Level 2
|
-
|
(10,158)
|
-
|
(10,158)
|
“Financial” and “operating” derivatives
|
|
Fair value through profit or loss
|
Level 2
|
(61,201)
|
(1,648)
|
(61,201)
|
(1,648)
|
|
|
|
|
(61,201)
|
(11,806)
|
(61,201)
|
(11,806)
|
|
|
|
|
|
|
|
|
Lease liabilities
|
19
|
Amortized cost
|
Level 2
|
(3,858,455)
|
(2,517,565)
|
(3,858,455)
|
(2,517,565)
|
Trade payables and supply chain finance operations
|
21
|
Amortized cost
|
Level 2
|
(6,774,205)
|
(1,829,756)
|
(6,774,205)
|
(1,829,756)
|
The Company estimates that cash
and cash equivalents, trade accounts receivable, trade accounts payable and other current liabilities balances are equivalent to
their book values, mainly due to the short-term maturities of these instruments.
The carrying amounts of financial
investments in Bank Deposit Certificates measured at amortized cost approximate their fair values as
the operations are carried out at floating interest rates.
The carrying amounts of borrowings,
financing and debentures are measured at their amortized cost and disclosed at fair value, which does not differ materially from
carrying amounts as the agreed interest rates are consistent with current market rates.
The fair value of foreign exchange
derivatives (swap and forward) is determined based on future exchange rates at the reporting date, with the resulting value discounted
to present value.
The
fair value of the investment in the Dynamo Beauty Fund, classified at level 3 of the fair value hierarchy is calculated based on
information on the net value of the investment in the Fund (NAV) calculated by the Fund's manager based on valuation assumptions
consistent with the accounting practices adopted in Brazil and IFRS, adjusted to reflect the fair value assumptions applicable
to the nature of the Company's investment. The Company's valuation considers inputs not observable in the model, in order to reflect
the contractual restrictions on this investment for early redemption of the security in the market. The significant unobservable
inputs used in the measurement of fair value reflect a discount due to the lack of liquidity of the security, which represent the
values that the Company determined that market agents would take into account for these
discounts when defining the investment price. 1% increase (decrease) in the applied discount (15.4%) would result in an increase
(decrease) in the fair value of the investment of R$ 185.
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
There were no transfers between
measurement levels in the fair value hierarchy for the year ended December 31, 2020 for these assets and liabilities.
|
7.
|
CASH AND CASH EQUIVALENTS
|
|
Company
|
Consolidated
|
|
2020
|
2019
|
2020
|
2019
|
Cash and banks
|
1,501
|
2,173,101
|
4,436,576
|
3,110,220
|
Certificate of Bank Deposits (a)
|
504,198
|
207,699
|
808,988
|
211,261
|
Repurchase transactions (b)
|
-
|
-
|
576,108
|
1,192,101
|
|
505,699
|
2,380,800
|
5,821,672
|
4,513,582
|
|
(a)
|
As of December 31, 2020, Certificate of Bank Deposits (“CDB”) short-term investments
are remunerated at an average rate of 103.2% of CDI (106.9% of CDI as of December 31, 2019) with daily maturities redeemable with
the issuer itself, without significant loss of value.
|
|
(b)
|
Repurchase transactions are securities issued by banks with a commitment by the bank to repurchase
the securities, and by the client to resell the security, at a defined interest rate and within a predetermined term, which are
backed by public or private securities (depending on the financial institution) and are registered within the Central of Custody
and Financial Settlement of Securities (“CETIP”). As of December 31, 2020, repurchase operations are remunerated at
an average rate of 100.0% of CDI (99.9% of the CDI on December 31, 2019).
|
|
8.
|
SHORT-TERM INVESTMENTS
|
|
Company
|
Consolidated
|
|
2020
|
2019
|
2020
|
2019
|
Exclusive investment funds (a)
|
340,999
|
669,769
|
-
|
-
|
Loan investment funds
|
-
|
-
|
817,253
|
407,928
|
Certificate of Bank Deposits (b)
|
-
|
-
|
292,878
|
21,327
|
Treasury bills (c)
|
-
|
-
|
505,152
|
374,690
|
Government bonds (LFT) (d)
|
-
|
-
|
864,940
|
221,900
|
Dynamo Beauty Ventures Ltd. Fund
|
-
|
-
|
16,104
|
7,402
|
Restricted cash
|
-
|
-
|
40,425
|
-
|
|
340,999
|
669,769
|
2,536,752
|
1,033,247
|
|
|
|
|
|
Current
|
340,999
|
669,769
|
2,520,648
|
1,025,845
|
Non-current
|
-
|
-
|
16,104
|
7,402
|
|
(a)
|
The Company and subsidiaries concentrate most of their investments in an exclusive investment fund,
which holds interest in shares of the Essential Investment Fund.
|
The values of the quotas held
by the Company are presented under the heading “Exclusive Investment Fund” at the Parent Company. The financial statements
of the Exclusive Investment Fund, in which the group has exclusive participation (100% of the quotas), were consolidated, except
for the quotas of the Natura Institute, and the amounts of its portfolio were segregated by type of investment and classified as
cash and marketable securities, based on the accounting practices adopted by the Company. For the purposes of consolidated presentation,
the fund balance, as well as the positions of the other subsidiaries are presented according to the financial component.
|
(b)
|
Investments in CDBs classified as short-term investments are remunerated at an average rate of
100.0% of the CDI (106.9% of the CDI as at December 31, 2019). As at December 31, 2020, the “Crer Para Ver” line within
the exclusive fund is R$ 57,609 (R$ 38,018 as at December 31, 2019).
|
|
(c)
|
As of December 31, 2020, investments in Treasury bills are remunerated at an average rate of 136.61%
of the CDI (106% as at December 31, 2019).
|
|
(d)
|
As of December 31, 2020, investments in Government Bonds (LFT) are remunerated at an average rate
of 105.9% of the CDI (100.4% of the CDI on December 31, 2019).
|
The composition of the securities
that make up the portfolio of the Essential Investment Fund, in which the
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
Company and its subsidiaries hold 100% interest, on December
31, 2020 and 2019, is as follows:
|
Consolidated
|
|
2020
|
2019
|
Certificate of Bank Deposits (CDB)
|
292,878
|
21,327
|
Repurchase transactions (cash and cash equivalent)
|
576,108
|
1,192,101
|
Financial letter
|
505,152
|
374,690
|
Government bonds (LFT)
|
864,940
|
221,900
|
|
2,239,078
|
1,810,018
|
|
9.
|
TRADE ACCOUNTS RECEIVABLE
|
|
Consolidated
|
|
2020
|
2019
|
Trade accounts receivable
|
4,029,643
|
1,793,759
|
Allowance for expected credit losses
|
(432,108)
|
(107,995)
|
|
3,597,535
|
1,685,764
|
Maximum exposure to credit risk
at the reporting date is the carrying amount of each aging range, net of the allowance for expected credit losses, as shown in
the aging list below:
|
Consolidated
|
|
2020
|
2019
|
Current
|
1,988,583
|
1,501,958
|
Past due:
|
|
|
Up to 30 days
|
1,506,460
|
142,069
|
31 to 60 days
|
173,121
|
36,466
|
61 to 90 days
|
111,735
|
27,789
|
91 to 180 days
|
249,744
|
85,477
|
Allowance for expected credit losses
|
(432,108)
|
(107,995)
|
|
3,597,535
|
1,685,764
|
The changes in the allowance
for expected credit losses for the year ended December 31, 2020 and 2019 are as follows:
|
Consolidated
|
Balance as at December 31, 2018
|
(129,242)
|
Additions
|
(209,515)
|
Write-offs (a)
|
232,034
|
Exchange variation
|
(1,272)
|
Balance as at December 31, 2019
|
(107,995)
|
Additions
|
(640,676)
|
Write-offs/reversals (a)
|
372,659
|
Exchange variation
|
(56,096)
|
Balance as at December 31, 2020
|
(432,108)
|
|
(a)
|
Refers to accounts overdue for more than 180 days which are written off when the Company has no
expectation of recovering the trade accounts receivable and sales of customer portfolio.
|
The following table shows trade
accounts receivable by exposure to doubtful accounts on December 31, 2020:
|
Consolidated
|
|
Trade accounts receivable
|
Allowance for expected credit losses
|
Current
|
1,988,583
|
(53,352)
|
Past due:
|
|
|
Up to 30 days
|
1,506,460
|
(76,848)
|
31 to 60 days
|
173,121
|
(56,124)
|
61 to 90 days
|
111,735
|
(54,172)
|
91 to 180 days
|
249,744
|
(191,612)
|
|
4,029,643
|
(432,108)
|
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
|
Consolidated
|
|
2020
|
2019
|
Finished products
|
3,592,864
|
1,253,145
|
Raw materials and packaging
|
1,015,156
|
253,063
|
Consumables
|
170,188
|
82,228
|
Work in progress
|
36,025
|
27,346
|
Allowance for losses
|
(269,963)
|
(185,232)
|
|
4,544,270
|
1,430,550
|
The changes in the provision
for inventory losses for the year ended December 31, 2020 and 2019 are as follows:
|
Consolidated
|
Balance as at December 31, 2018
|
(178,268)
|
Additions, net (a)
|
(147,140)
|
Write-offs (b)
|
136,431
|
Exchange rate variation
|
3,745
|
Balance as at December 31, 2019
|
(185,232)
|
Additions, net (a)
|
(341,799)
|
Write-offs (b)
|
354,692
|
Exchange rate variation
|
(97,624)
|
Balance as at December 31, 2020
|
(269,963)
|
|
(a)
|
Refer to the recognition of net allowance for losses due to discontinuation, expiration and quality,
to cover expected losses on the realization of inventories, pursuant to the Company’s and its subsidiaries policy.
|
|
(b)
|
Consist of write-offs of products discarded by the Company and its subsidiaries.
|
|
Company
|
Consolidated
|
|
2020
|
2019
|
2020
|
2019
|
ICMS on purchase of goods (a)
|
-
|
-
|
681,147
|
434,832
|
Taxes on purchase of goods – foreign subsidiaries
|
-
|
-
|
230,260
|
39,475
|
ICMS on purchases of PP&E
|
-
|
-
|
9,578
|
10,628
|
PIS and COFINS on purchases of PP&E (b)
|
-
|
-
|
-
|
3,826
|
PIS and COFINS on purchase of goods (c)
|
-
|
-
|
780,841
|
280,087
|
Withholding PIS, COFINS and CSLL
|
-
|
-
|
1,669
|
2,378
|
Withholding income tax
|
23,637
|
-
|
23,637
|
-
|
Tax on Manufactured Products - IPI (d)
|
-
|
-
|
77,096
|
30,190
|
Other
|
-
|
5
|
199,333
|
3,438
|
|
23,637
|
5
|
2,003,561
|
804,854
|
|
|
|
|
|
Current
|
23,637
|
5
|
1,071,349
|
395,640
|
Non-current
|
-
|
-
|
932,212
|
409,214
|
|
(a)
|
Tax credits related to the accumulated Brazilian tax on the circulation of goods, interstate and
inter-municipal transport and communication services (“ICMS”) were generated mainly by purchases, whose tax rate is
higher than the average sales and by the increase in exports.
|
|
(b)
|
Brazilian taxes on the acquisition of fixed assets: Social Integration Programs (“PIS”)
and Contribution for Social Security Financing (“COFINS”).
|
|
(c)
|
The accumulated tax credits for PIS and COFINS basically arise from credits on purchases of raw
materials used in production. The realization of these credits normally occurs through offsetting with sales operations in the
domestic market.
|
|
(d)
|
The balance will be used to IPI payable in future operations of the Company's subsidiaries.
|
|
12.
|
INCOME TAX AND SOCIAL CONTRIBUTION
|
The deferred Corporate Income
Tax - IRPJ and Social Contribution on Net Income - CSLL amounts arise from temporary differences in the subsidiaries. For certain
subsidiaries and the Company, deferred tax balances on tax losses were also recognized.
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
The amounts are as follows:
|
i)
|
Breakdown of deferred income tax and social contribution – Assets:
|
|
Consolidated
|
|
2020
|
2019
|
Tax loss carryforwards and negative basis of social contribution tax
|
456,567
|
193,566
|
Allowance for doubtful accounts
|
133,162
|
51,151
|
Allowance for losses on inventories
|
101,237
|
50,593
|
Provision for tax, civil and labor contingencies
|
57,560
|
53,377
|
Provision for ICMS – ST
|
19,552
|
24,659
|
Allowances for losses on advances to suppliers
|
265
|
898
|
Accrued benefits sharing and partnerships
|
25,912
|
17,483
|
Provision for profit sharing
|
77,434
|
54,427
|
Provision carbon credits
|
9,848
|
8,297
|
Profit not realized in inventories
|
40,706
|
32,899
|
INSS with Suspended Liability
|
-
|
17,757
|
Lease
|
30,493
|
22,268
|
Other expenses provision (a)
|
332,985
|
60,886
|
Post-employment healthcare plan
|
35,553
|
33,589
|
Net Operating Loss and Other Deduction Carryforwards
|
263,121
|
-
|
Stock option plan
|
334,416
|
112,095
|
Other temporary differences
|
208,279
|
35,323
|
Deferred income tax and social contribution assets
|
2,127,090
|
769,268
|
Effect of changes in fair value of derivative instruments, including
hedge accounting transactions
|
(638,071)
|
(247,163)
|
Amortization and depreciation - useful life differences
|
(104,750)
|
(118,632)
|
Fair value of identifiable net assets in business combinations of Emeis Holdings Pty Ltd
|
-
|
(24,516)
|
Provision/(reversal) for losses - property and intangible assets
|
(44,544)
|
(4,509)
|
Deferred income tax and social contribution liability
|
(787,365)
|
(394,820)
|
Total of Deferred income tax and social contribution
|
1,339,725
|
374,448
|
|
a)
|
Refers to temporary differences arising from the provision for invoices for services and suppliers
recorded for which invoices have not yet been issued.
|
Management assesses the possibility
of offsetting deferred income tax assets and deferred income tax liabilities according to each jurisdiction. As a result, there
are as income position deferred liabilities for Avon, The Body Shop and Aesop.
Management monitors the performance
of all its entities and evaluates whether deferred tax assets can be realized from the four sources of taxable income: loss carryback
potential, reversing taxable temporary differences, tax planning opportunities and forecasts of future taxable income. The Company
does not have deferred tax assets that cannot be supported by one or more of these sources of income.
|
ii)
|
Breakdown of deferred income tax and social contribution – Liabilities:
|
|
Consolidated
|
|
2020
|
2019
|
Fair value of identifiable net assets in business combination (a)
|
1,288,045
|
450,561
|
|
a)
|
The balance includes deferred income tax liability on the fair value of net identifiable assets in the acquisition of Avon,
The Body Shop and Aesop.
|
The Company has not recognized
certain deferred tax assets on losses. These losses relate to subsidiaries that have a history of losses and may not be used to
offset taxable income elsewhere in the Company. The subsidiaries neither have any taxable temporary difference nor any tax planning
opportunities available that could partly support the recognition of these losses as deferred tax assets. On this basis, the Company
has determined that it cannot recognize deferred tax assets on the tax losses carried forward.
Description
|
Amount
|
Indefinite
Expiration
|
Definite
Expiration
|
Net Operating Loss (a)
|
11,733,876
|
10,401,642
|
1,332,234
|
Credits (b)
|
96,893
|
-
|
96,893
|
Other Future Deductible Items
|
1,538,418
|
100,068
|
1,438,350
|
Total
|
13,369,187
|
10,501,710
|
2,867,477
|
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
|
a)
|
During 2021, expirations of approximately R$31 million are expected, the remaining expirations
would start to occur in 2022 and future period with the majority of loss/deduction carryforwards subject to expiration in 2031
and beyond.
|
|
b)
|
During 2021, expirations of approximately R$26 million are expected, the remaining expirations
would start to occur in 2022 with the vast majority of utilizable credits subject to expiration in 2027. In addition, R$ 2,4 million
of credits are currently subject to limitation, are not utilizable and will expire unutilized during 2022 to 2026.
|
Management continuously evaluates
tax planning opportunities to prevent tax attributes from expiring unutilized.
As of December 31, 2020, there are no prudent and feasible tax planning opportunities that management would and could implement.
In addition, for the attributes noted above, there are no
other sources of income available and as a result, these attributes remain unrecognized.
Management
continuously evaluates all sources of income to allow unrecognized deferred tax asset to become recognized when it is probable
that there are sufficient sources of income to allow for their recognition. Generally, recognition will occur when there
is a history of profits that can be sustained and relied upon in the future and/or when facts/circumstances change indicating that
a history of losses has been overcome due to elimination of loss making factors, changes in operations and other factors
|
12.2
|
Reconciliation of income tax and social contribution:
|
|
Company
|
Consolidated
|
|
2020
|
2019
|
2020
|
2019
|
|
|
|
|
|
Income / (loss) After income tax and social contribution
|
-
|
(157,710)
|
-
|
304,566
|
Taxes on Company Formation (a)
|
-
|
206,592
|
-
|
206,592
|
Income / (loss) before income tax and social contribution (b)
|
(650,196)
|
48,882
|
(388,935)
|
511,158
|
Income tax and social contribution at the rate of 34%
|
221,067
|
16,620
|
132,238
|
(173,794)
|
Benefit of expenses with research and technological innovation
|
-
|
-
|
23,033
|
19,228
|
Tax incentives
|
-
|
-
|
10,018
|
12,457
|
Subsidy for investments (c)
|
-
|
-
|
128,173
|
24,864
|
Effect from differences of tax rates of entities abroad
|
-
|
-
|
(166,394)
|
26,907
|
Taxation of profits of subsidiaries abroad
|
-
|
-
|
(56,194)
|
(60,305)
|
Unrecognized tax benefits
|
(221,067)
|
(3,635)
|
(104,160)
|
(8,893)
|
Tax Benefits of interest on equity (IOE)
|
-
|
-
|
10,275
|
37,628
|
Exercise of stock options and restricted stock plans
|
-
|
-
|
(9,770)
|
9,696
|
Non-Deductible Donation/Contribution
|
-
|
-
|
(12,509)
|
(4,146)
|
UK Tax Law Rate Change (d)
|
-
|
-
|
(63,428)
|
-
|
Withholding Taxes
|
-
|
-
|
(63,754)
|
-
|
Imputed Income
|
-
|
-
|
(67,529)
|
(1,176)
|
Other permanent differences
|
-
|
(2,867)
|
(34,743)
|
(31,556)
|
Income tax and social contribution expenses
|
-
|
10,118
|
(274,744)
|
(149,099)
|
|
|
|
|
|
Income tax and social contribution - current
|
-
|
10,118
|
(292,828)
|
(94,781)
|
Income tax and social contribution - deferred
|
-
|
|
18,084
|
(54,319)
|
|
|
|
|
|
Effective Rate- %
|
-
|
(20.7)
|
(70.6)
|
29.2
|
|
(a)
|
Tax levied on the formation of the Company resulting from the difference between Natura's accounting
balances and the acquisition cost used for the purpose of the contribution of shares issued by Natura to the Company's capital
stock (note 24). Management believes that, although the amount of the aforementioned special capital reserve constitutes part of
the taxable profit for tax purposes in Brazil, the nature of this amount is different from the nature of other sources of taxable
profit under the scope of IAS 12 (CPC 32). The main differences are (i) the Company did not generate taxable profits and this tax
is mainly related to the increase in equity that generates the special reserve for statutory purposes; (ii) the creation of the
special reserve is, in substance, a matter of reclassification; (iii) the tax is levied on the entity as a result of an additional
increase in the equity of the contribution made to the Company; and (iv) the Company's future profits, as well as Natura's future
and historical profits will continue to be taxed in accordance with tax legislation. The tax on the formation of the Company was
recognized in the income statement and presented as "Taxes on the formation of the Company".
|
|
(b)
|
The loss before tax consolidated related to 2020 is considering the results of continuing and discontinued
operations.
|
|
(c)
|
The Company has tax incentives arising from its ordinary operations (Grant Investment).
|
|
(d)
|
During 2020, the income tax rate in the UK was changed from 17% to 19% which resulted in an increase
in the Company’s Deferred Tax Liabilities associated with the UK.
Such increase was accrued through deferred income tax expense during 2020.
|
The movement in deferred asset
and liability income tax and social contribution for the period ended December 31, 2020 were as follows:
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
|
Consolidated
|
|
Asset
|
Liability
|
Balance at December 31, 2019
|
374,448
|
(450,561)
|
Effect on profit or loss
|
(19,639)
|
37,723
|
Reserve for grant of options and restricted shares
|
96,181
|
-
|
Effect on other comprehensive income
|
(61,658)
|
-
|
Currency Translation Effect
|
283,359
|
(314,527)
|
Business combination
|
667,034
|
(560,680)
|
Balance at December 31, 2020
|
1,339,725
|
(1,288,045)
|
Judicial deposits represent
restricted assets of the Company and its subsidiaries and are related to the amounts deposited and held in court until the resolution
of the disputes to which they are related. The judicial deposits held by the Company and its subsidiaries as at December 31, 2020
and 2019 are as follows:
|
Consolidated
|
|
2020
|
2019
|
Unaccrued tax lawsuits (a)
|
262,654
|
203,403
|
Accrued tax lawsuits (b)
|
252,961
|
116,415
|
Unaccrued civil lawsuits
|
9,671
|
2,541
|
Accrued civil lawsuits
|
2,189
|
426
|
Unaccrued labor lawsuits
|
14,166
|
8,683
|
Accrued labor lawsuits
|
24,549
|
5,787
|
Total judicial deposits
|
566,190
|
337,255
|
|
(a)
|
The tax procedure related to these judicial deposits refer mainly to the ICMS-ST, disclosed in
note 23.1.1, contingent liabilities - possible risk of loss.
|
|
(b)
|
The tax procedure related to these judicial deposits refer, substantially, to the sum of the amounts
disclosed in note 23.2.1, and the amounts presented in note 22.
|
Changes in escrow deposits balances
for the year ended December 31, 2020 and 2019 are presented below:
|
Consolidated
|
Balance at December 31, 2018
|
333,577
|
New deposits
|
2,542
|
Redemptions
|
(7,556)
|
Interests
|
13,352
|
Payments / Write-offs for expenses
|
(4,660)
|
Balance at December 31, 2019
|
337,255
|
Acquisition of subsidiary
|
283,885
|
New deposits
|
18,377
|
Redemptions
|
(64,761)
|
Interests
|
11,242
|
Payments / Write-offs for expenses
|
(17,739)
|
Exchange variance
|
(2,069)
|
Balance at December 31, 2020
|
566,190
|
Besides to judicial deposits,
the Company and its subsidiaries have insurance policies to guarantee certain lawsuits. Details of these insurances are presented
in note 35.
|
14
|
NON-CURRENT ASSETS HELD FOR SALE
|
The assets classified as held
for sale were acquired in the acquisition process of Avon (note 4). The change in the balance for the year ended December 31, 2020
is as follows:
|
Consolidated
|
Balance as at December 31, 2019
|
-
|
Avon acquisition
|
199,050
|
Additions (a)
|
25,779
|
Transfer to fixed assets (b)
|
(29,610)
|
Sale (c)
|
(61,760)
|
Exchange rate variation
|
47,820
|
Balance as at December 31, 2020
|
181,279
|
|
a)
|
During the fourth quarter of 2020, Avon made its operations in Saudi Arabia available for sale.
|
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
|
b)
|
During the first quarter of 2020, Avon identified new circumstances that, previously, were considered
unlikely and, as a result, decided not to proceed with the sale of two properties, one located in Brazil and the other, in Romania.
As a result, the subsidiary reclassified such properties from “Held for sale” to “Property, plant and equipment”
(“PP&E”). At the time of the reclassification, the depreciation was recorded, resulting in an immaterial impact
on the consolidated financial statements.
|
|
c)
|
During the third quarter of 2020, Avon complete the sale of two properties: (i) a distribution
center located in Hungary, and (ii) a plant located in China.
|
As of December 31, 2020, assets
held for sale include Avon properties, located in Brazil, Spain and Saudi Arabia.
|
15
|
OTHER CURRENT AND NON-CURRENT ASSETS
|
|
Company
|
Consolidated
|
|
2020
|
2019
|
2020
|
2019
|
Advance for advertising and marketing
|
-
|
-
|
42,233
|
28,669
|
Advances to suppliers
|
-
|
-
|
257,099
|
102,225
|
Advances to employees
|
-
|
-
|
65,180
|
13,983
|
Advance and security deposit for rent (a)
|
-
|
-
|
169,958
|
96,202
|
Prepaid insurance expenses
|
-
|
-
|
200,074
|
29,647
|
Surplus pension plan (b)
|
-
|
-
|
683,425
|
-
|
Advances to customs broker - Import taxes
|
-
|
-
|
34,016
|
34,932
|
Sublease receivables (c)
|
-
|
-
|
357,538
|
-
|
Carbon credits
|
-
|
-
|
4,097
|
3,508
|
Receivables from service providers (d)
|
-
|
-
|
135,030
|
-
|
Other
|
2,127
|
-
|
195,138
|
39,868
|
|
2,127
|
-
|
2,143,788
|
349,034
|
|
|
|
|
|
Current
|
1,979
|
-
|
616,120
|
265,198
|
Non-current
|
148
|
-
|
1,527,668
|
83,836
|
|
a)
|
Mainly related to: (i) advances of rental agreements that were not included in the initial measurement
of lease liabilities / right-of-use of the subsidiary The Body Shop, in accordance with the exemptions on IFRS 16 / CPC 06(R2);
and (ii) security deposits for the rental of certain stores of the subsidiaries The Body Shop and Aesop, which will be returned
by the landlord at the end of the rental agreements.
|
|
b)
|
Pension plan arising from the acquisition of Avon (note 4 and 29.2).
|
|
c)
|
Refers to the sublease receivable from the New York office owned by Avon.
|
|
d)
|
Refers to receivables mainly arising from damage that occurred with carriers and insurance companies.
|
|
Company
|
|
2020
|
2019
|
Investments in subsidiaries, net of losses
|
15,433,251
|
3,392,677
|
Goodwill from the acquisition of Avon (Note 4)
|
11,511,028
|
-
|
Total
|
26,944,279
|
3,392,677
|
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
Information and changes in the
balances for the years ended on December 31, 2020 and 2019:
|
Natura Cosméticos S.A. (1)
|
Avon Products, Inc.
|
Natura &Co International S.à r.l.
|
Total
|
Percentage of participation
|
100.00%
|
100.00%
|
100.00%
|
|
Equity of subsidiaries
|
6,929,074
|
(4,583,531)
|
5,641,757
|
7,987,300
|
|
|
|
|
|
Equity participation (capital deficit)
|
6,929,074
|
(4,583,531)
|
5,641,757
|
7,987,300
|
Fair value adjustment of acquired assets and liabilities
|
-
|
7,445,951
|
-
|
7,445,951
|
Goodwill
|
-
|
11,511,028
|
-
|
11,511,028
|
Total
|
6,929,074
|
14,373,448
|
5,641,757
|
26,944,279
|
|
|
|
|
|
Subsidiaries net income (loss) for the year
|
1,102,271
|
(1,527,153)
|
32,103
|
(392,779)
|
|
|
|
|
|
Balances on December 31, 2018
|
-
|
-
|
-
|
-
|
Share of profit (loss) of equity investees
|
89,332
|
-
|
-
|
89,332
|
Exchange rate variation and other adjustments in the translation of investments of foreign subsidiaries
|
(73,268)
|
-
|
-
|
(73,268)
|
Effect of hyperinflationary economy adjustment
|
(1,428)
|
-
|
-
|
(1,428)
|
Actuarial gain (loss), net of taxes
|
(4,186)
|
-
|
-
|
(4,186)
|
Contribution of the Parent Company to stock option plans granted to subsidiaries executives and other reserves, net of tax effects
|
36,423
|
-
|
-
|
36,423
|
Effect of hedge accounting, net of tax effects
|
(15,972)
|
-
|
-
|
(15,972)
|
Effect of change in interest in subsidiary
|
519,090
|
-
|
-
|
519,090
|
Capital increase
|
2,842,686
|
-
|
-
|
2,842,686
|
Balances on December 31, 2019
|
3,392,677
|
-
|
-
|
3,392,677
|
|
|
|
|
|
Share of the profit (loss) of equity investees
|
1,102,271
|
(1,527,153)
|
32,103
|
(392,779)
|
Exchange rate variation and other adjustments in the conversion of investments of foreign subsidiaries
|
1,970,795
|
1,870,219
|
(456,731)
|
3,384,283
|
Unrealized losses on the revaluation of balances between companies
|
-
|
350,950
|
-
|
350,950
|
Hyperinflationary economy adjustment effect
|
66,788
|
-
|
-
|
66,788
|
Contribution of the Parent Company to stock option plans granted to subsidiaries executives and other reserves, net of tax effects
|
127,930
|
-
|
-
|
127,930
|
Effect on hedge accounting, net of tax effects
|
116,348
|
-
|
-
|
116,348
|
OCI from benefit and defined contribution plans
|
(19,555)
|
(61,399)
|
-
|
(80,954)
|
Capital increase
|
300,000
|
465,936
|
6,066,328
|
6,832,264
|
Distribution of dividends and interest on own equity
|
(128,180)
|
-
|
-
|
(128,180)
|
Write-offs Avon PSU plans
|
-
|
(91,219)
|
-
|
(91,219)
|
Acquisition value
|
-
|
13,366,114
|
57
|
13,366,171
|
Balances at December 31, 2020
|
6,929,074
|
14,373,448
|
5,641,757
|
26,944,279
|
|
(1)
|
The investment balance in the direct subsidiary Natura Cosméticos
S.A. includes goodwill arising from the acquisitions of the indirect subsidiaries TBS (R$ 1,946,742) and Aesop (R$ 142,090) the
according note 18.
|
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
|
17
|
PROPERTY, PLANT AND EQUIPMENT
|
|
Consolidated
|
|
Useful life range
(in years)
|
2019
|
Company acquisition
|
Additions
|
Write-offs
|
impairment
|
Transfers
|
Exchange rate variation
|
2020
|
Cost:
|
|
|
|
|
|
|
|
|
|
Vehicles
|
2 to 5
|
45,578
|
25,789
|
14,594
|
(17,274)
|
-
|
1,184
|
9,356
|
79,227
|
Templates
|
3
|
192,556
|
-
|
1,243
|
(19,713)
|
-
|
5,650
|
8,116
|
187,852
|
Tools and accessories
|
3 to20
|
11,974
|
52,410
|
11,625
|
(1,743)
|
-
|
5,888
|
5,524
|
85,678
|
Facilities
|
3 to 60
|
309,772
|
1,431
|
81
|
(3,599)
|
-
|
8,791
|
(23,005)
|
293,471
|
Machinery and accessories
|
3 to 15
|
866,451
|
740,328
|
20,098
|
(5,134)
|
-
|
58,649
|
139,301
|
1,819,693
|
Leasehold improvements
|
2 to 20
|
615,103
|
58,548
|
34,324
|
(8,761)
|
-
|
51,588
|
213,155
|
963,957
|
Buildings
|
14 to 60
|
386,957
|
1,203,081
|
12,275
|
-
|
(115)
|
48,551
|
248,427
|
1,899,176
|
Furniture and fixture
|
2 to 25
|
397,727
|
32,566
|
32,530
|
(6,300)
|
(26)
|
11,239
|
98,812
|
566,548
|
Land
|
-
|
35,157
|
570,572
|
57
|
-
|
-
|
4,252
|
51,575
|
661,613
|
IT equipment
|
3 to 15
|
297,228
|
112,369
|
27,254
|
(10,652)
|
-
|
36,554
|
81,019
|
543,772
|
Other assets
|
-
|
-
|
36,423
|
-
|
-
|
-
|
-
|
264
|
36,687
|
Projects in progress
|
-
|
156,011
|
78,965
|
440,170
|
(592)
|
-
|
(305,305)
|
39,136
|
408,385
|
Total cost
|
|
3,314,514
|
2,912,482
|
594,251
|
(73,768)
|
(141)
|
(72,959)
|
871,680
|
7,546,059
|
|
|
|
|
|
|
|
|
|
|
Accumulated depreciation
|
|
|
|
|
|
|
|
|
|
Vehicles
|
|
(16,924)
|
-
|
(24,150)
|
10,081
|
-
|
(2,093)
|
44
|
(33,042)
|
Templates
|
|
(175,938)
|
-
|
(10,092)
|
19,684
|
-
|
-
|
(190)
|
(166,536)
|
Tools and accessories
|
|
(3,255)
|
-
|
(42,932)
|
-
|
-
|
10
|
7,018
|
(39,159)
|
Facilities
|
|
(167,362)
|
-
|
(19,933)
|
285
|
-
|
1,044
|
9,240
|
(176,726)
|
Machinery and accessories
|
|
(416,736)
|
-
|
(193,657)
|
2,759
|
-
|
(1,202)
|
30,074
|
(578,762)
|
Leasehold improvements
|
|
(267,371)
|
-
|
(130,631)
|
7,124
|
(4,900)
|
(4,107)
|
(80,669)
|
(480,554)
|
Buildings
|
|
(101,785)
|
-
|
(88,593)
|
-
|
-
|
-
|
10,649
|
(179,729)
|
Furniture and fixture
|
|
(193,973)
|
-
|
(81,287)
|
4,744
|
(284)
|
4,093
|
(51,904)
|
(318,611)
|
IT equipment
|
|
(197,281)
|
-
|
(96,768)
|
8,591
|
(36)
|
-
|
(26,362)
|
(311,856)
|
Other assets
|
|
-
|
-
|
(25,078)
|
-
|
-
|
-
|
(949)
|
(26,027)
|
Total accumulated depreciation
|
|
(1,540,625)
|
-
|
(713,121)
|
53,268
|
(5,220)
|
(2,255)
|
(103,049)
|
(2,311,002)
|
Net total
|
|
1,773,889
|
2,912,482
|
(118,870)
|
(20,500)
|
(5,361)
|
(75,214)
|
768,631
|
5,235,057
|
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
|
Consolidated
|
|
Useful life range (in years)
|
2018
|
Additions
|
Write-offs
|
impairment
|
Transfers
|
Other changes including exchange rate variation
|
2019
|
Cost
|
|
|
|
|
|
|
|
|
Vehicles
|
2 to 5
|
78,072
|
12,463
|
(41,883)
|
-
|
99
|
(3,173)
|
45,578
|
Templates
|
3
|
203,814
|
1,499
|
(23,823)
|
-
|
10,874
|
192
|
192,556
|
Tools and accessories
|
3 to 20
|
8,161
|
314
|
(445)
|
-
|
3,910
|
34
|
11,974
|
Facilities
|
3 to 60
|
310,282
|
49
|
-
|
-
|
(1,534)
|
975
|
309,772
|
Machinery and accessories
|
3 to 15
|
819,919
|
9,563
|
(1,259)
|
-
|
54,336
|
(16,108)
|
866,451
|
Leasehold improvements
|
2 to 20
|
577,217
|
46,869
|
(23,243)
|
(1,958)
|
20,645
|
(4,427)
|
615,103
|
Buildings
|
14 to 60
|
940,002
|
2,245
|
-
|
(887)
|
(555,221)
|
818
|
386,957
|
Furniture and fixture
|
2 to 25
|
362,817
|
40,118
|
(3,031)
|
(3,514)
|
16,978
|
(15,641)
|
397,727
|
Land
|
-
|
30,525
|
-
|
-
|
-
|
4,653
|
(21)
|
35,157
|
IT equipment
|
3 to 15
|
263,524
|
21,976
|
(3,902)
|
-
|
18,483
|
(2,853)
|
297,228
|
Projects in progress
|
-
|
103,463
|
204,107
|
(2,247)
|
-
|
(146,598)
|
(2,714)
|
156,011
|
Total cost
|
|
3,697,796
|
339,203
|
(99,833)
|
(6,359)
|
(573,375)
|
(42,918)
|
3,314,514
|
|
|
|
|
|
|
|
|
|
Accumulated depreciation
|
|
|
|
|
|
|
|
|
Vehicles
|
|
(31,784)
|
(15,832)
|
27,478
|
-
|
(7)
|
3,221
|
(16,924)
|
Templates
|
|
(191,501)
|
(8,314)
|
23,739
|
-
|
148
|
(10)
|
(175,938)
|
Tools and accessories
|
|
(2,954)
|
(687)
|
410
|
-
|
-
|
(24)
|
(3,255)
|
Facilities
|
|
(147,309)
|
(20,703)
|
-
|
-
|
1,234
|
(584)
|
(167,362)
|
Machinery and accessories
|
|
(379,050)
|
(56,617)
|
657
|
-
|
-
|
18,274
|
(416,736)
|
Leasehold improvements
|
|
(217,167)
|
(90,281)
|
19,089
|
-
|
5,292
|
15,696
|
(267,371)
|
Buildings
|
|
(191,422)
|
(7,315)
|
-
|
-
|
96,558
|
394
|
(101,785)
|
Furniture and fixture
|
|
(138,078)
|
(78,988)
|
2,734
|
-
|
(184)
|
20,543
|
(193,973)
|
IT equipment
|
|
(161,817)
|
(44,606)
|
3,443
|
-
|
(936)
|
6,635
|
(197,281)
|
Total accrued depreciation
|
|
(1,461,082)
|
(323,343)
|
77,550
|
-
|
102,105
|
64,145
|
(1,540,625)
|
Net total
|
|
2,236,714
|
15,860
|
(22,283)
|
(6,359)
|
(471,270)
|
21,227
|
1,773,889
|
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
|
Consolidated
|
|
Useful life range (years)
|
2019
|
Acquisition of subsidiary
|
Additions
|
Write-offs
|
Reversal (provision) of impairment
|
Transfers
|
Other changes including exchange rate variation
|
2020
|
Cost
|
|
|
|
|
|
|
|
|
|
Software
|
2.5 to 10
|
1,313,090
|
291,555
|
82,718
|
(15,095)
|
-
|
258,092
|
128,790
|
2,059,150
|
Trademarks and patents (Defined useful life)
|
20 to 25
|
116,805
|
517,592
|
-
|
-
|
-
|
-
|
260,181
|
894,578
|
Trademarks and patents (Indefinite useful life)
|
-
|
2,171,585
|
2,022,163
|
-
|
-
|
-
|
-
|
1,553,309
|
5,747,057
|
Goodwill Avon (Note 4)
|
|
-
|
11,511,028
|
-
|
-
|
-
|
-
|
1,788,821
|
13,299,849
|
Goodwill Emeis Brazil Pty Ltd. (a)
|
-
|
100,237
|
-
|
-
|
-
|
-
|
-
|
41,853
|
142,090
|
Goodwill The Body Shop (b)
|
-
|
1,434,369
|
34,251
|
-
|
-
|
-
|
-
|
478,121
|
1,946,741
|
Goodwill acquisition of TBS stores
|
-
|
1,456
|
-
|
-
|
-
|
-
|
-
|
-
|
1,456
|
Relationship with retail clients
|
10
|
1,987
|
-
|
-
|
-
|
-
|
-
|
798
|
2,785
|
Key money (indefinite useful life) (c)
|
-
|
17,801
|
-
|
-
|
-
|
-
|
1,315
|
7,653
|
26,769
|
Key money (Defined useful life) (d)
|
3 to 18
|
12,447
|
-
|
150
|
-
|
(2,051)
|
1,647
|
(1,333)
|
10,860
|
Relationship with franchisees and sub franchisees and sales representatives (e)
|
7 to 15
|
602,958
|
1,884,249
|
-
|
-
|
-
|
-
|
472,312
|
2,959,519
|
Technology developed (by acquired subsidiary)
|
5
|
-
|
1,131,573
|
-
|
-
|
-
|
-
|
463,468
|
1,595,041
|
Other intangible assets
|
2 to 10
|
110,288
|
159
|
176,015
|
(15,024)
|
-
|
(175,414)
|
12,251
|
108,275
|
Total cost
|
|
5,883,023
|
17,392,570
|
258,883
|
(30,119)
|
(2,051)
|
85,640
|
5,206,224
|
28,794,170
|
|
|
|
|
|
|
|
|
|
|
Accumulated amortization
|
|
|
|
|
|
|
|
|
|
Software
|
|
(649,347)
|
-
|
(365,184)
|
44
|
-
|
(3,643)
|
(4,368)
|
(1,022,498)
|
Trademarks and patents
|
|
(44,108)
|
-
|
(36,548)
|
-
|
-
|
-
|
(19,387)
|
(100,043)
|
Key money
|
|
(2,197)
|
-
|
(535)
|
-
|
-
|
10
|
(6,149)
|
(8,871)
|
Relationship with retail clients
|
|
(1,939)
|
-
|
(252)
|
-
|
-
|
-
|
(648)
|
(2,839)
|
Relationship with franchisees and sub franchisees and sales representatives
|
|
(95,772)
|
-
|
(278,048)
|
-
|
-
|
-
|
(45,241)
|
(419,061)
|
Technology developed
|
|
-
|
-
|
(294,713)
|
-
|
-
|
-
|
(24,296)
|
(319,009)
|
Other intangible assets
|
|
(13,159)
|
-
|
(6,496)
|
15,020
|
-
|
-
|
(86)
|
(4,721)
|
Total accumulated amortization
|
|
(806,522)
|
-
|
(981,776)
|
15,064
|
-
|
(3,633)
|
(100,175)
|
(1,877,042)
|
Net total
|
|
5,076,501
|
17,392,570
|
(722,893)
|
(15,055)
|
(2,051)
|
82,007
|
5,106,049
|
26,917,128
|
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
|
Consolidated
|
|
Useful life range (years)
|
2018
|
Additions
|
Write-offs
|
Reversal (provision) of impairment
|
Transfers
|
Other changes including exchange variation
|
2019
|
Cost
|
|
|
|
|
|
|
|
|
Software
|
2.5 to 10
|
1,089,900
|
83,064
|
(546)
|
-
|
118,442
|
22,230
|
1,313,090
|
Trademarks and patents (Defined useful life)
|
20 to 25
|
111,801
|
-
|
-
|
-
|
(154)
|
5,158
|
116,805
|
Trademarks and patents (Indefinite useful life)
|
-
|
2,040,067
|
-
|
-
|
-
|
-
|
131,518
|
2,171,585
|
Goodwill Emeis Brazil Pty Ltd. (a)
|
-
|
96,867
|
-
|
-
|
-
|
-
|
3,370
|
100,237
|
Goodwill The Body Shop (b)
|
-
|
1,348,670
|
-
|
-
|
-
|
-
|
85,699
|
1,434,369
|
Goodwill acquisition of The Body Shop stores
|
-
|
1,456
|
-
|
|
|
|
-
|
1,456
|
Relationship with retail clients
|
10
|
1,740
|
-
|
-
|
-
|
-
|
247
|
1,987
|
Key money (indefinite useful life) (c)
|
-
|
102,310
|
-
|
-
|
-
|
(101,001)
|
16,492
|
17,801
|
Key money (Defined useful life) (d)
|
3 to 18
|
48,888
|
-
|
-
|
2,818
|
(39,283)
|
24
|
12,447
|
Relationship with franchisees and sub franchisees (e)
|
7 to 15
|
590,588
|
-
|
(17,958)
|
-
|
(371)
|
30,699
|
602,958
|
Technology developed (by acquired subsidiary)
|
5
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Other intangible assets
|
2 to 10
|
121,697
|
145,483
|
(1,133)
|
-
|
(146,364)
|
(9,395)
|
110,288
|
Total cost
|
|
5,553,984
|
228,547
|
(19,637)
|
2,818
|
(168,731)
|
286,042
|
5,883,023
|
|
|
|
|
|
|
|
|
|
Accumulated amortization
|
|
|
|
|
|
|
|
|
Software
|
|
(483,666)
|
(169,174)
|
6,817
|
-
|
270
|
(3,594)
|
(649,347)
|
Trademarks and patents
|
|
(37,898)
|
(4,330)
|
-
|
-
|
154
|
(2,034)
|
(44,108)
|
Key money
|
|
(2,835)
|
-
|
-
|
-
|
7,336
|
(6,698)
|
(2,197)
|
Relationships with retail clients
|
|
(1,149)
|
(194)
|
-
|
-
|
-
|
(596)
|
(1,939)
|
Relationship with franchisees and sub franchisees
|
|
(55,508)
|
(43,150)
|
-
|
-
|
371
|
2,515
|
(95,772)
|
Technology developed
|
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Other intangible assets
|
|
(22,383)
|
(1,601)
|
585
|
-
|
261
|
9,979
|
(13,159)
|
Total accrued amortization
|
|
(603,439)
|
(218,449)
|
7,402
|
-
|
8,392
|
(428)
|
(806,522)
|
Net total
|
|
4,950,545
|
10,098
|
(12,235)
|
2,818
|
(160,339)
|
285,614
|
5,076,501
|
|
|
|
|
|
|
|
|
|
|
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
|
a)
|
Goodwill related to the acquisition of Emeis Holdings Pty Ltd. acquisition,
classified as future economic benefits from synergies. It does not have defined useful life and it is subject to annual impairment
tests.
|
|
b)
|
Goodwill related to the acquisition of The Body Shop, classified as future
economic benefits from synergies. It does not have defined useful life and it is subject to annual impairment tests. In addition,
on June 30, 2020, The Body Shop International Limited acquired the entity Aeon Forest Co. Ltd, for R$ 133,275 (¥ 2,632,000).
On October 1st, 2020, the transaction was concluded and resulted in an assigned amount of goodwill of R$ 34,251.
|
|
c)
|
Key money with indefinite useful life refers to payments made to former
tenants, to get the right to rent the property under lease and can be subsequently negotiated with future tenants in the case of
termination of the lease agreement. This balance was considered the scope of the lease standard (CPC 06 (R2) / IFRS 16), applicable
from January 1st, 2019 (note 3.29). The balance not reclassified to the right of use asset, refers to contracts that
the standard exempts on the initial date, that is, short-term contracts. The remaining balance is not amortized and is subject
to an annual impairment test.
|
|
d)
|
Key money with defined useful life refers to payments made to ex-tenants
or lessors, to obtain the right to rent the property under the terms of the lease and which cannot be negotiated or recovered later.
This balance was considered as the scope of the lease standard (CPC 06 (R2) / IFRS 16), applicable from January 1st,
2019. The balance not reclassified to the Right of Use asset, refers to contracts that the standard exempt on the initial date,
that is, short-term contracts. The remaining balance is amortized over the term of the agreements.
|
|
e)
|
The balance refers to identifiable intangible assets from relationship
with The Body Shop franchisees and sub-franchisees (relationship where the franchisee owns all rights to operate within a territory)
and sub-franchisees (relationship where a franchisee operate a single store within a market), with estimated useful life of 15
years. In 2019 there is a write-off related to agreements with sub-franchisees in Brazil. In addition, the balance position classified
as the acquisition of a subsidiary represents the fair value of the relationship between Avon and its sales representatives.
|
|
a)
|
Impairment test of intangible assets with indefinite useful lives
|
Goodwill
arising from expected future profitability of acquired companies and intangible assets with an indefinite useful life were allocated
to the subsidiaries’ CGU groups. The accordance with CPC 01 (R1) / IAS 36 - Impairment of Assets, when a CGU or group of
CGU has an intangible asset with an indefinite allocated life, the Company must annually perform the impairment test of its book
value. The groups of CGU with intangible assets with indefinite useful life as at December 31, 2020 are presented below:
CGU groups
|
Trademarks and patents
|
Goodwill
|
Total
|
|
2020
|
2019
|
2020
|
2019
|
2020
|
2019
|
Natura &Co Latam
|
5,403
|
2,566
|
9,994,861
|
-
|
10,000,264
|
2,566
|
Avon International
|
2,850,397
|
-
|
3,304,988
|
-
|
6,155,385
|
-
|
TBS International
|
2,891,257
|
2,169,019
|
1,946,741
|
1,434,369
|
4,837,998
|
3,603,388
|
Aesop International
|
-
|
-
|
142,090
|
100,238
|
142,090
|
100,238
|
Total
|
5,747,057
|
2,171,585
|
15,388,680
|
1,534,607
|
21,135,737
|
3,706,192
|
The main assumptions used
to calculate the fair value less cost to sell as at December 31, 2020 are presented below:
|
Aesop
|
The Body Shop
|
Avon International
|
Natura &Co Latam
|
Measurement of recoverable value (fair value less cost to sell)
|
Discounted cash flow based on financial budgets approved by Senior Management during a discretionary period of five years with a terminal value projected for the end of the period.
|
Budgeted gross margin
|
Gross margins are based on average amounts obtained in the 2 years prior to the beginning of the budgeted period and projections for the next 5 years.
|
Estimated cost
|
Costs based on historical data and market trends, optimization of retail and direct sales operations (renewal of the geographical presence of stores, revitalization of the franchise network) and physical expansion with growth in market share.
|
Perpetuity growth rate (*)
|
Constant growth of 4.20%.
|
Constant growth of 4.10%.
|
Constant growth of 4.30%.
|
Constant growth of 5.50%.
|
Discount rate (WACC)
|
Discount rates represent the risk assessment in the current market, specific to each group of CGU, taking into account the value of money over time and the individual risks of related assets that were not incorporated in the assumptions included in the cash flow model. These cash flows were discounted using a discount rate of 13.42% p.a. for Natura &Co Latam, 11.14% p.a. for Avon International, 7.80% p.a. for TBS International and 9.11% p.a. for Aesop International, in real terms. The discount rate was based on the weighted average cost of capital that reflects the specific risk of each segment.
|
(*) The rates are based
on published market analyzes and projections with regard to the operating segment in which they operate and adjusted to reflect
the assumptions considered by Management in the approved projections and to reflect the inflation differential of other currencies,
when applicable.
(**) Due to the Covid-19
pandemic, the Company´s Management identified impairment indicators during the first quarter of 2020 and carried out an impairment
test considering each CGU of the group. Based on the analysis conducted by the Management, there was no need to record impairment
losses for the balances of these assets as of March 31, 2020.
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
The Company performed a
sensitivity analysis of variables: (i) discount rate and (ii) growth rate in perpetuity, given its potential impacts on cash flows.
An increase of 1 percentage point in the discount rate or a decrease of 1 percentage point in the growth rate of the perpetuity
of the cash flow of each group of CGU would not result in the need to recognize impairment losses. Based on Management’s
assessment, the need to recognize impairment losses for intangible assets with indefinite useful lives in the year ended December
31, 2020 was not identified.
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
|
19
|
RIGHT OF USE AND LEASES
|
|
|
Consolidated
|
|
Useful life in Years (a)
|
2019
|
Acquisition of subsidiary
|
Additions
|
Write-offs
|
Impairment (b)
|
Transfers (c)
|
Exchange rate variation
|
2020
|
Cost
|
|
|
|
|
|
|
|
|
|
Vehicles
|
3
|
40,018
|
42,467
|
61,878
|
(441)
|
-
|
-
|
13,945
|
157,867
|
Machinery and equipment
|
3 to 10
|
15,578
|
14,034
|
11,265
|
-
|
-
|
-
|
12,171
|
53,048
|
Facilities
|
3 to 10
|
784,900
|
489,740
|
146,695
|
(16,094)
|
-
|
-
|
211,592
|
1,616,833
|
IT equipment
|
10
|
283
|
18,429
|
6,211
|
(323)
|
-
|
-
|
5,400
|
30,000
|
Retail stores
|
3 to 10
|
2,350,377
|
-
|
384,502
|
(25,189)
|
(148,050)
|
(2,962)
|
779,426
|
3,338,104
|
Tools and accessories
|
3
|
2,803
|
-
|
-
|
-
|
-
|
-
|
384
|
3,187
|
Total cost
|
|
3,193,959
|
564,670
|
610,551
|
(42,047)
|
(148,050)
|
(2,962)
|
1,022,918
|
5,199,039
|
|
|
|
|
|
|
|
|
|
|
Accumulated depreciation
|
|
|
|
|
|
|
|
|
|
Vehicles
|
|
(8,109)
|
-
|
(54,558)
|
192
|
-
|
-
|
(947)
|
(63,422)
|
Machinery and equipment
|
|
(4,317)
|
-
|
(14,899)
|
-
|
-
|
-
|
(1,829)
|
(21,045)
|
Facilities
|
|
(97,190)
|
-
|
(291,431)
|
12,448
|
-
|
-
|
(23,592)
|
(399,765)
|
IT equipment
|
|
(214)
|
-
|
(18,694)
|
-
|
-
|
-
|
(253)
|
(19,161)
|
Retail stores
|
|
(463,332)
|
-
|
(643,441)
|
3,527
|
-
|
-
|
(188,100)
|
(1,291,346)
|
Tools and accessories
|
|
(936)
|
-
|
(936)
|
-
|
-
|
-
|
(381)
|
(2,253)
|
Total accrued depreciation
|
|
(574,098)
|
-
|
(1,023,959)
|
16,167
|
-
|
-
|
(215,102)
|
(1,796,992)
|
Net total
|
|
2,619,861
|
564,670
|
(413,408)
|
(25,880)
|
(148,050)
|
(2,962)
|
807,816
|
3,402,047
|
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
|
Consolidated
|
|
Useful life in Years (i)
|
First-time adoption (Note 3.29)
|
Additions
|
Write-offs
|
Transfers (ii)
|
Other changes
|
2019
|
Cost Value:
|
|
|
|
|
|
|
|
Vehicles
|
3
|
-
|
40,069
|
(146)
|
-
|
95
|
40,018
|
Machinery and equipment
|
3 to 10
|
-
|
14,954
|
(40)
|
-
|
664
|
15,578
|
Facilities
|
3 to 10
|
103,945
|
187,294
|
-
|
481,235
|
12,426
|
784,900
|
IT equipment
|
10
|
-
|
279
|
-
|
-
|
4
|
283
|
Retail stores
|
3 to 10
|
1,819,951
|
416,250
|
(76,022)
|
150,374
|
39,824
|
2,350,377
|
Tools and accessories
|
3
|
-
|
2,650
|
-
|
-
|
153
|
2,803
|
Total cost
|
|
1,923,896
|
661,496
|
(76,208)
|
631,609
|
53,166
|
3,193,959
|
|
|
|
|
|
|
|
|
Depreciation value:
|
|
|
|
|
|
|
|
Vehicles
|
|
-
|
(8,083)
|
38
|
-
|
(64)
|
(8,109)
|
Machinery and equipment
|
|
-
|
(4,126)
|
-
|
-
|
(191)
|
(4,317)
|
Facilities
|
|
-
|
(95,734)
|
-
|
-
|
(1,456)
|
(97,190)
|
IT equipment
|
|
-
|
(209)
|
-
|
-
|
(5)
|
(214)
|
Retail stores
|
|
-
|
(466,590)
|
(2,968)
|
-
|
6,226
|
(463,332)
|
Tools and accessories
|
|
-
|
(882)
|
-
|
-
|
(54)
|
(936)
|
Total accrued depreciation
|
|
-
|
(575,624)
|
(2,930)
|
-
|
4,456
|
(574,098)
|
Net total
|
|
1,923,896
|
85,872
|
(79,138)
|
631,609
|
57,622
|
2,619,861
|
|
(a)
|
The useful lives applied refer to the term of the contracts in which the Company is sure that it
will use the assets underlying the lease contracts according to the contractual terms.
|
|
(b)
|
Of the total amount of impairment recorded in 2020, R$ 144,500 refers to the impairment loss of
legacy stores of The Body Shop that were previously included in the store closure plan, which were subsequently impacted by the
effects of the pandemic, predominantly in the United States.
|
|
(c)
|
Refers to key money related to store rentals. This amount is transferred from right of use to intangible
assets when a new commercial agreement with the lessor is not yet signed.
|
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
|
Consolidated
|
|
2020
|
2019
|
Amounts recognized in the statement of income for the year ended December 31, 2020 and 2019
|
|
|
Financial expense on lease
|
229,544
|
134,579
|
Amortization of right of use
|
1,023,959
|
575,624
|
Appropriation in the result of variable lease installments not included in the measurement of rental liabilities
|
45,952
|
31,023
|
Sublease revenue
|
(27,079)
|
(2,698)
|
Short-term rental expenses and low-value assets
|
72,546
|
126,067
|
Benefits granted by lessor related to Covid-19
|
(58,700)
|
-
|
Other lease-related expenses
|
40,206
|
22,214
|
Impairment losses
|
144,500
|
-
|
Total
|
1,470,928
|
886,809
|
|
|
|
Amounts recognized in the financing cash flow statement:
|
|
|
Lease payments (principal)
|
843,338
|
497,905
|
Values recognized in the operating cash flow statement:
|
|
|
Lease payments (interest)
|
225,420
|
134,579
|
Variable lease payments, not included in the measurement of rental liabilities
|
13,033
|
11,199
|
Short-term and low-value assets leases payments
|
51,675
|
69,162
|
Lease-related payments
|
41,944
|
26,460
|
Total
|
1,175,410
|
739,305
|
|
Consolidated
|
|
2020
|
2019
|
Current
|
1,059,661
|
542,088
|
Non-current
|
2,798,794
|
1,975,477
|
Total
|
3,858,455
|
2,517,565
|
Below are the changes in lease liability balances
for the year ended December 31, 2020:
|
Consolidated
|
Balance as at December 31, 2019
|
2,517,565
|
New leases
|
559,905
|
Acquisition of subsidiary
|
777,200
|
Lease payments (principal)
|
(843,338)
|
Lease payments (interest)
|
(225,420)
|
Recognition of financial charges
|
229,544
|
Write-offs (a)
|
(193,174)
|
Exchange rate variation
|
1,036,173
|
Balance as at December 31, 2020
|
3,858,455
|
|
(a)
|
Refers mainly to the termination of contracts related to store leases.
|
The maturity analysis of the
lease liability non-current balance of are as follows:
|
Consolidated
|
|
2020
|
2019
|
2022
|
419,240
|
374,746
|
2023
|
408,977
|
361,688
|
2024
|
406,572
|
358,274
|
2025 onwards
|
1,564,005
|
880,769
|
Total
|
2,798,794
|
1,975,477
|
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
The table below set forth the
rates applied, according to the lease terms:
As described in note 3.13.2,
the Company’s subsidiaries applied its incremental borrowing rate as the discount rate on lease liabilities. Considering
that the Company's lease contracts are substantially contracts with payment flows indexed by inflation indices and, also considering
the disclosure suggestions published in CVM Circular Letter 02/19, the Company’s subsidiaries present below additional information
on the characteristics of the lease contracts so that users of the financial statements may, at its discretion, carry out projections
of future payment flows indexed to inflation. Most of the lease liabilities refer to Avon, The Body Shop and Aesop operations,
which contracts were signed substantially in developed economies countries. Therefore, for these countries, the potential effects
of the discount would not be significant given its history of low inflation rates.
|
|
Contractual Payments - Consolidated
|
Maturity
|
Average discount rate
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
Onwards 2025
|
2020-2022
|
1.9% to 10.5%
|
566,802
|
32,692
|
8,946
|
-
|
-
|
-
|
-
|
2023-2025
|
1.9% to 14.0%
|
32,802
|
304,688
|
305,886
|
302,042
|
298,194
|
271,790
|
-
|
2026-2028
|
1.9% to 10,2%
|
69,488
|
74,145
|
78,169
|
83,769
|
90,725
|
98,267
|
661,521
|
2029-2031
|
8.2% to 13.6%
|
4,778
|
4,778
|
4,778
|
4,778
|
4,778
|
4,778
|
16,324
|
Total
|
|
673,870
|
416,303
|
397,779
|
390,589
|
393,697
|
374,835
|
677,845
|
Projected inflation 1
|
3.40%
|
3.40%
|
3.40%
|
3.60%
|
3.60%
|
3.60%
|
3.80%
|
1 Rates obtained through future prices
of DI coupons versus National Consumer Price Index (IPCA) observed in B3, applied to Brazilian contracts.
|
20
|
BORROWINGS, FINANCING AND DEBENTURES
|
|
Reference
|
Company
|
Consolidated
|
|
2020
|
2019
|
2020
|
2019
|
Raised in local currency:
|
|
|
|
|
|
Financing Agency for Studies and Projects FINEP
|
|
-
|
-
|
73,076
|
101,988
|
Debentures
|
A
|
-
|
-
|
4,042,515
|
4,251,231
|
BNDES
|
|
-
|
-
|
7,789
|
3,539
|
BNDES – FINAME
|
|
-
|
-
|
15
|
183
|
Promissory notes
|
B
|
515,966
|
2,883,382
|
773,949
|
2,883,382
|
Working capital – Mexico Operation
|
|
-
|
-
|
14,453
|
31,802
|
Working capital – Aesop Operation
|
|
-
|
-
|
-
|
100,438
|
Working capital – The Body Shop Operation
|
C
|
-
|
-
|
500,835
|
-
|
Working capital – Avon Operation
|
|
-
|
-
|
145,495
|
-
|
Notes – Avon (1)
|
D
|
-
|
-
|
4,033,682
|
-
|
Total in local currency
|
|
515,966
|
2,883,382
|
9,591,809
|
7,404,414
|
|
|
|
|
|
|
Raised in Foreign currency:
|
|
|
|
|
|
BNDES
|
|
-
|
-
|
1,639
|
8,029
|
Export Credit Note (NCE)
|
|
-
|
-
|
-
|
81,210
|
Representative debt securities (“Notes”) (1)
|
E
|
-
|
-
|
3,969,226
|
3,090,490
|
Resolution nº 4131/62
|
F
|
-
|
-
|
260,239
|
202,231
|
Total in foreign currency
|
|
-
|
-
|
4,231,104
|
3,381,960
|
Grand total
|
|
515,966
|
2,883,382
|
13,822,913
|
10,786,374
|
|
|
|
|
|
|
Current
|
|
515,966
|
2,883,382
|
3,805,649
|
3,354,355
|
Non-current
|
|
-
|
-
|
10,017,264
|
7,432,019
|
|
|
|
|
|
|
Debentures
|
|
|
|
|
|
Current
|
|
-
|
-
|
2,169,786
|
246,017
|
Non-current
|
|
-
|
-
|
1,872,729
|
4,005,214
|
(1) Balances resulting
from the business combinations with Avon (Note 4) recorded at the estimated fair value.
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
Reference
|
Currency
|
Maturity
|
Charges
|
Effective interest rate
|
Guarantees
|
A
|
Real
|
August, 2024
|
Interest of 109% to 112% of CDI, and 1.4% + CDI 1.75% + CDI, 1.00% + CDI and 1.15% + CDI, as maturing on March, 2020; September, 2020; September, 2021; September 2022 and August 2024.
|
109.5% - 113.1%
CDI + 1.15% -
CDI + 1.79%
|
None
|
B
|
Real
|
Until April, 2021
|
Interest of 3.25% p.a. + CDI
|
CDI + 3.30%
|
Approval of subsidiary Indústria e Comércio de Cosméticos Natura Ltda.
|
C
|
British
Pounds
|
March, 2021
|
Libor + interest of 2.00% p.a.
|
Libor + interest of 2.00% p.a.
|
Approval of subsidiary
Natura Cosméticos
S.A.
|
D
|
Dollar
|
March, 2023 and March 2043
|
Interest of 7.00% p.a. and Interest of 8.95% p.a.
|
Interest of 7.00% p.a. and Interest of 8.95% p.a.
|
None
|
E
|
Dollar
|
February, 2023
|
Interest of 5.375% p.a.
|
6,1%
|
None
|
F
|
Dollar
|
May, 2022
|
Libor + interest 1.1% p.a.
|
Libor + interest 1.1% p.a.
|
Approval of subsidiary
Indústria e Comércio
de Cosméticos Natura Ltda.
|
Changes in the balances of borrowings, financings
and debentures for the year ended December 31, 2020 and 2019 are as follows:
|
Company
|
Consolidated
|
Balance as at December 31, 2018
|
-
|
7,994,145
|
New borrowings and financing
|
2,879,038
|
5,346,145
|
Repayment
|
|
(2,643,575)
|
Accrued finance costs
|
4,344
|
494,422
|
Finance costs payment
|
-
|
(499,798)
|
Exchange rate variation (unrealized)
|
-
|
88,097
|
Exchange rate variation (realized)
|
-
|
5,903
|
Translation effects (OCI)
|
-
|
1,035
|
Balance at December 31, 2019
|
2,883,382
|
10,786,374
|
Assumed in a business combination (note 4)
|
-
|
7,250,735
|
New borrowings and financing
|
500,000
|
1,354,765
|
Repayment
|
(2,881,160)
|
(8,483,892)
|
Accrued finance costs
|
62,634
|
1,029,705
|
Finance costs payment
|
(48,890)
|
(1,293,094)
|
Exchange rate variation (unrealized)
|
-
|
973,442
|
Exchange rate variation (realized)
|
-
|
35,429
|
Translation effects (OCI)
|
-
|
2,169,449
|
Balance as at December 31, 2020
|
515,966
|
13,822,913
|
The maturities of non-current portion of borrowings,
financing and debentures liabilities are as follows:
|
Company
|
Consolidated
|
|
2020
|
2019
|
2020
|
2019
|
2021
|
-
|
-
|
-
|
2,279,759
|
2022
|
-
|
-
|
586,002
|
527,596
|
2023
|
-
|
-
|
6,306,782
|
3,052,769
|
2024 onwards
|
-
|
-
|
3,124,480
|
1,571,895
|
Total
|
-
|
-
|
10,017,264
|
7,432,019
|
20.1
Main changes in borrowings and financing
On February 25, 2014, the Company
conducted the 5th issuance of simple, registered, book-entry, non-convertible, unsecured debentures of Natura, in the total amount
of R$ 600,000 shares. A total of 60,000 debentures were issued, of which 20,000 debentures were in the 1st series, with maturity
date on February 24, 2017, in the amount of R$ 214,385; 20,000 debentures were in the 2nd series, with maturity date on February
25, 2018; and 20,000 debentures were in the 3rd series, with maturity date on February 25, 2019, with an interest rate of 107.0%,
107.5% and 108.0% of the cumulative variation of the Brazilian Interbank Deposits (“DI”) average daily rates, respectively.
On March 16, 2015, the Company
carried out the 6th issuance of simple, registered, book-entry, non-convertible, unsecured debentures of Natura, amounting to R$
800,000. 80,000 debentures were issued, of which 40,000 were in the 1st series, with maturity date on March 16, 2018, 25,000 were
in the 2nd series, with maturity date on March 16, 2019, and 15,000 were in the 3rd series, with maturity date on March 16, 2020,
with an interest rate
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
of 107.0%, 108.25% and 109.0%, respectively, of the cumulative variation of the Brazilian Interbank Deposits
(“DI”) average daily rates.
On September 28, 2017, the Company
carried out the 7th issuance of simple, registered, book-entry, non-convertible, unsecured debentures of Natura, in the total amount
of R$ 2,600,000. A total of 260,000 debentures were issued, of which 77,273 were in the 1st series, with maturity date on September
25, 2020, and 182,727 were in the 2nd series, due on September 25, 2021, with an interest rate of CDI rate + 1.4% p.a. and CDI
rate + 1.75% p.a., respectively.
On February 16, 2018, the Company
carried out the 8th issuance of simple, non-convertible and unsecured debentures, with personal guarantee, in a single series,
for public distribution with restricted placement efforts, in accordance with CVM Instruction 476 from January 16, 2009 (“CVM
Instruction 476”), in the total amount of R$ 1,400,000, whose proceeds will be used to settle the promissory notes balance.
Compensatory interest was paid in three (3) installments, starting on the issuance date, with the first payment on August 14, 2018
and other payments on February 14, 2019 and maturity date on August 14, 2019. On September 28, 2018, there was a repayment, in
the amount of R$ 1,000,000, due to early maturity, early optional redemption and optional extraordinary payment, established in
the indenture, and remuneration corresponding to 110.0% of the cumulative variation of the Brazilian Interbank Deposits (“DI”)
average daily rates. The outstanding balance of the 8th issuance amounting to R$ 400,000 was settled on maturity date, that is,
August 14, 2019.
On September 21, 2018, the Company
carried out the 9th issuance of non-convertible unsecured debentures, with personal guarantee, in three series, for public distribution
with restricted placement efforts, in accordance with CVM Instruction 476, in the aggregate amount of R$ 1,000,000, used in the
partial early amortization of R$ 1,000,000 related to the 8th issuance. The issuance consisted of 100,000 debentures, of which
38,904 were in the 1st series, with maturity date on September 21, 2020, 30,831 were in the 2nd series, with maturity date on September
21, 2021, and 30,265 were in the 3rd series, with maturity date on September 21, 2022, and remuneration corresponding to 109.5%,
110.5% and 112.0%, respectively, of the cumulative variation of the Brazilian Interbank Deposits (“DI”) average daily
rates, respectively.
On July 22, 2019, the Company
carried out the 10th issuance of simple, non-convertible, unsecured debentures in four series, for public distribution with restricted
placement efforts, in accordance with CVM Instruction 476, in the aggregate amount of R$ 1,576,450. A total of 157,645 registered,
book-entry, non-convertible and unsecured debentures were issued in four series, without no certificate issue or provisory certificate,
at a nominal unit value of R$ 10, of which 40,000 were in the 1st series, maturing on August 26, 2024; 9,570 in the 2nd series,
maturing on August 26, 2024; 68,623 in the 3rd series, maturing on August 26, 2024, and 39,452 in the 4th series, maturing on August
26, 2024, and paying remuneration corresponding to 100% of the cumulative variation of the Brazilian Interbank Deposits (“DI”)
average daily rates plus 1% for the 1st series and 100% of the cumulative variation of the Brazilian Interbank Deposits (“DI”)
average daily rates plus 1.15% for other series.
The funds from the 10th issuance
were used as follows. 1st series: full amortization of the 8th issuance of debentures in the amount of R$ 400,000; 2nd grade: partial
amortization of the 3rd grade of the 6th issuance in the amount of R$ 92,820; 3rd grade: partial amortization of the 1st grade
of the 7th issuance in the amount of R$ 664,090; 4th grade: partial amortization of the 1st grade of the 9th issuance in the amount
of R$ 382,960.
The appropriation of costs related
to the issuance of debentures in the year ended December 31, 2020 was R$ 3,888 (R$ 4,760 as of December 31, 2019), recorded monthly
under financial expenses, in accordance with the effective interest rate method. Issuance costs to appropriate amounted to R$ 9,466
as of December 31, 2020 (R$ 13,354 as of December 31, 2019).
On January 14, 2020, partial
optional early redemption of the Promissory Notes of the 1st series was made in the amount of R$ 1,830,000.
On April 29, 2020, the 2nd issue
of Promissory Notes by Natura &Co, in a single series, in the amount of R$ 500,000 and the 4th issue of Promissory Notes by
subsidiary Natura, in a single series in the amount of R$ 250,000 were made. The promissory notes were publicly distributed with
restricted placement efforts, pursuant to CVM Instruction 476, of January 16, 2009. The funds were used for cash strengthening
and increased liquidity.
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
On June 29, 2020, took place
the total optional early redemption of the 1st issue of the first series of Promissory Notes by Natura &Co in the amount of
R$ 370,000, and the partial optional early redemption of the 1st issue of Promissory Notes of the second series in the amount of
R$ 140,000.
Accrued costs related to the
emission of the Promissory Notes in the year ended December 31, 2020 amounted to R$ 25,205 (R$ 11,135 on December 31, 2019), recorded
monthly in account of finance costs according to the effective interest rate method. As of December 31, 2020, the balance of issuance
costs to be appropriated is R$ 2,121 (R$ 20,962 on December 31, 2019).
|
iii)
|
Working capital - The Body Shop
|
As presented in Note No. 6.2(e),
The Body Shop had on December 31, 2019 a credit line of up to £ 70 million (seventy million pounds), corresponding to R$
500,835 as at December 31, 2020, guaranteed by Natura, which could be withdrawn in installments to meet The Body Shop short-term
financing needs. This credit line was used during the second quarter of 2020, for working capital and liquidity reinforcement with
payment of annual interest of Libor + 2%.
|
iv)
|
Debt Securities Representative ("Notes")
- Avon
|
The subsidiary
Avon has the following debt securities representative (“notes”) issued:
Notes - Avon
|
Main US$
|
Main R$
|
Annual percentage interest rate
|
Maturity
|
Unguaranteed
|
461,883
|
2,400,267
|
7.00%
|
March 15, 2023
|
Unguaranteed
|
216,085
|
1,122,929
|
8.95%
|
March 15, 2043
|
The effects of allocating fair
values from the business combination (note 4) were added to the notes issued by Avon, which at December 31, 2020 amounted to R$
449,712.
20.2
Covenants
The restrictive clauses associated
with the debt contracts of the Company and its subsidiaries, establish the maintenance of minimum financial indicators resulting
from the ratio of the division of the net treasury debt by the EBITDA of the last 12 months, as well as non-financial indicators
according to each contract. As of December 31, 2020 and 2019, the Company and its subsidiaries are in compliance with such restrictive
clauses.
|
21
|
TRADE ACCOUNTS PAYABLE AND REVERSE FACTORING OPERATIONS
|
|
Company
|
Consolidated
|
|
2020
|
2019
|
2020
|
2019
|
Domestic trade accounts payables
|
4,748
|
-
|
5,462,377
|
1,581,759
|
Foreign trade accounts payables (a)
|
4,945
|
-
|
1,014,356
|
105,073
|
Subtotal
|
9,693
|
-
|
6,476,733
|
1,686,832
|
Reverse factoring operations (b)
|
-
|
-
|
297,472
|
142,924
|
Total
|
9,693
|
-
|
6,774,205
|
1,829,756
|
|
(a)
|
Refers to imports mainly denominated in US dollars, Euros and British pounds
|
|
(b)
|
The Company and its subsidiaries have contracts signed with Banco Itaú Unibanco S.A. to
structure a “supply chain finance” the operation with the Company’s main suppliers. Further details on these
operations are included in note 3.16.
|
|
Company
|
Consolidated
|
|
2020
|
2019
|
2020
|
2019
|
ICMS (ordinary)
|
-
|
-
|
134,165
|
120,300
|
ICMS-ST provision (a)
|
-
|
-
|
61,521
|
72,423
|
Taxes on invoicing – foreign abroad
|
-
|
-
|
364,291
|
145,992
|
Social Security Tax (INSS) - suspension of the enforceability
|
-
|
-
|
-
|
50,147
|
Withholding tax (IRRF)
|
828
|
987
|
131,368
|
48,593
|
Other taxes payable - foreign subsidiaries
|
-
|
-
|
48,365
|
1,180
|
Income tax
|
468
|
63
|
15,943
|
1,207
|
PIS and COFINS payable
|
11,857
|
-
|
11,857
|
-
|
INSS and service tax (ISS) payable
|
-
|
-
|
32,954
|
3,218
|
Others
|
-
|
-
|
94,357
|
399
|
|
13,153
|
1,050
|
894,821
|
443,459
|
|
|
|
|
|
Current
|
13,153
|
1,050
|
785,367
|
320,890
|
Noncurrent
|
-
|
-
|
109,454
|
122,569
|
|
(a)
|
The Company's subsidiaries have discussions about the illegality of changes in state laws to charge
ICMS-ST. Part of the amount recorded as tax payable but not yet paid is being discussed in court by the Company’s subsidiaries,
and in some cases, the amounts are deposited in court, as mentioned in note 13.
|
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
|
23
|
PROVISION FOR TAX, CIVIL AND LABOR RISKS
|
The Company and its subsidiaries
are involved in certain legal proceedings arising in the normal course of its business, which include civil, tax, social security,
labor, business and others.
The Company's management believes
that, based on the elements existing on the base date of these financial statements, the provision for tax, civil, labor, commercial
and other risks is sufficient to cover possible losses on administrative and legal proceedings, as shown below.
|
23.1
|
Contingencies assessed as probable risk of loss
|
The changes in the tax, civil and labor provision
and contingent liabilities are presented below:
|
Consolidated
|
|
Tax
|
Civil
|
Labor
|
Business Combination
|
Total
|
|
2020
|
2019
|
2020
|
2019
|
2020
|
2019
|
2020
|
2020
|
2019
|
Balance at the beginning of the year
|
127,842
|
163,852
|
30,653
|
32,300
|
61,571
|
65,655
|
-
|
220,066
|
261,807
|
Acquisition of subsidiary (1)
|
671,667
|
-
|
37,364
|
-
|
163,962
|
-
|
820,103
|
1,693,096
|
-
|
Additions
|
169,824
|
14,497
|
186,182
|
14,072
|
44,566
|
45,983
|
9,772
|
410,344
|
74,552
|
Reversals
|
(71,797)
|
(54,168)
|
(62,013)
|
(4,766)
|
(4,601)
|
(40,127)
|
(67,482)
|
(205,893)
|
(99,061)
|
Payments
|
(54,590)
|
(1,150)
|
(31,169)
|
(11,418)
|
(48,792)
|
(14,611)
|
-
|
(134,551)
|
(27,179)
|
Inflation adjustment
|
5,623
|
4,440
|
4,164
|
309
|
6,508
|
5,009
|
21,671
|
37,966
|
9,758
|
Exchange rate variation
|
83,202
|
371
|
12,525
|
156
|
27,284
|
(338)
|
13,629
|
136,640
|
189
|
Transfers (2)
|
-
|
-
|
(99,309)
|
-
|
841
|
-
|
-
|
(98,468)
|
-
|
Balance as at December 31, 2020
|
931,771
|
127,842
|
78,397
|
30,653
|
251,339
|
61,571
|
797,693
|
2,059,200
|
220,066
|
|
|
|
|
|
|
|
|
|
|
Current
|
|
|
|
|
|
|
|
58,756
|
18,650
|
Non-current
|
|
|
|
|
|
|
|
2,000,444
|
201,416
|
|
(1)
|
Amounts arising from lawsuits with probability of possible and remote loss of tax nature in the
amount of R$ 709,751, labor in the amount of R$ 54,728 and civil in the amount of R$ 55,624, measured and recorded at the estimated
fair value resulting from the business combination with Avon, in accordance with paragraph 23 of CPC 15 / IFRS 3 (Note 4) , additionally,
the fair value of contingent liabilities includes liabilities assumed and recognized by Avon prior to the allocation of fair value,
in the amount of R$ 872,993.
|
|
(2)
|
Balance arising from other obligations of the subsidiary Avon, related to reclassifications of
processes previously recognized as contingent liabilities to other accounts payable.
|
The consolidated tax contingencies
and classified as probable loss, mainly involve (i) discussions about the illegality of changes in state laws to collection of
ICMS, and (ii) discussions related to the exclusion of IPI charges from the income tax calculation basis, withhold income tax,
as well as several lawsuits related to income tax and social contribution taxation. Part of the amount not paid is being discussed
in court, and in some cases, the amounts are deposited in court, as mentioned in note 13. The tax provision also includes attorneys'
fees for the sponsorship of tax proceedings, when applicable.
|
23.1.2
|
Civil, commercial and other
|
On December 31, 2020, the Company
and its subsidiaries are parties to commercial and other civil lawsuits and procedures, mainly related to indemnity claims. Provisions
are periodically reviewed based on the evolution of processes and the evolution of jurisprudence to reflect the best estimate.
The subsidiary Avon has been
named a defendant in numerous personal injury lawsuits filed in U.S. courts, alleging that certain talc products the Avon sold
in the past were contaminated with asbestos. Many of these actions involve a number of co-defendants from a variety of different
industries, including manufacturers of cosmetics and manufacturers of other products that, unlike the Avon’s products, were
designed to contain
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
asbestos. As of December 31, 2020, there were 164 individual cases pending against the Avon. During the three
months ended December 31, 2020, 31 new cases were filed and 14 cases were dismissed, settled or otherwise resolved. The value of
the settlements was not material, either individually or in the aggregate, to the Avon’s results of operations for the year
ended December 31, 2020. Additional similar cases arising out of the use of the Avon’s talc products are reasonably anticipated.
We believe that the claims asserted
against us in these cases are without merit. We are defending vigorously against these claims and will continue to do so. To date,
the Avon has not proceeded to trial in any case filed against it and there have been no findings of liability enforceable against
the Company. However, nationwide trial results in similar cases filed against other manufacturers of cosmetic talc products have
ranged from outright dismissals to very large jury awards of both compensatory and punitive damages. Given the inherent uncertainties
of litigation, we cannot predict the outcome of all individual cases pending against the Company, and we are only able to make
a specific estimate for a small number of individual cases that have advanced to the later stages of legal proceedings. For the
remaining cases, we provide an estimate of exposure on an aggregated and ongoing basis, which takes into account the historical
outcomes of all cases we have resolved to date. Any accruals currently recorded on the Avon’s balance sheet with respect
to these cases are not material. However, any adverse outcomes, either in an individual case or in the aggregate, could be material.
Future costs to litigate these cases, which we expense as incurred, are not known but may be significant, though some costs will
be covered by insurance.
The Company and its subsidiaries
as of December 31, 2020 are parties to labor claims filed by former employees and service providers, mainly related to the payment
of severance pay, overtime, salary premiums and monies owed as a result of join liability and discussion about the recognition
of any employment relationship. None of these processes is individually relevant. Provisions are periodically reviewed based on
the progress of lawsuits and history of losses on labor claims to reflect the best estimate.
|
23.2
|
Contingencies assessed as possible risk of loss
|
The Company’s subsidiaries
have contingencies whose expectation of loss assessed by the Company's Management and supported by the legal advisors is classified
as possible and, therefore, no provision has been recorded. On December 31, 2020, the contingencies classified as possible loss
probability totaled R$ 9,559,550 (R$ 3,642,219 on December 31, 2019), in which R$ 797,693 (R$ 0 on December 31, 2019) were logged
at the estimated fair value resulting from the business combinations with Avon Products Inc., shown in the table above.
The tax cases with
possible losses totaling R$ 9,205,601 (R$ 3,503,392 at December 31, 2019).
Below are the most
relevant tax contingencies related to the following matters:
|
a)
|
Infraction notices in which the Brazilian Federal Revenue Office requires IPI tax debts, due to
the alleged non-observance of the minimum tax base, provided for in the legislation, when sales transactions destined to interdependent
wholesalers. Currently, tax assessment notices are pending judgment at the administrative court level. As at December 31, 2020,
the total amount under discussion is R$ 1,963,984 (R$ 208,204 as at December 31, 2019).
|
|
b)
|
Lawsuits in which the industrial establishment equivalence is discussed, as provided for in the
Decree nº 8.393/2015, which now requires IPI taxation of products listed in the referred legal provision in outbound transactions
carried out by interdependent wholesalers. As of December 31, 2020, the total amount under discussion classified as a possible
loss is R$ 1,660,532 (R$ 389,017 as at December 31, 2019).
|
|
c)
|
Administrative and judicial processes that discuss the illegality of changes in Federal State laws
regarding the collection of ICMS and ICMS-ST. As at December 31, 2020, the total amount under discussion is R$ 1,503,657 (R$ 406,002
as of December 31, 2019).
|
|
d)
|
Infraction notices in which the Brazilian Federal Revenue Office requires IRPJ and CSLL tax debts
to challenge the tax deductibility of the amortization of goodwill generated in the context of a corporate reorganization between
related parties. Currently, the legality of the administrative decisions that rejected the motions for clarification presented
to challenge the special appeals dismissed is being discussed in the courts. As at December 31, 2020, the total amount under discussion
classified as a possible loss is R$ 1,396,782 (R$ 1,379,189 as at December 31, 2019).
|
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
|
e)
|
Infraction notices in which the Finance Department of the São Paulo Federal State requires
the collection of ICMS-ST, which was fully collected by the recipient of the goods, the distributor. Currently, the process is
pending judgment at the administrative court level. As of December 31, 2020, the total amount under discussion classified as a
possible loss is R$ 529,660 (R$ 521,903 as at December 31, 2019).
|
|
f)
|
Infraction notices in which the Brazilian Federal Revenue Office requires IPI tax debts for disagreeing
with the tax classification adopted by the Company for some products. The tax assessment notices are awaiting judgment at the administrative
court level. As at December 31, 2020, the total amount in discussion classified as a possible loss is R$ 524,500 (R$ 218,204 as
at December 31, 2019).
|
|
23.2.2
|
Civil, commercial and other
|
As of December 31, 2020, civil,
commercial and other lawsuits with possible losses total R$ 133,302 (R$ 61,532 on December 31, 2019).
Below are the most relevant
contingencies related to the following matters:
On February 14, 2019, a purported
shareholder’s class action complaint (Bevinal v. Avon Products, Inc., et al., No. 19-cv-1420) was filed in the United States
District Court for the Southern District of New York against the Avon and certain former officers of Avon. The complaint was subsequently
amended and recaptioned "In re Avon Products, Inc. Securities Litigation". The amended complaint is brought on behalf
of a purported class consisting of all purchasers or acquirers of Avon common stock between January 21, 2016 and November 1st,
2017, inclusive. The complaint asserts violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange
Act") based on allegedly false or misleading statements and alleged market manipulation with respect to, among other things,
changes made to Avon’s credit terms for Representatives in Brazil. Avon and the individual defendants filed a motion to dismiss
which the court denied. During 2020, the parties reached an agreement on a settlement of this class action. The terms of settlement
include releases by members of the class of claims against Avon and the individual defendants and payment of R$ 75,352 ($ 14.500).
Approximately R$ 10,393 ($ 2,000) of the settlement was paid by the Avon (which represented the remaining deductible under the
Avon’s applicable insurance policies) and the remainder of the settlement was paid by Avon’s insurers. On August 31,
2020, the court granted preliminary approval of the settlement, and on February 3rd, 2021, the court entered an order
and judgment granting final approval of the settlement. The time to appeal this judgment has not yet expired.
As of December 31, 2020, contingencies
classified as possible loss, totaled R$ 220,648 (R$ 77,295 as of December 31, 2019). No lawsuit is individually significant.
The updated amounts of PIS and
COFINS installment refund requests calculated with the inclusion of ICMS in tax base, not recorded until December 31, 2020, amounts
to R$ 133,397 (R$ 26,933 on December 31, 2019), which refers to lawsuits still under discussion.
The Company and its subsidiaries,
supported by the positioning of its legal counsel, observe the CPC 25 / IAS 37 -Provisions, Contingent Liabilities and Contingent
Assets and the Circular Letter / CVM / SNC / SEP / No 01/2019.
|
Consolidated
|
|
2020
|
2019
|
Pension and post-employment healthcare plans(a)
|
783,184
|
98,792
|
Deferred revenue from performance obligations with customers (b)
|
422,353
|
76,250
|
Provisions for incentives to consultants (c)
|
292,034
|
-
|
Provisions for operating expenses (marketing / technology, etc.) (d)
|
535,276
|
156,895
|
Discontinued operations (e)
|
153,140
|
-
|
Provision for store renovation
|
99,702
|
15,997
|
Crer Para Ver (f)
|
75,508
|
51,543
|
Provisions for rentals (g)
|
70,598
|
26,568
|
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
Provision for restructuring (h)
|
68,954
|
3,401
|
Long-term incentives (i)
|
52,745
|
3,022
|
Provisions for apportionment of benefits and partnerships payable
|
10,005
|
7,860
|
Other provisions (j)
|
373,891
|
67,846
|
Carbon credit
|
5,560
|
4,519
|
Exclusivity contract
|
3,000
|
5,400
|
Total
|
2,945,950
|
518,093
|
|
|
|
Current
|
1,832,811
|
396,391
|
Non-current
|
1,113,139
|
121,702
|
|
a)
|
As of December 31, 2020, Avon's pension and post-retirement plans amounts to R$ 648,990 and Natura's
post-employment healthcare plans amounts to R$ 134,194 (R$ 98,792 as of December 31, 2019).
|
|
b)
|
Refers to the deferral of revenue related performance obligations of loyalty programs based on
points, sale of gift cards not yet converted into products and programs and events to honor direct selling consultants, of which
R$ 318,686 related Avon and R$ 103,667 related to Natura consolidated.
|
|
c)
|
Provision for incentive and recognition programs for consultants.
|
|
d)
|
Refers to the Group's operating provisions mainly due to spending on provision of technology services,
marketing and advertising, etc., to comply with the accrual basis.
|
|
e)
|
As of December 17, 2015, Avon has contracts that resulted in the separation of operations in the
United States, Canada and Puerto Rico. These transactions were closed on March 1st, 2016. From that date, contingent
liabilities prior to this transaction and related operations in the United States, Canada and Puerto Rico, are treated as discontinued
operations. During the year ended December 31, 2020, Avon recorded R$ 143,112 as administrative expenses related to these provisions.
|
|
f)
|
Refers to Social program contribution for developing the quality of education.
|
|
g)
|
Refers to the (grace) period granted by lessors for the start of payment of rental of certain retail
stores, for rental agreements that were not included in the initial measurement of lease liabilities / right-of-use of the subsidiary
The Body Shop, in accordance with the exceptions permitted under IFRS 16 / (CPC 06 (R2)).
|
|
h)
|
Provision for costs directly related to the plan for changes in the organizational structure, mainly
of Avon and The Body Shop organizational structures.
|
|
i)
|
Refers substantially to the variable remuneration plans for Avon executives.
|
|
j)
|
Refers to provisions for insurance coverage, indemnities and long-term contractual obligations.
|
Post-employment
health care and Pension plan
|
a)
|
Defined benefit pension and postretirement plans (Avon)
|
The Avon subsidiary have contributory
and noncontributory defined benefit retirement plans for substantially all of its employees. The benefits of these plans are generally
based on the employee's length of service and the average compensation near retirement, with certain plans have vesting requirements.
The plans are funded based on legal requirements and cash flow.
The Avon subsidiary's largest
defined benefit pension plan outside the United States (“US”) is in the United Kingdom (“UK”). The UK defined
benefit pension plan was frozen for future accruals as of April 1st, 2013. The US defined benefit pension plan, the
Avon Products, Inc. Personal Retirement Account Plan (the "PRA"), is closed to employees hired on or after January 1st,
2015. Qualified retirement benefits for US-based employees hired on or after January 1st, 2015 will be provided exclusively
through Personal Savings Account Plan (the "PSA"), as described in note 29.3.
The most recent actuarial valuation
of plan assets and the present value of the defined benefit obligation was carried out on December 31, 2020. The present value
of the defined benefit obligation and the respective cost of current services and cost of past services were measured at projected
unit credit method.
The change in actuarial liabilities
for the year ended December 31, 2020 is shown below:
|
Consolidated
|
|
Pension Plan
|
Post-retirement benefits
|
Total
|
Balance at beginning of year
|
413,070
|
107,735
|
520,805
|
Cost of services - current
|
28,015
|
-
|
28,015
|
Interest cost
|
13,760
|
3,610
|
17,370
|
Administrative costs
|
2,476
|
-
|
2,476
|
Company contributions
|
(17,212)
|
-
|
(17,212)
|
Benefits paid
|
(4,611)
|
(27,852)
|
(32,463)
|
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
Actuarial gain (loss) in OCI
|
74,460
|
2,063
|
76,523
|
Reclassifications
|
(14,451)
|
-
|
(14,451)
|
Plan amendments
|
-
|
(21,147)
|
(21,147)
|
Special termination benefits
|
-
|
(29,915)
|
(29,915)
|
Transfers
|
-
|
(25,273)
|
(25,273)
|
Others
|
(2,814)
|
985
|
(1,829)
|
Foreign currency changes
|
117,268
|
28,823
|
146,091
|
Balance at end of year
|
609,961
|
39,029
|
648,990
|
The significant actuarial assumptions
for the determination of the actuarial liability are discount rate and rate of compensation increase. The details of the assumptions
are as follows:
|
2020
|
|
Pension Plan
|
Post-retirement benefits
|
Discount rate
|
0.30% to 8.50%
|
3.95%
|
Rate of compensation increase
|
1.80% to 6.60%
|
n/a
|
The analysis of the quantitative
sensitivity analysis of discount rates and increase in compensation, if the behavior of such rate increased or decreased by 0.5%
and its respective effect on the balance (present value of the obligation, or “PVO”) calculated on actuarial liabilities,
as of December 31, 2020 is shown below:
|
Rate
|
Chance
|
PVO
|
Discount rate
|
1.53%
|
0.5% increase
|
(331,549)
|
Discount rate
|
1.53%
|
0.5% decrease
|
372,084
|
Rate of compensation increase
|
2.74%
|
0.5% increase
|
12,472
|
Rate of compensation increase
|
2.74%
|
0.5% decrease
|
(11,952)
|
The sensitivity analysis presented
above have been determined based on a method that extrapolates the impact on the defined benefit obligation, as a result of reasonable
changes in main assumptions occurring at the reporting date, keeping all other assumptions constant. The sensitivity analysis is
based on a change in a significant assumption, keeping all other assumptions constant.
The sensitivity analysis presented
may not be representative of the actual change in the defined benefit obligation as it is unlikely that the changes in assumptions
would occur in isolation of one another as some of the assumptions may be correlated. In addition, when presenting the above sensitivity
analysis, the present value of the defined benefit obligation has been calculated using the projected credit unit method at the
reporting date, which is the same as that applied in calculating the defined benefit obligation liability recognized in the statement
of financial position.
The following are the expected
payments of contributions to the defined benefit plan in future years:
|
Consolidated
|
2021
|
103,363
|
2022
|
89,038
|
2023
|
87,706
|
2024
|
86,157
|
2025
|
83,276
|
2026 to 2030
|
395,832
|
The average duration of the
defined benefit plan obligation at the end of the reporting period is 9.13 years.
|
b)
|
Post-employment healthcare plan (Natura Cosméticos)
|
Post-employment healthcare plan
as detailed in note 3.20.4. The number of active employees eligible for the healthcare plan after termination is closed to new
inclusions. On December 31, 2020 and 2019, the obligation weighted average duration is around 19.8 and 20.8 years, respectively,
and its actuarial calculation base is as follows:
|
Ø
|
1,064 (2019: 1,175) active employees of the companies;
|
|
Ø
|
537 (2019: 477) retired and dependent on companies.
|
The actuarial liability was
calculated, on December 31, 2020 and 2019, considering the following main assumptions:
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
|
2020
|
2019
|
Discount rate
|
7.02%
|
7.39%
|
Initial growth rate of medical cost
|
3.75%
|
7.17%
|
Inflation rate
|
3.10%
|
3.80%
|
Final growth rate of medical cost
|
6.97%
|
7.17%
|
Growth rate of medical costs due to aging - costs
|
Per age range
1.25% a 4.75%
p.a.
|
Per age range
1.54% to 4.5% p.a.
|
Growth rate of medical costs by aging - contributions
|
0.00%
|
0.00%
|
Percentage of adherence to the plan in retirement
|
Bradesco Plan
69.00% /
Unimed Plan 84.00%
|
87.00%
|
Schedule of disabled mortality
|
Mercer Disability
|
Mercer Disability
|
Schedule of mortality
|
AT-2000
|
AT-2000
|
Schedule of turnover
|
Proportional calculation at the time of service
|
Proportional calculation at the time of service
|
Maintaining the initial level
of growth in medical costs at a real rate of 3.75% and reducing the annual discount rate from 7.39% to 7.02% generated a loss of
R$ 3,891.
The table below sets forth the
Medical Inflation Rate and the Discount Rate sensitivity analysis, if such rates increased or decreased by 0.5% and 1%, and their
respective effect on the balance (present value of the obligation, or “PVO”) calculated on the actuarial liabilities
(maintaining the other assumptions):
|
Rate
|
Chance
|
VPO
|
Discount rate
|
7.02%
|
0.5% increase
|
110,383
|
Discount rate
|
7.02%
|
0.5% decrease
|
165,801
|
Rate of compensation
|
6.97%
|
1% increase
|
164,501
|
Rate of compensation
|
6.97%
|
1% decrease
|
110,866
|
The changes of actuarial
liabilities for the years ended December 31, 2020 and 2019, is set forth in the table below:
|
Consolidated
|
|
2020
|
2019
|
Balance at the beginning of the year
|
(98,792)
|
(78,904)
|
Cost of the Company´s current service
|
(620)
|
(816)
|
Cost of interest
|
(7,223)
|
(7,125)
|
Expenses paid
|
2,069
|
2,427
|
Actuarial gains (losses) in OCI
|
(29,628)
|
(14,374)
|
Total
|
(134,194)
|
(98,792)
|
As at December 31, 2020, the
capital stock is R$ 12,377,999, consisting of 1,375,158,636 registered common shares, with no par value (R$ 1,485,436,464, composed
by 865,659,942 on December 31, 2019).
|
25.2
|
Policy for dividends and interest on equity distribution
|
The shareholders are entitled
to receive every year a mandatory minimum dividend of 30% of net income, considering principally the following adjustments:
|
Ø
|
Increase in the amounts resulting from
the reversal, in the period, of previously recognized reserves for contingencies.
|
|
Ø
|
Decrease in the amounts intended for the
recognition, in the period, of the legal reserve and reserve for contingencies.
|
|
Ø
|
Whenever the amount of the minimum mandatory dividend exceeds the realized portion of net income
for the year, management may propose, and the General Meeting approves, allocate the excess to the constitution of the unrealized
profit reserve (article 197 of Law 6,404/76).
|
The Board of Directors may pay
or credit interest on equity in accordance with applicable law.
As of December 31, 2020, the
“Treasury shares” has the following composition:
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
|
Number of shares
|
Amount R$ (thousands)
|
Average price per share - R$
|
Balance as at December 31, 2019
|
-
|
-
|
-
|
Used
|
(1,102,001)
|
(52,849)
|
47.53
|
Acquisition
|
1,418,702
|
64,516
|
45.48
|
Balance as at December 31, 2020
|
316,701
|
11,667
|
38.04
|
The minimum and maximum cost
of the balance of treasury shares on December 31, 2020 and 2019 are R$ 25.00 and R$ 49.71, respectively.
The acquisition of the subsidiary
Avon resulted in the issuance of Natura &Co shares for the total subscription amount of R$ 13,274,894. Of this amount, R$ 3,397,746
were allocated to the share capital account and the remainder amount of R$ 9,877,148 were allocated to the Company’s capital
reserve. This incorporation of shares was approved at the Company’s Board of Directors meeting held on January 3, 2020.
The approval of the capital
increase of R$ 2,000,000, approved on June 30, 2020, allocated the amount R$ 1,118 to the capital reserve.
The capital reserve had decreased
of R$ 147,592, due to the allocation to the profit reserve and an increase of R$ 58,496, due to the effects of IAS 29 - Accounting
in Hyperinflationary Economics (CPC 42), and an increase of R$ 52,041 referring to the changes of the stock option and restricted
share plans.
The capital reserve as at December
31, 2020 is R$ 11,052,470 (R$ 1,210,924 as at December 31, 2019).
As of December 31, 2020, the
profit reserve increased by R$ 155,884, of which (i) R$ 8,292 were due to effects of IAS 29 (CPC 42), applied to balances up to
December 31, 2020, and (ii) R$ 147,592 due to the reclassification of capital reserve.
The profit reserve balance as
at December 31, 2020 amounted to R$ 6,864 (R$ 149,020 on December 31, 2019).
|
25.6
|
Equity valuation adjustment – Other comprehensive income
|
The Company recognizes in this
equity item the exchange rate variation effect from investments in foreign subsidiaries, including exchange rate variations in
a hyperinflationary economy, actuarial gains and losses arising from the employee benefit plan, and the effect from cash flow hedge
operations. For exchange rate variation, the accumulated effect will be reversed to the statement of income as a gain or loss only
in the event of disposal or write-off of the investment. For actuarial losses and gains, the amounts will be recognized when the
actuarial liability is remeasured. The cash flow hedge transactions are transferred to the statement of income in case an ineffective
portion is identified or when the hedge relationship is terminated.
The determination of the Company’s
operating segments is based on its Corporate Governance structure, which divides the business into the following segments for purposes
of decision making and Management analysis.
Since January 3, 2020, as a
result of the acquisition of Avon (note 4), the Company’s Management has the following corporate governance structure:
|
Ø
|
Natura &Co Latam Operation – all Natura Cosméticos, Avon, Aesop and TBS operations
located in Brazil and Latin America;
|
|
Ø
|
Avon International – all Avon operations, with the exception of Avon operations located in
Brazil and Latin America;
|
|
Ø
|
TBS International – all The Body Shop operations, with the exception of The Body Shop operations
located in Brazil and Latin America; and
|
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
|
Ø
|
Aesop International - all Aesop operations, with the exception of Aesop operations located in Brazil
and Latin America.
|
In addition to the segment analysis,
the Company's Management also analyzes revenues at various levels, mainly through the sales channels: direct sales, operations
in the retail market, e-commerce, B2B and franchises. However, the segregation by this type of operation is not yet considered
significant for disclosures by Management.
Revenue by segment is as follows
for the year ended December 31, 2020:
|
Ø
|
Avon International - 25%
|
|
Ø
|
TBS International - 14%
|
|
Ø
|
Aesop International - 5%
|
The accounting practices for
each segment are described in note 3.
The following tables provide
the summarized financial information related to the segments and geographic distribution of the Company's commercial operations
for December 31, 2020 and 2019.
Additionally, as described above,
as a result of the acquisition of Avon in 2020, the company changed its corporate governance structure, and also the disclosures
of segments. Therefore, the comparative figures originally disclosed in the 2019 financial statements, are presented to reflect
the current structure of corporate governance.
|
2020
|
|
Reconciliation to net income (loss) for the year
|
|
Net revenues
|
Performance assessed by the Company
|
Depreciation and amortization
|
Financial income
|
Financial expenses
|
Income tax
|
Net income (loss)
|
Natura &Co LATAM
|
20,542,345
|
2,369,515
|
(874,584)
|
3,402,578
|
(3,891,641)
|
(428,191)
|
577,679
|
Avon International
|
9,097,375
|
185,914
|
(814,678)
|
979,267
|
(1,442,216)
|
(121,603)
|
(1,213,315)
|
TBS International
|
5,332,922
|
935,255
|
(761,224)
|
82,736
|
(157,705)
|
(66,626)
|
32,436
|
Aesop International
|
1,949,338
|
606,544
|
(268,092)
|
23,152
|
(72,056)
|
(55,219)
|
234,328
|
Corporate expenses
|
-
|
(731,889)
|
(278)
|
250,658
|
(210,192)
|
396,895
|
(294,806)
|
Consolidated
|
36,921,980
|
3,365,339
|
(2,718,856)
|
4,738,391
|
(5,773,810)
|
(274,744)
|
(663,678)
|
|
2019
|
|
Reconciliation to net income (loss) for the year
|
|
Net revenues
|
Performance assessed by the Company
|
Depreciation and amortization
|
Financial income
|
Financial expenses
|
Income tax
|
Net income (loss)
|
Natura &Co Latam
|
9,113,856
|
1,372,172
|
(370,953)
|
1,893,333
|
(2,613,294)
|
41,623
|
322,880
|
TBS International
|
4,028,660
|
806,357
|
(559,921)
|
44,953
|
(99,765)
|
(37,736)
|
153,888
|
Aesop International
|
1,302,174
|
351,944
|
(186,542)
|
9,337
|
(34,204)
|
(47,768)
|
92,768
|
Corporate expenses
|
-
|
(61,809)
|
-
|
8,161
|
(48,611)
|
(311,810)
|
(414,069)
|
Consolidated
|
14,444,690
|
2,468,664
|
(1,117,416)
|
1,955,784
|
(2,795,874)
|
(355,691)
|
155,467
|
|
2020
|
2019
|
|
Non-current assets
|
Total assets
|
Current liabilities
|
Non-current liabilities
|
Non-current assets
|
Total assets
|
Current liabilities
|
Non-current liabilities
|
Natura &Co Latam
|
20,228,016
|
27,644,907
|
12,410,585
|
9,060,600
|
4,574,087
|
9,328,858
|
3,116,454
|
8,235,678
|
Avon International
|
12,486,733
|
19,097,959
|
405,975
|
5,625,774
|
-
|
-
|
-
|
-
|
TBS International
|
7,821,884
|
10,474,191
|
2,291,459
|
1,812,991
|
6,146,960
|
7,369,250
|
1,065,447
|
1,477,149
|
Aesop International
|
1,395,628
|
2,148,869
|
488,662
|
618,531
|
1,033,408
|
1,435,830
|
255,616
|
590,917
|
Corporate
|
250,516
|
1,551,671
|
562,905
|
253,007
|
-
|
3,050,574
|
3,080,906
|
-
|
Consolidated
|
42,182,777
|
60,917,597
|
16,159,586
|
17,370,903
|
11,754,455
|
21,184,512
|
7,518,423
|
10,303,744
|
|
26.2
|
Revenue and non-current assets, by geographical area of operations
|
|
2020
|
2019
|
Net revenues
|
Natura &Co Latam
|
Avon International
|
TBS International
|
Aesop
International
|
Natura &Co Latam
|
TBS International
|
Aesop International
|
Asia
|
-
|
1,625,965
|
339,223
|
963,875
|
-
|
282,391
|
500,549
|
North America
|
4,050,130
|
-
|
775,398
|
295,425
|
770,635
|
768,311
|
212,011
|
Mexico
|
3,205,609
|
-
|
-
|
-
|
767,361
|
-
|
-
|
Other
|
844,521
|
-
|
775,398
|
295,425
|
3,274
|
768,311
|
212,011
|
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
South America
|
16,484,363
|
-
|
-
|
-
|
8,337,408
|
-
|
-
|
Brazil
|
11,113,810
|
-
|
-
|
-
|
6,321,751
|
-
|
-
|
Argentina
|
1,999,461
|
|
-
|
-
|
794,749
|
-
|
-
|
Other
|
3,371,092
|
-
|
-
|
-
|
1,220,908
|
-
|
-
|
Europe, Middle East and Africa (EMEA)
|
7,852
|
7,471,410
|
3,688,970
|
412,354
|
5,813
|
2,644,704
|
262,068
|
United Kingdom
|
-
|
967,487
|
2,933,031
|
217,181
|
-
|
1,979,096
|
138,604
|
Other
|
7,852
|
6,503,923
|
755,939
|
195,173
|
5,813
|
665,608
|
123,464
|
Oceania
|
-
|
-
|
529,331
|
277,684
|
-
|
333,254
|
327,546
|
Consolidated
|
20,542,345
|
9,097,375
|
5,332,922
|
1,949,338
|
9,113,856
|
4,028,660
|
1,302,174
|
No individual or aggregate customer
(economic group) represents more than 10% of the Company's revenues.
Non-current assets
|
2020
|
2019
|
Natura Holding
|
Natura &Co Latam
|
Avon International
|
TBS International
|
Aesop International
|
Natura &Co Latam
|
TBS International
|
Aesop International
|
Asia
|
-
|
-
|
244,184
|
232,849
|
291,845
|
-
|
140,760
|
227,670
|
North America
|
-
|
6,981,436
|
-
|
470,019
|
323,398
|
185,646
|
523,351
|
272,676
|
Mexico
|
-
|
703,608
|
-
|
-
|
-
|
183,250
|
-
|
-
|
Other
|
-
|
6,277,828
|
-
|
470,019
|
323,398
|
2,396
|
523,351
|
272,676
|
South America
|
250,516
|
13,236,399
|
-
|
-
|
-
|
4,378,676
|
-
|
-
|
Brazil
|
250,516
|
12,154,025
|
-
|
-
|
-
|
4,197,259
|
-
|
-
|
Argentina
|
-
|
259,227
|
-
|
-
|
-
|
63,050
|
-
|
-
|
Other
|
-
|
823,147
|
-
|
-
|
-
|
118,367
|
-
|
-
|
Europe, Middle East and Africa (EMEA)
|
-
|
10,181
|
12,242,549
|
6,614,038
|
236,411
|
9,765
|
5,105,903
|
190,442
|
United Kingdom
|
-
|
-
|
10,420,939
|
6,025,732
|
100,327
|
-
|
4,602,066
|
76,073
|
Other
|
-
|
10,181
|
1,821,610
|
588,306
|
136,084
|
9,765
|
503,837
|
114,369
|
Oceania
|
-
|
-
|
-
|
504,978
|
543,974
|
-
|
376,946
|
342,620
|
Consolidated
|
250,516
|
20,228,016
|
12,486,733
|
7,821,884
|
1,395,628
|
4,574,087
|
6,146,960
|
1,033,408
|
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
|
26.3
|
Reconciliation of recast operating segments
|
Due to the new presentation
and disclosure of the operating segments, as a result of the Avon acquisition in 2020 described above, the changes in the operating
segment information are as follows:
Presented in the financial statements of December 31, 2019
|
December 31, 2019
|
Non-current assets
|
Total assets
|
Liabilities
|
Non-current liabilities
|
Natura Brazil (a)
|
4,181,261
|
7,618,551
|
2,207,944
|
8,119,890
|
Natura LATAM (a)
|
349,698
|
1,592,912
|
774,521
|
105,423
|
Natura others (a)
|
12,161
|
18,126
|
8,591
|
1,558
|
Aesop (b)
|
1,035,432
|
1,442,214
|
274,539
|
592,531
|
The Body Shop (c)
|
6,175,903
|
7,462,135
|
1,171,922
|
1,484,342
|
Corporative
|
-
|
3,050,574
|
3,080,906
|
-
|
Consolidated
|
11,754,455
|
21,184,512
|
7,518,423
|
10,303,744
|
|
|
|
|
|
|
|
(a)
|
Amounts included in the new Natura &Co Latam segment.
|
|
(b)
|
Amounts related to Brazil and Latin America’s Aesop operations represented by non-current
assets (R$ 2,024), total assets (R$ 6,384), current liabilities (R$ 18,923) and non-current liabilities (R$ 1,614), included in
the new Natura &Co Latam segment.
|
|
(c)
|
Amounts related to Brazil and Latin America’s The Body Shop operations represented by non-current
assets (R$ 28,943), total assets (R$ 92,885), current liabilities (R$ 106,475) and non-current liabilities (R$ 7,193), included
in the new Natura &Co Latam segment.
|
Presented in the financial statements of December 31, 2019
|
December 31, 2019
|
Net revenues
|
Performance evaluated by the Company
|
Depreciation and amortization
|
Financial
income
|
Financial expense
|
Income tax
|
Net income (loss)
|
Natura Brazil (a)
|
6,260,779
|
1,269,761
|
(282,597)
|
1,845,246
|
(2,536,542)
|
(89,901)
|
205,967
|
Natura LATAM (a)
|
2,742,467
|
379,921
|
(60,918)
|
48,087
|
(70,237)
|
(70,992)
|
225,861
|
Natura other (a)
|
9,086
|
(46,199)
|
(14,010)
|
-
|
(202)
|
-
|
(60,411)
|
Aesop (b)
|
1,303,050
|
350,437
|
(186,657)
|
9,337
|
(34,392)
|
(47,768)
|
90,957
|
The Body Shop (c)
|
4,129,308
|
783,145
|
(573,234)
|
44,953
|
(105,890)
|
(41,812)
|
107,162
|
Corporate
|
-
|
(268,401)
|
-
|
8,161
|
(48,611)
|
(105,218)
|
(414,069)
|
Consolidated
|
14,444,690
|
2,468,664
|
(1,117,416)
|
1,955,784
|
(2,795,874)
|
(355,691)
|
155,467
|
|
a)
|
Amounts included in the new Natura &Co Latam segment.
|
|
b)
|
Amounts related to Brazil and Latin America’s Aesop operations represented by net revenues
(R$ 3,188), performance evaluated by the Company (R$ 902), depreciation and amortization (R$ 715), financial expenses (R$ 194),
net income (loss) of (R$ 1,812), included in the new Natura &Co Latam segment.
|
|
c)
|
Amounts related to Brazil and Latin America’s The Body Shop operations represented by revenues
(R$ 100,649), performance evaluated by the Company (R$ 131,106), depreciation and amortization (R$ 13,313), financial expenses
(R$ 6,126), income tax (R$ 4,076) and net income (loss) of (R$ 154,620), included in the new Natura &Co Latam segment.
|
|
Consolidated
|
Gross revenues:
|
2020
|
2019
|
Domestic market
|
15,373,742
|
8,907,766
|
Foreign market
|
31,784,934
|
10,739,036
|
Other sales
|
538,942
|
61,302
|
Subtotal
|
47,697,618
|
19,708,104
|
|
|
|
Returns and cancellations
|
(617,140)
|
(73,183)
|
Commercial discounts and rebates
|
(1,062,204)
|
(1,292,134)
|
Taxes on sales
|
(9,096,294)
|
(3,898,097)
|
Subtotal
|
(10,775,638)
|
(5,263,414)
|
Total net revenues
|
36,921,980
|
14,444,690
|
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
|
28
|
OPERATING EXPENSES AND COST OF SALES
|
Classified by function
|
Company
|
Consolidated
|
|
2020
|
2019
|
2020
|
2019
|
Cost of sales
|
-
|
-
|
13,229,715
|
4,033,454
|
Selling, marketing and logistics expenses
|
-
|
-
|
15,702,787
|
6,395,586
|
Administrative, R&D, IT and project expenses
|
92,301
|
-
|
5,955,996
|
2,405,576
|
Total
|
92,301
|
-
|
34,888,498
|
12,834,616
|
Classified by nature
|
|
|
|
|
Cost of sales
|
-
|
-
|
13,229,715
|
4,033,454
|
Raw material/packaging material/resale
|
-
|
-
|
11,222,801
|
3,457,481
|
Employee benefits expense (note 29)
|
-
|
-
|
638,525
|
293,374
|
Depreciation and amortization
|
-
|
-
|
215,355
|
57,443
|
Other
|
-
|
-
|
1,153,034
|
225,156
|
|
|
|
|
|
Selling, marketing and logistics expenses
|
-
|
-
|
15,702,787
|
6,395,586
|
Logistics costs
|
-
|
-
|
2,479,156
|
797,055
|
Employee benefits expense (note 29)
|
-
|
-
|
4,198,147
|
1,667,202
|
Marketing, sales force and other selling expenses
|
-
|
-
|
7,723,827
|
3,164,875
|
Depreciation and amortization
|
-
|
-
|
1,301,657
|
766,454
|
|
|
|
|
|
Administrative, R&D, IT and project expenses
|
92,301
|
-
|
5,955,996
|
2,405,576
|
Innovation expenses
|
-
|
-
|
270,256
|
89,675
|
Employee benefits expense (note 29)
|
71,463
|
-
|
2,498,024
|
1,223,586
|
Other administrative expenses
|
20,838
|
-
|
1,985,872
|
798,796
|
Depreciation and amortization
|
-
|
-
|
1,201,844
|
293,519
|
|
|
|
|
|
Total
|
92,301
|
-
|
34,888,498
|
12,834,616
|
|
Company
|
Consolidated
|
|
2020
|
2019
|
2020
|
2019
|
Payroll, profit sharing and bonuses
|
43,133
|
-
|
5,407,990
|
2,315,517
|
Pension Plan
|
-
|
-
|
186,373
|
93,528
|
Share-based payments (note 33.5)
|
12,394
|
-
|
163,345
|
58,855
|
Charges on restricted shares (note 33.5)
|
5,890
|
-
|
68,617
|
59,753
|
Health care, food and other benefits
|
1,448
|
-
|
684,992
|
253,510
|
Charges, taxes and social contributions
|
879
|
-
|
635,248
|
231,384
|
INSS
|
7,719
|
-
|
188,131
|
171,615
|
Total
|
71,463
|
-
|
7,334,696
|
3,184,162
|
The Board of Directors meets
annually to, within the bases of the plans approved by the General Meeting, establish share-based payment plans, indicating the
managers and employees who may receive options to purchase or subscribe the Company's shares and the total amount to be distributed.
The subsidiary Emeis Holdings
Pty Ltd., made available until June 2019 to eligible executives a long-term incentive program, based on criteria linked to specific
operational goals and objectives established and approved at the beginning of the relationship between the parties, being such
obligation recorded in liabilities and their remeasurement with effect in the result.
The share-based payment plans
were originally granted considering Natura Cosméticos shares that were traded at B3. However, as part of the corporate restructuring
(note 1), on December 18, 2019 the Company started to trade its own shares in replacement of Natura Cosméticos shares. As
a result, Natura Cosméticos shares originally granted were replaced on this date by the Natura &Co Holding's shares.
Such modification did not impact the executives and the respective plans.
Options
granted in 2020
On March 27, 2020, the Company’s
Board of Directors approved the new long-term stock-based incentive plans of the Company named “Co-investment Plan”
and “Long-term Incentive Plan” for 2020.
The “Co-Investment Plan”
consists of the granting of the Company’s common shares to a group of employees who may invest part of their participation
on the Profit Share Program (up to 50%) in the purchase of shares so
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
that the Company will assign the same number of shares as
the amount invested by the beneficiary. The rights of the participants regarding the Co-Investment Plan will only be fully acquired
to the extent that the participant remains continuously linked as an employee of the Company and its subsidiaries until the 3rd
anniversary of the grant date.
The “Long-Term Incentive
Plan”, granted on September 29, 2020, consists of the granting of the Company’s common shares to a group of employees
and, unless otherwise provided by the Company's Board of Directors, the rights of participants in relation to Performance shares
will only be fully acquired to the extent that (i) the participant remains continuously linked as an employee of the Company and
its subsidiaries until the 3rd anniversary of the grant date; and (ii) performance conditions are met. For certain participants,
there is a different condition for item (i) above, in which 50% of the Performance Shares granted will be acquired on the 3rd anniversary
of the grant date and the remaining 50% will be acquired on the 4th anniversary of the grant date.
The changes in the number of
outstanding stock options and their related weighted-average prices, as well as variations in the number of restricted stocks,
are as follows:
|
Stock Option Plan and Strategy Acceleration Plan
|
|
Average exercise price per option1 - R$
|
Options (thousands)1
|
Balance as at December 31, 2019
|
16.51
|
17,568
|
Arising from the acquisition of Avon (note 4)
|
0.01
|
1,994
|
Granted
|
0.01
|
117
|
Expired / Cancelled
|
21.25
|
(167)
|
Exercised
|
16.65
|
(2,267)
|
Balance as at December 31, 2020
|
16.49
|
17,245
|
|
Restricted shares
(thousands)1
|
Performance shares
(thousands)2
|
Balance as at December 31, 2019
|
3,092
|
688
|
Granted
|
5,026
|
-
|
Expired
|
(22)
|
(51)
|
Exercised
|
(1,136)
|
-
|
Balance as at December 31, 2020
|
6,960
|
637
|
|
a)
|
The number of restricted shares granted, expired and exercised are shown already considering the
stock split approved at the Extraordinary Shareholders Meeting held on September 17, 2019.
|
|
b)
|
The number of performance shares granted, expired and exercised are shown considering the split
of shares approved at the General Meeting on September 17, 2019.
|
Out of the 17,245 thousand options
existing as at December 31, 2020 (17,568 thousand options as at December 31, 2019), 3,405 thousand options (604 thousand options
as of December 31, 2019) can be exercised.
The expense related to the fair
value of the restricted options and shares, including the charges related to the restricted shares, recognized in the year ended
December 31, 2020, according to the elapsed period for the acquisition of the right to exercise the restricted options and shares,
amounted to R$ 231,939 on the consolidated (R$ 119,659 as of December 31, 2019).
The outstanding stock options
and the restricted stock as at the end of the period have the following maturity dates and exercise prices:
As of December
31, 2020 - restricted shares
Grant date
|
Conditions for acquiring the rights from grant date
|
Exercise price - R$
|
Fair value – R$
|
Existing options
(thousands) ¹
|
Remaining contractual life (years)
|
Vested options (thousands)
|
March 18, 2013
|
4 years of service
|
37.60
|
6.05
|
300
|
0.2
|
300
|
March 17, 2014
|
4 years of service
|
25.16
|
4.27
|
96
|
1.2
|
96
|
March 16, 2015
|
From 2 to 4 years of service
|
13.60
|
4.85 to 5.29
|
184
|
2.2
|
184
|
July 28, 2015
(Strategy acceleration)
|
From 4 to 5 years of service
|
12.90
|
6.20 to 6.23
|
1,020
|
2.6
|
1,020
|
March 15, 2016
|
From 2 to 4 years of service
|
12.84
|
7.16 to 7.43
|
184
|
3.3
|
182
|
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
July 11, 2016
(Strategy acceleration)
|
From 4 to 5 years of service
|
11.41
|
6.84 to 6.89
|
1,924
|
3.6
|
606
|
March 10, 2017
|
From 2 to 4 years of service
|
12.59
|
6.65 to 6.68
|
598
|
4.3
|
272
|
March 10, 2017
(Strategy acceleration)
|
From 4 to 5 years of service
|
12.59
|
6.87 to 6.89
|
2,210
|
4.3
|
-
|
March 12, 2018
|
From 2 to 4 years of service
|
16.96
|
7.96 to 8.21
|
1,846
|
5.3
|
488
|
March 12, 2018
(Strategy acceleration)
|
From 3 to 5 years of service
|
12.16 to 16.96
|
8.21 to 9.67
|
3,800
|
5.3
|
-
|
April 12, 2019
|
From 3 to 4 years of service
|
23.54
|
11.71 to 11.82
|
1,636
|
6.3
|
-
|
April 12, 2019
(Strategy acceleration)
|
From 4 to 5 years of service
|
23.54
|
11.51 to 11.71
|
1,900
|
6.3
|
-
|
Between December 31, 2002 to May 09, 2017
|
1 year of service
|
0.01
|
19.80
|
65
|
-
|
65
|
Between March 14 to December 17, 2018
|
From 1 to 3 years of service
|
0.01
|
19.70
|
319
|
0.4
|
55
|
Between March 13 to December 16, 2019
|
From 1 to 3 years of service
|
0.01
|
19.58
|
1,046
|
0.2 to 1.4
|
33
|
June 8, 2020
|
1 year of service
|
0.01
|
16.86
|
117
|
0.7
|
104
|
|
|
|
|
17,245
|
|
3,405
|
¹
The number of restricted shares and performance shares granted, expired and exercised are shown already considering the stock split
approved at the Extraordinary Shareholders Meeting held on September 17, 2019.
As of
December 31, 2020 – Restricted shares
Grant date
|
Conditions for acquiring the rights from grant date
|
Existing stock
(thousands) 1
|
Fair value (R$)
|
Remaining contractual life (years)
|
March 10, 2017
|
From 2 to 4 years of service
|
208
|
11.69 to 12.51
|
0.4
|
March 12, 2018 – Plan I
|
From 2 to 4 years of service
|
470
|
15.18 to 15.9
|
0.5 to 1.5
|
March 12, 2018 – Plan III
|
From 1 to 3 years of service
|
74
|
15.54 to 16.27
|
0.5
|
March 12, 2018 – Extraordinary Plan I
|
From 1 to 3 years of service
|
4
|
15.54 to 16.28
|
0.4
|
August 13, 2018 – Extraordinary Plan VI
|
From 1.6 to 3.6 years of service
|
50
|
12.24 to 13.13
|
0.5 to 1.5
|
April 12, 2019 – Plan I
|
From 2 to 4 years of service
|
814
|
21.62 to 22.53
|
0.5 to 2.5
|
April 12, 2019 – Plan II
|
From 1 to 3 years of service
|
312
|
22.14 to 22.85
|
0.5 to 1.5
|
March 27, 2020 – Co-Investment Plan
|
From 1 to 3 years of service
|
1,789
|
29.00
|
0.5 to 2.5
|
September 29, 2020 – Long-term Incentive Plan
|
From 3 to 4 years of service
|
3,239
|
73.46
|
3 to 4
|
|
|
6,960
|
|
|
¹
The number of restricted shares and performance shares granted, expired and exercised are shown already considering the stock split
approved at the Extraordinary Shareholders Meeting held on September 17, 2019.
As of December 31, 2020 –
Performance shares
Grant date
|
Conditions for acquiring the rights from grant date
|
Existing shares
(thousands) ¹
|
Fair value (R$)
|
Remaining contractual life (years)
|
Undelivered shares
(thousands)
|
May 21, 2019
|
From 3 to 4 years of service as from the grant date and fulfilment of the performance conditions
|
637
|
23.10 to 45.70
|
1.5 to 2.5
|
-
|
|
|
637
|
|
|
-
|
¹
The number of restricted shares and performance shares granted, expired and exercised are shown already considering the stock split
approved at the Extraordinary Shareholders Meeting held on September 17, 2019.
As of December 31, 2020, the
market price was R$ 52.50 per share, already considering the stock split (R$ 38.67 as of December 31, 2019).
29.2 Avon Products Inc. plans
Share-Based
Compensation Plans
Prior to being acquired by the
Company, Avon Products Inc. (“Avon”) had two share-based incentive plans, the 2013 Stock Incentive Plan (the “2013
Plan”) and the Omnibus Incentive Plan 2016 (the "2016 Plan"), both plans approved by the shareholders, which provided
for various types of share-based incentive compensation awards,
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
including stock options, restricted shares, restricted share units
and performance restricted share units. After the approval of the shareholders of the 2016 Plan in May 2016, there were no further
awards made in the 2013 Plan.
Stock options and restricted
shares were issued in the 2016 Plan, and units of restricted shares and units of restricted performance were issued in the 2013
and 2016 Plans. There were also outstanding stock options under prior shareholder-approved plans.
On January 3rd, 2020,
after the conclusion of the transaction with Natura &Co, equity compensation was either cancelled in exchange for the right
to receive an amount in cash or was converted into an award denominated in Natura &Co Shares. Subsequent to the Transaction,
Avon joined the Natura &Co Stock-Based Compensation Plan, so that the 2013 Plan and the 2016 Plan are no longer in effect.
Under the Natura &Co Stock-Based
Compensation Plan, Avon issued nominal cost options and performance stock units. Nominal cost options were granted in exchange
for Avon restricted stock units and performance restricted stock units and vested as a single tranche in line with the vesting
date of the original Avon awards. Nominal cost options will automatically exercise on vest date. Performance stock units generally
vest after three years, only upon the satisfaction of certain market and/or performance conditions.
Stock Options
Prior to being acquired by the
Company, Avon granted premium-priced stock options, in which the exercise price was equal to a 25% premium for both, respectively,
from the closing market price of Avon stock price at the date of grant. The premium-priced stock options vest on a three-year graded
vesting schedule and the fair value of each premium-priced stock option was estimated on the date of grant using a Monte-Carlo
simulation.
On January 3rd, 2020,
upon the completion of the Transaction with Natura &Co, each outstanding stock option, whether or not then vested or exercisable,
was automatically canceled in exchange for the right to receive an amount in cash, without interest, equal to the number of Avon
Common Shares underlying such stock option immediately prior to the effective time of the Transaction multiplied by the excess,
if any, of the per share cash-out price over the exercise price per share. The “per share cash-out price” was the closing
price of an Avon Common Share on the NYSE on the Transaction’s closing date. No amount was payed upon cancellation of stock
option with an exercise price per share that is greater than the per share cash-out price.
Restricted
Stock Units (RSU) and Performance Restricted Stock Units (PRSU)
Prior to being acquired by the
Company, during the years 2019, 2018, 2017 and 2016, Avon granted, performance restricted stock units that would vest and settle
after three years based on the relative total shareholder return of Avon common stock against companies included in the S&P
400 index as of the date of grant over a three year performance period ("2019 PRSUs", "2018 PRSUs", "2017
PRSUs" and "2016 PRSUs", respectively). The fair value of the PRSUs was estimated on the date of grant using a Monte-Carlo
simulation that estimates the fair value based on Avon's share price activity, expected term of the award, risk-free interest rate,
expected dividends and the expected volatility of the stock.
On January 3, 2020, upon the
completion of the Transaction with Natura &Co, each outstanding Restricted Stock Unit ("RSU") was converted into
an award denominated in Natura &Co Holding shares equal to the number of Avon Common Shares subject to each RSU immediately
prior to the Transaction multiplied by the Exchange Ratio of 0.30. In addition, each outstanding PRSU was converted into an award
denominated in Natura &Co Holding Shares, that is subject only to time-based vesting, equal to the number of Avon Common Shares
subject to each PRSU immediately prior to the Transaction, giving effect to market conditions that are deemed to be attained, multiplied
by the Exchange Ratios of 0.30. The terms and conditions, including service conditions but excluding market conditions, applicable
to each RSU and PRSU will continue in full force and effect with respect to the Company’s Nominal Cost Options.
29.3 Employee benefit plans
The Company and some of its
subsidiaries grant defined contribution retirement plans to eligible employees and, through some of their subsidiaries abroad,
grant defined benefit plans to employees that are eligible.
Defined
contribution plans
The Company, through its subsidiary
Avon, offers a defined contribution plan for employees in the United
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
Kingdom (“UK”), which allows eligible participants
to contribute eligible compensation through payroll deductions. The Company double employee contributions up to the first 5% of
eligible compensation and therefore the maximum level provided by Avon is 10% of eligible compensation. The Company made matching
contributions in cash to the UK defined contribution plan of R$39,200 in 2020, which follow the same investment allocation that
the participant has selected for his or her own contributions.
The Company, through its subsidiary
Avon, offers a qualified defined contribution plan for U.S.-based employees, the Avon Personal Savings Account Plan (the "PSA"),
which allows eligible participants to contribute up to 25% of eligible compensation through payroll deductions. Avon matches employee
contributions dollar for dollar up to the first 3% of eligible compensation and fifty cents for each dollar contributed from 4%
to 6% of eligible compensation. In 2020, Avon made matching contributions in cash to the PSA of R$5,200 in 2020, which follow the
same investment allocation that the participant has selected for his or her own contributions.
For U.S.-based employees hired
on or after January 1, 2015, Avon made additional contributions to a Retirement Savings Account ("RSA") within the PSA.
Such contributions will range from 3% to 6% of a participant's eligible compensation depending on the sum of the participant's
age and length of service (as of December 31 of the prior year). Investment of such contributions will follow the same investment
allocation that the participant has selected for his or her own contributions to the PSA. A participant will be vested in the RSA
generally after three full years of applicable service.
Defined
benefit pension and postretirement plans
The Company, through its subsidiary
Avon and certain subsidiaries, have contributory and noncontributory defined benefit retirement plans for substantially all employees
of those subsidiaries. Benefits under these plans are generally based on an employee’s length of service and average compensation
near retirement, and certain plans have vesting requirements.
The actuarial liability for
the health care plan of the Company and its subsidiaries refers to a post-employment benefit plan for employees and former employees
who made fixed contributions to the cost of the health plan until April 30, 2010, date when the design of the health plan was changed,
and the employees' fixed contributions were eliminated. For those who have contributed to the medical plan for ten years or more,
the right to maintenance is guaranteed as an indefinite (lifetime) beneficiary, and for those who have contributed for less than
ten years, the right to maintenance is guaranteed as beneficiary, at the rate of one year for each year of fixed contribution.
This group of current employees, in case of termination, may choose to remain on the plan in accordance with applicable legislation,
assuming the payment of the monthly fee charged by the health plan operators. However, this monthly fee does not necessarily represent
the user's total cost, which is assumed by the Company and its subsidiaries, based on the excess cost subsidy, as an of additional
benefit form.
Avon’s
largest defined benefit pension plan outside the United States (“US”) is in the UK, which has been frozen for future
accruals as of April 1st, 2013. The U.S. defined benefit
pension plan, the Personal Retirement Account Plan (the "PRA"), is closed to employees hired on or after January 1st,
2015, so that qualified retirement benefits for US-based employees hired on or after January 1st,
2015 will be provided solely through the PSA.
|
30
|
FINANCE INCOME (EXPENSES)
|
|
Company
|
Consolidated
|
|
2020
|
2019
|
2020
|
2019
|
FINANCE INCOME:
|
|
|
|
|
Interest on short-term investments
|
28,674
|
1,360
|
167,967
|
83,115
|
Gains on monetary and exchange rate variations (a)
|
126,677
|
6,801
|
1,886,940
|
854,025
|
Gains on swap and forward transactions (c)
|
31,787
|
-
|
2,532,487
|
961,185
|
Gains on swap and forward derivatives mark to market
|
-
|
-
|
12,314
|
1,709
|
Monetary adjustment reversal on provision for tax risks and tax obligations
|
-
|
-
|
42,378
|
25,469
|
Other financial income
|
4,441
|
-
|
96,305
|
30,281
|
Subtotal
|
191,579
|
8,161
|
4,738,391
|
1,955,784
|
|
|
|
|
|
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
FINANCE EXPENSES:
|
|
|
|
|
Interest on financing
|
(18,088)
|
(4,344)
|
(1,104,863)
|
(503,040)
|
Interest on leases
|
-
|
-
|
(229,544)
|
(134,579)
|
Losses on monetary and exchange rate variations (b)
|
(7,617)
|
(24,814)
|
(2,308,134)
|
(937,925)
|
Losses on swap and forward transactions (d)
|
-
|
-
|
(1,579,695)
|
(964,116)
|
Losses on swap and forward derivatives mark to market
|
-
|
-
|
(13,691)
|
(1,452)
|
Adjustment of provision for tax, civil and labor risks and tax liabilities
|
-
|
-
|
(15,626)
|
(13,822)
|
Appropriation of funding costs (debentures and notes)
|
-
|
(10,153)
|
(11,082)
|
(22,671)
|
Interest on pension plan
|
-
|
-
|
(10,323)
|
-
|
Hyperinflationary economy adjustment (Argentina)
|
-
|
-
|
(20,625)
|
(13,947)
|
Debt structuring expenses for Avon acquisition
|
(110,741)
|
-
|
(110,741)
|
(115,781)
|
Other financial expenses
|
(49,212)
|
(9,300)
|
(369,486)
|
(88,541)
|
Subtotal
|
(185,658)
|
(48,611)
|
(5,773,810)
|
(2,795,874)
|
Net finance income (expenses), net
|
5,921
|
(40,450)
|
(1,035,419)
|
(840,090)
|
The breakdown set forth below
is intended to better explain the results of the foreign exchange rate hedging transactions entered into by the Company as well
as its related items recorded in the financial income (expenses) and shown in the previous table:
|
Company
|
Consolidated
|
|
2020
|
2019
|
2020
|
2019
|
(a) Gains on monetary and exchange rate variations
|
31,532
|
6,801
|
1,791,795
|
854,025
|
Gains on exchange rate variation on borrowings, financing and debentures
|
-
|
-
|
714,681
|
677,462
|
Exchange rate variation on imports
|
-
|
-
|
35,218
|
11,221
|
Exchange rate variation on export receivables
|
-
|
-
|
69,365
|
26,144
|
Exchange rate variation on accounts payable from foreign subsidiaries
|
31,532
|
-
|
450,468
|
132,397
|
Exchange variations of bank accounts in foreign currency
|
-
|
6,801
|
522,063
|
6,801
|
|
|
|
|
|
(b) Losses on monetary and exchange rate variations
|
(7,617)
|
(24,814)
|
(2,308,134)
|
(937,925)
|
Losses on exchange rate variation on borrowings, financing and debentures
|
-
|
-
|
(1,301,812)
|
(768,939)
|
Exchange rate variation on imports
|
-
|
-
|
(58,623)
|
(33,718)
|
Exchange rate variation on export receivables
|
-
|
-
|
(55,829)
|
(23,393)
|
Exchange rate variation on accounts payable from foreign subsidiaries
|
-
|
-
|
(365,214)
|
(86,764)
|
Exchange rate variation on financing
|
-
|
-
|
(525,173)
|
(297)
|
Exchange variations of bank accounts in foreign currency
|
(7,617)
|
(24,814)
|
(1,483)
|
(24,814)
|
|
|
|
|
|
(c) Gains on swap and forward transactions
|
31,787
|
-
|
2,532,487
|
961,185
|
Revenue from swap exchange coupons
|
-
|
-
|
207,783
|
182,897
|
Gains from exchange variations on swap instruments
|
31,787
|
-
|
2,324,704
|
778,288
|
|
|
|
|
|
(d) Losses on swap and forward transactions
|
-
|
-
|
(1,579,695)
|
(964,116)
|
Losses on exchange rate variation on swap instruments
|
-
|
-
|
(691,941)
|
(690,409)
|
Financial costs of swap instruments
|
-
|
-
|
(869,890)
|
(273,707)
|
Loss on interest rate swap
|
-
|
-
|
(17,864)
|
-
|
|
31
|
OTHER OPERATING INCOME (EXPENSES), NET
|
|
Company
|
Consolidated
|
|
2020
|
2019
|
2020
|
2019
|
Other operating income, net
|
|
|
|
|
Result on write-off of property, plant and equipment
|
-
|
-
|
11,855
|
6,098
|
ICMS-ST (a)
|
-
|
-
|
18,653
|
42,336
|
Proceeds from the sale of customer portfolio (b)
|
-
|
-
|
-
|
23,092
|
Tax Credits
|
-
|
-
|
105,234
|
-
|
PIS/COFINS credits (c)
|
-
|
|
-
|
42,983
|
Base PIS/COFINS excluding ICMS (d)
|
-
|
-
|
-
|
52,631
|
Other operating income
|
-
|
-
|
10,757
|
-
|
Total other operating income
|
-
|
-
|
146,499
|
167,140
|
|
|
|
|
|
Other operating expenses, net
|
|
|
|
|
Crer para Ver (e)
|
-
|
-
|
(54,500)
|
(36,156)
|
Expense on the sale of customer portfolio
|
-
|
-
|
(7,498)
|
-
|
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
Expenses related Avon acquisition (f)
|
(171,013)
|
-
|
(303,916)
|
(141,348)
|
Transformation and integration plan (g)
|
-
|
-
|
(256,700)
|
(51,520)
|
Taxes contingencies
|
-
|
-
|
(10,100)
|
21,402
|
Other operating expenses
|
(24)
|
-
|
(29,975)
|
(8,829)
|
Total other operating expenses
|
(171,037)
|
-
|
(662,689)
|
(216,451)
|
Other operating income (expenses), net
|
(171,037)
|
-
|
(516,190)
|
(49,311)
|
|
a)
|
Refers to the requirement of ICMS tax substitution, for different
Federal States (details in note 23). During 2020, provision reversals were made due to the change in the loss estimate for some
Federal States.
|
|
b)
|
Refers to revenue from the recurring sale of the portfolio of customers overdue for more than 180
days, net of legal costs with lawsuits filed by debtors against the company acquiring the portfolio. The proceeds for the sale,
as well as the reimbursement of the legal costs, are received after the overdue receivables are written-off due to the sale.
|
|
c)
|
Tax credits from prior periods related
to the change on PIS and COFINS taxation in 2019.
|
|
d)
|
The Company and its subsidiaries are discussing in court the non-inclusion of ICMS in the basis
for calculating contributions to PIS and COFINS. The impact in 2020 refers to processes under discussion that have been closed,
for which the asset has been recognized.
|
|
e)
|
Allocation to Natura Institute of operating profit from sales of the non-cosmetic product line
“Crer Para Ver”, specifically allocated to social projects aimed at the development of education quality.
|
|
f)
|
Refers to expenses related to the Avon acquisition process, of which the following stand out: financial
structuring expenses (R$ 115,696), legal expenses (R$ 17,281), regulatory expenses (R$ 18,030) and executive compensation plans
(R$ 152,909).
|
|
g)
|
Expenses related to the implementation of the TBS transformation and integration Avon plan, which
is based on five pillars, namely: (1) renewal of the brand; (2) optimization of retail operations; (3) improvement of omni-channel;
(4) improvement of operating efficiency; and (5) organization redesign.
|
The basic earnings per share
are calculated by dividing the profit (loss) attributable to holders of Company by weighted average number of ordinary shares outstanding,
excluding common shares purchased by the Company and held as treasury shares.
|
Consolidated
|
|
2020
|
2019
|
Net income (loss) attributable to owners of the Company
|
(650,196)
|
155,467
|
Weighted average number of issued shares (a)
|
1,246,180,219
|
865,660,042
|
Weighted average number of treasury shares (a)
|
(572,130)
|
-
|
Weighted average number of outstanding shares
|
1,245,608,090
|
865,660,042
|
Basic earnings (loss) per share - R$ (b)
|
(0.5220)
|
0.1796
|
|
(a)
|
The number of shares and earnings per share already consider the stock split on September 17, 2019
and its retrospective effect.
|
|
(b)
|
As at December 31, 2020, the basic earnings (loss) per share is equal to the diluted one, due to
the loss for the year.
|
Diluted earnings per share are
calculated by adjusting the weighted average number of common shares outstanding, assuming the conversion of all potential common
shares that would cause dilution. The Company has stock options, restricted shares and strategy acceleration that would have a
dilutive effect on any earnings per share. Considering that in the year ended December 31, 2020, the Company recorded a loss, any
adjustment would have an anti-diluting effect and, therefore, the diluted earnings per share for the year ended December 31, 2020
are equivalent to the basic earnings per share.
Diluted earnings per share for
the year ended on December 31, 2019 are presented below:
|
Consolidated
|
|
2019
|
Net income attributable to the Company’s controlling shareholders
|
155,467
|
Weighted average number of issued shares (a)
|
865,660,042
|
Adjustment for stock options and restricted shares(a)
|
8,124,575
|
Weighted average number of ordinary shares for diluted earnings calculation
|
873,784,617
|
Diluted earnings per share - R$
|
0.1779
|
|
(a)
|
The number of shares and earnings per share already consider the stock split on September 17, 2019
and their retrospective effects.
|
The basic earnings per share
for net loss of discontinued operations for the year ended December 31, 2020 are presented below:
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
|
Consolidated
|
|
2020
|
Net loss attributable to the Company’s controlling shareholders
|
(143,112)
|
Weighted average number of issued shares (a)
|
1,246,180,219
|
Weighted average number of treasury shares (a)
|
(572,130)
|
Weighted average number of outstanding shares
|
1,245,608,090
|
Basic loss per share - R$ (b)
|
(0.1149)
|
|
(a)
|
The number of shares and earnings per share already consider
the stock split on September 17, 2019 and its retrospective effect.
|
|
33
|
RELATED-PARTY TRANSACTIONS
|
In the course of the Company's
operations, rights and obligations are generated between related parties, arising from administrative expenses and provision of
services.
|
33.1
|
Receivables and payables with related parties
|
The Company had transactions
with related parties recognized as presented below:
|
Company
|
|
2020
|
2019
|
Current assets:
|
|
|
Natura Cosméticos S.A. (a)
|
108,953
|
-
|
Natura Cosméticos S.A. – Argentina (b)
|
1,870
|
-
|
The Body Shop International (b)
|
2,490
|
-
|
Aesop HK (b)
|
300
|
-
|
Aesop UK (b)
|
1,913
|
-
|
Aesop USA (b)
|
276
|
-
|
Emeis cosmetics (b)
|
150
|
-
|
Total current assets
|
115,952
|
-
|
|
|
|
Current liabilities:
|
|
|
Natura Cosméticos S.A. (b)
|
5,673
|
-
|
Indústria e Comércio de Cosméticos Natura Ltda. (b)
|
1,521
|
-
|
Total current liabilities
|
7,194
|
-
|
|
(a)
|
Refers to interest on equity.
|
|
(b)
|
Refers to the allocation of expenses related to the stock option and restricted stock plans.
|
|
33.2
|
Transactions with related parties
|
In the year ended December 31,
2020, Natura &Co reimbursed the amount of R$ 148,274 of expenses regarding the transaction costs for the acquisition of Avon
paid by its subsidiary Natura Cosméticos. This reimbursement was registered in the profit or loss line item “Other
revenues (expenses)”. For the other transactions, they were not carried forward as income statement, as they refer to the
transfer of expenses related to stock option plans and restricted shares.
|
33.3
|
Transactions with uncontrolled and unconsolidated related parties
|
Natura Institute holds shares
in the investment fund “Fundo de Investimento Essencial”. As at December 31, 2020, the balance is R$ 3,414 (R$ 3,766
on December 31, 2019).
On June 5, 2012, an agreement
was entered between Indústria e Comércio de Cosméticos Natura Ltda., and Bres Itupeva Empreendimentos Imobiliários
Ltda., (“Bres Itupeva”), for the construction and leasing of processing center to distribution and warehousing of products
(HUB), in Itupeva (SP). In 2019, the Bres Itupeva
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
granted its credits to BRC Securitizadora S/A, to which Natura makes monthly
payments. Messrs. Antônio Luiz da Cunha Seabra, Guilherme Peirão Leal and Pedro Luiz Barreiros Passos, members of
the group of controlling shareholders of Natura Cosméticos S.A., indirectly hold controlling interests in Bres Itupeva.
The amount involved in the registered transaction is recorded under “Right of Use” of "Buildings" in the
amount of R$ 39,346 (R$ 44,244 under “Builds” of Property, Plant and Equipment as at December 31, 2019) ) and in the
year ended December 31, 2020, the total amount paid as rent was R$ 13,086 (R$ 13,038 for the year ended December 31, 2019).
Natura
Cosméticos S.A. and Raia Drogasil S.A. entered into a purchase and sale agreement and other covenants for selling products
in Raia and Drogasil. Mr. Guilherme Peirão Leal and Mr. Pedro Luiz Barreiros Passos, members of the Natura Cosméticos
S.A. controlling group, indirectly hold shareholding interest in Raia Drogasil S.A. This contract was finalised during the financial
year 2020.
In the year ended December 31,
2020, Natura Cosméticos S.A. and its subsidiary transferred to the Natura Institute, in the form of a donation associated
with maintenance, the amount of R$ 692 corresponding to 0.5% of net income for the prior fiscal year, and a donation associated
with the net sales of products in the Natura Crer Para Ver line, in the amount of R$ 35,000 (R$ 23,000 as at December 31, 2019).
The Company and its subsidiaries
have a structure of internal controls to support the identification, monitoring and approving of transactions between Related Parties
|
33.4
|
Key management personnel compensation
|
The total compensation of the Company’s Management
is as follows:
|
2020
|
2019
|
|
Compensation
|
Compensation
|
|
Fixed
|
Variable
|
Total
|
Fixed
|
Variable
|
Total
|
|
(a)
|
(b)
|
(a)
|
(b)
|
Board of Directors
|
16,123
|
65,011
|
81,134
|
22,056
|
30,919
|
52,975
|
Executive Board
|
49,187
|
80,218
|
129,405
|
32,963
|
42,142
|
75,105
|
|
65,310
|
145,229
|
210,539
|
55,019
|
73,061
|
128,080
|
|
a)
|
The line item “Executive Board” includes the amount of R$ 1,201 referred to the amortization
of the Confidentiality and Non-Compete Agreement during the fiscal year ended December 31, 2020 (R$ 536 in the fiscal year ended
December 31, 2019).
|
|
b)
|
Refers to profit sharing regarding the Restricted Stock Plan and Strategy Acceleration Program,
including charges, as applicable, to be determined in the year. The amounts include additions to and/or reversals of provisions
made in the previous year, due to final assessment of the targets determined to the board members and officers, statutory and non-statutory,
in relation to profit sharing.
|
|
33.5
|
Share-based payments
|
Breakdown of the Company officers and executives’
share-based payments compensation:
|
Grant of options
|
|
2020
|
2019
|
|
Stock option balance (number)1 (a)
|
Average fair value of stock options1 – R$
|
Average exercise price1 - R$ (b)
|
Stock option balance (number) 1 (a)
|
Average fair value of stock options1 – R$
|
Average exercise price1 - R$ (b)
|
Officers
|
12,847,760
|
8.64
|
16.49
|
13,059,677
|
8.40
|
16.51
|
|
|
|
|
|
|
|
|
|
Restricted shares
|
|
2020
|
2019
|
|
Stock option balance (number)1 (a)
|
Average exercise price1 - R$ (b)
|
Stock option balance (number)1 (a)
|
Average exercise price1 - R$ (b)
|
Officers
|
5,293,874
|
51.20
|
1,012,641
|
19.23
|
|
|
|
|
|
|
|
(1)
|
The number of stock options granted, expired and exercised and their respective fair values is
shown already considering the stock split approved at the Extraordinary Shareholders Meeting held on September 17, 2019.
|
|
(2)
|
The number of restricted stock and performance shares granted, expired and exercised is shown already
considering the stock split approved at the Extraordinary General Meeting on September 17, 2019.
|
|
(a)
|
Refers to the balance of the options and restricted shares vested and non-vested, not exercised,
at the reporting dates.
|
|
(b)
|
Refers to the weighted-average exercise price of the option at the time of the stock option plans,
adjusted for interest based on the Extended Consumer Price Index (IPCA) through the end of the reporting period. The new Stock
Option Plan implemented in 2015, include no monetary adjustment.
|
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
|
34.1
|
Contracts related to supply of inputs
|
The subsidiary Indústria
e Comércio de Cosméticos Natura Ltda., has commitments arising from electric power supply agreements, with physical
delivery, for its manufacturing activities, as described below:
|
Ø
|
Agreements started in 2019 and effective up to 2022, with the value of Megawatts/h between R$ 155
and R$ 305.
|
|
Ø
|
Agreements started in 2020 and effective up to 2022, with the value of Megawatts/h between R$ 204
and R$ 238
|
The amounts are carried based
on electric power consumption estimates in accordance with the contract period, whose prices are based on volumes, also estimated,
resulting from the subsidiary’s continuous operations.
Total minimum supply payments,
measured at nominal value, according to the contract, are:
|
2020
|
2019
|
Less than one year
|
1,413,904
|
17,918
|
One to five years
|
885,990
|
13,160
|
Total
|
2,299,894
|
31,078
|
The Company and its subsidiaries
have in place an insurance policy that considers principally risk concentration and materiality, taking into consideration the
nature of its activities and the guidance of its insurance advisors. As at December 31, 2020, insurance coverage is as follows:
Item
|
Type of coverage
|
Amount insured
|
2020
|
2019
|
Industrial complex and administrative sites
|
Any damages to buildings, facilities, inventories, and machinery and equipment
|
3,062,806
|
2,322,801
|
Vehicles
|
Fire, theft and collision for the Company and subsidiaries vehicles
|
232,459
|
212,027
|
Loss of profits
|
No loss of profits due to material damages to facilities buildings and production machinery and equipment
|
1,894,813
|
1,582,000
|
Transport
|
Damages to products in transit
|
46,019
|
32,309
|
Civil liability
|
Protection against error or complaints in the exercise of professional activity that affect third parties
|
730,740
|
532,510
|
Environmental liability
|
Protection against environmental accidents that may result in environmental lawsuits
|
30,000
|
30,000
|
NATURA &CO HOLDING S.A.
NOTES TO THE INDIVIDUAL AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED DECEMBER 31, 2020
(Amounts in thousands of Brazilian reais - R$, unless otherwise stated)
|
36
|
ADDITIONAL INFORMATION RELATING TO THE STATEMENTS OF CASH FLOWS
|
The following table presents additional information
on transactions related to the cash flow statement:
|
Company
|
Consolidated
|
|
2020
|
2019
|
2020
|
2019
|
Non-cash items
|
|
|
|
|
Hedge accounting, net of tax effects
|
-
|
-
|
116,348
|
70,569
|
Dividends and interest on equity declared and not yet paid
|
-
|
-
|
-
|
110,671
|
Net effect of acquisition of property, plant and equipment and intangible assets not yet paid
|
-
|
-
|
172,104
|
(18,645)
|
Consideration for acquisition of subsidiary
|
13,366,114
|
-
|
13,366,114
|
-
|
Contract with Bresco IX Empreendimentos
Imobiliários Ltda.
On January 8, 2021, the subsidiary
Natura Cosméticos signed a build-to-suit construction and lease agreement with the related party Bresco IX Empreendimentos
Imobiliários Ltda. (“Bresco IX”) for the build-to-suit construction of a distribution center in the city of
Murici, Federal State of Alagoas, for a later lease. The lease agreement foresees a total investment of R$ 113,742 and the lease
term is expected to be 15 years.
Bresco IX's hiring process followed
market values and all hiring requirements, as well as governance policies and procedures of the Company and its subsidiaries.